var title_f5_21_5456="Flexion point fetal skull";
var content_f5_21_5456=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F69870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F69870&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Flexion point in relation to fetal skull landmarks",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 364px; height: 418px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The flexion point is the location on the fetal head where outward traction pulls the head so as to allow flexion at the neck while keeping the mentovertical diameter in the direction of the birth canal. In the normally molded fetal head, the flexion point is in the midline, over the sagittal suture, approximately 6 cm from the anterior fontanelle and 3 cm from the posterior fontanelle. Since most of the commonly used vacuum cups have a diameter between 50 and 70 mm, when the center of the cup is placed over the flexion point, the edges of the cup should be approximately 3 cm from the anterior fontanelle and just at the edge of the posterior fontanelle. The anterior fontanelle is the reference point for checking the application because access to the posterior fontanelle is partially blocked once the extractor cup is in place.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Modified from: O'Grady, PJ, Gimovsky, ML, McIIhargie, CJ. Vacuum Extraction. Modern Obstetric Practice 1995; 63.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5456=[""].join("\n");
var outline_f5_21_5456=null;
var title_f5_21_5457="Pheo surgical specimen";
var content_f5_21_5457=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F86207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F86207&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 533px\">",
"   <div class=\"ttl\">",
"    Pheochromocytoma: Surgical specimen",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 513px; height: 185px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAC5AgEDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6B+IPjSy8D6XaX2o2l9drdXQtI47NUL7yjvk73UYxG3f0rh/+F9aL/wBC54k/74tP/kil/aZ/5Fjw5/2Gl/8ASW5rgPhp4C0zxXoGv6xreuarp8OnXjQ4tTAI0iW3hkLHfExzl279McVtGEOTmlfc83EYjEfWPYUOX4b63726Hf8A/C+tF/6FzxJ/3xaf/JFJ/wAL70T/AKFzxJ/3xa//AB+uL+F/g3wV8SdNvL3QvEHjCEWkwhlhuxZJIMrlWwsLDaecc9jxXmWjTSXGj2M8zbpJYEd2xjJKgk1pTpU6jsrnHjMbjcHFSmou/a59A/8AC+tF/wChc8Sf98Wv/wAfo/4X3on/AELniX/vi1/+P14VSGtfqsO7PP8A7exP8sfuf+Z7t/wvvRP+hc8Sf98Wn/yRR/wvvRB/zLniT/vi1/8Aj9eE+tHSj6rDuw/t/Efyx+5/5nu3/C+9E/6FzxJ/3xa//JFH/C+9E/6FzxJ/3xa//H68Jxzz2oo+qx8w/t/E/wAsfuf+Z7t/wvzRP+hc8S/98Wv/AMfo/wCF96J/0LniT/vi1/8Aj9eE9+lJjjqaPqsO4f2/iP5Y/c/8z3f/AIX5on/Qu+JP++LX/wCP0n/C/dD/AOhd8Sf98Wv/AMfrwjHHrSNj0pfVodw/t/Efyx+5/wCZ7x/wv3Q8/wDIu+JP++LX/wCP0n/C/dD/AOhd8S/98Wv/AMfrwfjB4pOgo+rQ7j/t7Efyx+5/5nvX/C/dD/6F3xJ/3xa//H6T/hf2hjP/ABTviX/vi1/+P14MqliAD1pZU8uNmGXKkbsdBn3rCqqNL42d2ExuYYy/saadvX/M94/4X9oX/Qu+JP8Avi1/+P0n/C/9C/6F3xL/AN8Wv/x+vnadb+4t2ks0VQvTOCTUCSaoLVDJZmSbBy0ZG1sc8Z6HHaslVoNtXPSq0M2pRUnTTv2v/mfSP/C/tC6f8I74k/74tf8A4/Sf8L/0L/oXfEv/AHxa/wDx+vmLTNdS6d1kV4pUOGRxhl/CtSO9Rh96towpy2Z5NXM8ZSlyzgr+j/zPon/hf+hf9C94k/74tf8A4/R/wv8A0H/oXvEn/fFr/wDH6+e0mDDIP5U/GQcdav2EWYvO8Qt4r8f8z6A/4aB0H/oXvEv/AHxa/wDx+j/hoHQf+he8Sf8AfFr/APH6+fyOOeabjDdKPYRD+3K/Zfj/AJn0F/w0DoH/AEL3iT/vi1/+P0f8NA6D/wBC94l/74tf/j9fPf8AFkelHf2o9hEP7br9l+P+Z9CH9oHQQM/8I94kx/1ztf8A4/Sf8NBaB/0L3iT/AL92v/x+vnxjnFIR6UnQiP8Atuv2X4/5n0H/AMNB+H8/8i/4k/792v8A8frW8JfGfRPE/ibT9EtdI1u1ub1nSOS5SARgrG8hyUlY9Ebt1xXzIRXW/B0Y+LnhL/r4uP8A0jnqJUklc6MLmtatVjTklZ+v+Z7/AOOfijpng/X10i70rV725Nsl2Ws1hKKju6gEySoc5jboPSsH/he+j/8AQt+JP++bT/5Irjfjv/yVM/8AYGtP/R91WXF4U0S00DwJLqF/4xvtY8U2cc0Nvpv2AKJPJSRxmVFCj5+MsenWmoU1BSlfU6ZYnGVMRUo0OW0Lb36q/Q9G/wCF7aP/ANC34k/75tP/AJIo/wCF7aP/ANC34k/75tP/AJIrzfUfDWhT/DCbxh4c1nxI5hvYLU22pLagAm6jhkVhHFzwxwVbr3rm+/1rWlQpVVdXPPx2aY7BSUaig79r/wCaPbP+F7aPj/kW/En/AHzaf/JFL/wvXSP+hb8S/wDfNp/8kV4ljsaMce9a/U4d2cP+seJ/lj9z/wAz2z/he2j/APQt+JP++bT/AOSKP+F7aP8A9C34k/75tP8A5IrxMrzxQRgYo+pw7sP9Y8T/ACx+5/5ntn/C9tH/AOhb8S/982n/AMkUf8L20f8A6FvxJ/3zaf8AyRXieOKF6dKX1OHdj/1jxP8ALH7n/me2f8L20f8A6FvxJ/3zaf8AyRQfjvo46+G/Ev8A3zaf/JFeJnpScYo+pw7sP9Y8T/LH7n/me2f8L30b/oW/Ev8A3zaf/JFH/C99H/6FvxJ/3zaf/JFeJkDtSHij6pDuw/1jxP8ALH7n/me2j476Of8AmW/En/fNp/8AJFH/AAvfR/8AoW/Ev/fNp/8AJFeIkYP1pMcml9Uh3Y/9YsT/ACx+5/5nt/8AwvjRv+hb8S/982n/AMkUn/C+dG/6FzxJ/wB82n/yRXiGeKD0o+qQ7sP9YsT/ACx+5/5nuH/C+NG/6FzxL/3zaf8AyRR/wvjRv+hb8S/98Wn/AMkV4Y2ARkjPpRj8hS+qw7sr/WHE/wAsfuf+Z7l/wvnRf+hc8Sf98Wn/AMkUf8L50X/oXPEn/fNp/wDJFeGd+KDR9Vh5h/rDif5Y/c/8z3P/AIX1ov8A0LniT/vi0/8Akij/AIX1ov8A0LniX/vi1/8AkivCzSUvq0O7D/WHE/yx+5/5nuv/AAvnRf8AoXPEv/fNr/8AJFJ/wvrRf+hc8Sf98Wn/AMkV4XRR9WgP/WDE/wAsfuf+Z7p/wvrRf+hc8Sf98Wn/AMkUf8L60X/oXPEv/fFr/wDJFeFGlo+rR7h/rBif5Y/c/wDM90/4X3on/QueJP8Avi0/+SKP+F96J/0LniT/AL4tf/j9eEnrR/Sl9WiH+sGJ/lj9z/zPdv8Ahfeif9C54k/74tf/AI/XWfDz4h6d45uNSg0/T9SspbBYXkW9WIbhIZApXy5H/wCebZzjtXy3ivXP2Zf+Q94v/wCvaw/9CuqyqUlCN0ehl2bVsVW9nNK1ul/8z3yiiiuc+gPIP2mP+RY8Of8AYZX/ANJLmuO8A6DrPij4OeNdD8O3Npa3d/rHkSTXLMqrCba18zG1SSSuRj3PNdj+0v8A8ix4c/7DI/8ASS5r5/n0qwuZmluLG1llb7zyQqzHtySK6qVN1KVl3PBxuMjg8aqklf3bfifRXgT4Zah4H+IUupaVqi3fh+70yKzuorrYk4lhAWJlWKNUKhAF555JOa+cPD3/ACANN/69Yv8A0AUp0TSs/wDIMsf/AAHT/Cr0caRxpHGiqigKqqMAAdgK3o0XTbbZ5mZZlHGRjGMbWCg/ypetHStzxxPrS9qUAY5pCPlp2EJiijnHFA/WkAhoFL2oFACEU0jP4U6kwM0hoaR701yqLluKlCM2doLH0FOkt2MfTEikZ7/XFcGMxscPotz6LI8hqZnPmlpBdf8AISw3XS+SkQE8jfKHOMKB1NWjp0qaA/zLJI7lm2cADt1qSwtyr52I7EFWDjIORjNd3DpyW1ilqybgyhpJNvBDDg57YIrxVKWIk5SZ+jUMFTwMY06S0RyPga1tHTfNcRiQ5X5xhUI/hOe5HIx70zxBaqJ7trFUitSSSiOdpOMcZ55rCbFlqs8T48vd6kAEH29uKu21358pjEe2InKoWyM+tTUlpoj1YUpXc2cRr/hOa+uGvraR4rqQBiwPB9OBXFXFxq+mTBbgygKcDeMq3417ldxLFbqhwyjoecg+lczrenRzRHdGpRh8yHmtKOJd+WR5eMy2jiE5xVmcz4e11LlArkLKPvKT/KurglWQDHeuGufCuJFewmMTA87jnH0raiafTFgSSQ3hYYLouNv1zXp0sQk7M+JzLh6tG9SlH+vI6PjHFJjHPesq21u2kmELOI5D/C/BP51qAhgOe3au2MlLY+Yq0KlF8tRWEH6+tISRgU9h0+lNYcYPemzMQEkdjTeccUrZFKvrxxxSGNPHX6V1vwd/5K54S/6+Lj/0juK5PgDnFdZ8Hv8AkrvhL/r4uP8A0juKzqfCzsy//eYep1/x2/5Km3/YFtP/AEfdVst4Gv8Axb4J+EF/Z2ejaha6PpkMtzY6pIyR3Ae2iAHEUg4IzyvpWN8dv+SqN/2BbT/0fdV5p/YWkf8AQKsP/AdP8KqNB1aUbPa52VszjgMdW5o35uX8F/wT17xF4Sv/AAd8CtestTubd3uNZtruK2tSzQWUb3tvtgiLAEquPQdenr5n35qhFoulwypJHptkjoQyssCAqR0IOKvmuihRdJNNnj5rmEcdOMoq1kJzmg57UuaWtzyhKXHSikpiE79KD0pQPfNBHYikMaaCOlOI4xSdvekFxvA5oI7UcDmndqB3Iz97mk796cw45pvQ+1JlITjJyKp6ldi3t22svmHoCa04LZ7oShDhkXeBxz69faucuLASTST7GIPQnvXm4zGqk3TW59jw7wzPMFHFTa5E9ursYWmarLceKfszTlo4YgpyerV3CHK8dDXk3ieCTTNWivYEZAThyDwT/wDXFd/4f1eC/tEaNwTjkelPCVk1ZnPxFlrw9XmgrLY2SOaQ9qdlSOtBHPNd58wMYU3H5U/6UhHFKw7jaBTj9KOfxpWGNpDTj1pPTNIYg6e9J25pQOtJSGIeleufszca94u/69rD/wBDuq8jPTivXP2Zv+Q/4v8A+vaw/wDQrqsK/wAB7GR/70vRnvdFFFcJ9oeQftMf8ix4c/7DK/8ApJc14Zyele6ftL/8iz4c/wCwyP8A0kua8L4r0MJ8D9T5LPv94j/hX5sbS49eKcPbmk5yc10ni2ENHenFaguZkgBzln6hB/X0qJ1IwV5Ox0YbCVsVNU6MXJ+RLijpVH7VcOrGONVUe24ilS+dTieLnH3l7/hXKsfRbtc9urwlmNOHPyJ+SepcPWjPSqMt8NvEcg/I1HHeludpx9Kv63Sf2jjlw/mEfipM0sc0n0qoL1BjccGpPtcWPmYA1pGtCWzOKrl+Io/xINfInoOAOSOmTTIpUkOFIJqG5kDL5a/iT3rPEYmNKN76nblGTVsxxEaUVp1fZFzSpWmmIxtTORj0961kBO4iMnnqKzdKlhhXpubuM9TWxbXL24dzGrIBnHQAY9a+UqN1ZuUj9gWFhhoKlRjaK2ItOnRdQxPG3yOM7evrXpYm03U7OaVXLeWcKhVvNVcfdIzjG4cfWvN7zzbi+t1aKGKWKPyzGmdxB+ZXJ753dfapo7u60q8aeG4Yuy7SckA/h3rqpVFT917HPiKXM01ozmfGiiHXbnyVbyllzzwSO/Sr9jp6f2bHc5Ys3OAelX9esrXUEWdS0bkYZB61zOkX81oJbZpFZY3KYPp61M/eTSOqE3K0YP8ApG1M6kKFmDA9dwzWHqsWZcRsWx95iMAVq3U0CqAXRe+A3Ws7UZoXwY3UgccGsad73JS5pJJmQExle5p6RqoIYdelW40hiDvI2XxkA96rQsrqMnac966ea5TtF2aKN5p1vOR5kauBzgjvTIo7qyfdbSGWAf8ALGU5/Ju1ahjwcEg1Pb2xlyACWxwK0jWcNUzmxOWYfGQaqxTRTt9QSWLdKrQOOCj44/H0qysisoZGDKe46UuqWvl24DxoGPcVzosri0kaXTZfLJ5aNuYz+Hb6iu2ljub4kfGY/hHkvLCyv5P/ADOi+vcUh4FZFnrcT3C2t2hguewJyr/Q1r8ZyD1rujNSV0fH18PUw8+SqrMQdTxxXW/B4j/hbnhL1+0XH/pHcVyXHJrrvg9/yVvwl/18XH/pHcVNT4WbZf8A7zD1Ov8AjqM/FNs/9AW0/wDR91XDeldz8dP+Spt/2BrT/wBH3VcRiuvCr90v66nFnn+/VPl+SG454pQPzpe1Lz1rpseSNIOcUDn8KX8KO9IBO496CMU4jvR14osFxMYoIpxzSHpTFcbjikxTzkUhH5UrDuNxSEHtT8Uh9KVhpkfB+tARnYLGu52OAB3p/FNaGZ/mgDF4wX+XsB1NYYifsqUp9juy3DLF4qnQeikytYmW/wBSFvbhXtwp8xucn2xVy8R0uVieLYpbn2x0rP08yafcMqNzJwdneujhBvCiSx7ZV6M3f3NfIYqtOtLnk7n7ZlOEw+XQdKgvd9epxWsWEcqS208YeNl7ivM5Gn8N640UUhMJIbr1U/1Fe531hHc3SxlnL7WwF7kcn8K8k8dafJMyzQwMZYyQ+0ZwtdGDq30ZOcYeniKXNa76ne6VcfabVHznIq/muL8EarbjTYoZXxMoxtJ5+tdXHeQSttjdSR1ANfRUaicVd6n41jMNKjVlG2iLHXmkJz1FLR+tbnEJSClPBoxk8UhiH6UnFL70hoAQ0mPWnYpp96llISvW/wBmf/kP+L/+vaw/9Duq8lPWvW/2Z/8AkP8Ai/8A69rD/wBDuq58R8B7GR/70vRnvVFFFcJ9qeQ/tLc+GfDf/YZH/pJc14cF9cV7l+0p/wAi34b/AOwyP/SS5rxDn079K9DC/A/U+Uz1XxEfT9WMKnt69KZLIkKhpGC5ztA6mpZZFigZ26DsO9c7qV2JEIzmVjxj+EVlisV7L3I7/kduQ5B9e/f1tKa+9vsv1H6jqTldsZ2qT0H+NQxPO0efLCr6mn2Fuo2vN1A44q44ErjYMV4tSq5P3tT9PweA9jG1GPIuyK0V3dRKUiKqDyTioZ9RvkySyOB6qD/Stm3sg65GMjuKbcafGAd7nPpWCqQvqh1KLbfvGE+skj/SLdDz1T5TUtvf28jDqpx1qW505CTkkjOOO1YVzbmCVlU5APDAYzXRFQlsc/tatJ73R08wifYEfegHp0qte6eWt0d0GxzgetY9lebCFfP1rodPimv3ihRic5K5IAAxk8mocXT2Z1RlSxMOWSXzK1vaSWYyhkUe+TU2STljk1eWH9wS9wzDJBVW7VVliaGV43xuU4OCCPzFZe059zpwmFhR92Kt6EluMgkozID/AAnHNaCaiyoQpMmRgKV5P1qhbRiVwjFlQ/3f51qLa2ytKLbzzjkSScADPUgDgcj/ACazkkzaqot2kGm38ihfNie5CKVUM2No9M+gq89yrIS64D+p6D0rHutsVwS05mRlOWiOzkrnHI7EjP0NUoN7SLtBY9qLNmNTDxqe9sdND9mhtyJMFOT3P5CuZ1dLJbgm1twGbqxJGfwrdtrJkiZ5CGkbqfQ+1ZksUnnmKOESOQcuei+/tTi9TzKcPe01MUxPJ8sSMfYDOKp3EQA2mNgw6nJBrpdMWW1w8Y3AtyevQU+4hS7mZnljZsZx3I+lae25X5F14NaJHHLHK7EFyOMjPem/aJY8Bhx2IroJrC3kmJDFSDjr1rP1q3hhiQ27k7uCCc1tGopOxwSVWMtGZv8AawjkVZDjPQ44P41sWGpKHR1cLk4zmuckiw2SMhuDWRJcGzmLxMTCDsdDn5T61s6akrA8VOno9UekXUct0oLSBsHjFNtrbyQ4PLHnGKw/Dmr+ZGAXGV6d8iunS6gcHccP9K5JqUPdNqeI5+hgeI9It7qwcsm1lG5WHBBrG8GazLdh7S6bMkY+Vj1I9667VpA1tIVcONteS6Vc/Y9dSQnC+YVb6E12YKpJLU8DPcNHEU9teh6qR611vwez/wALc8Jf9fFx/wCkdxXIQuHjDjmuw+D3/JXPCR/6eLj/ANI7ivUn8LZ8PgNMTBeZ2Hxz/wCSptn/AKA1p/6Puq4n612/xy/5Km3/AGBrT/0fdVw5rswv8Jf11ODPP9+qfL8kAFLigd6X6V0nkjTRjg04igCiwXEPQUYoxmjFIA6ig98UopPrQAo6YoFAoHHWmIQe1H4UHrzTjjNADQvFLbxRzX9rFKxBaQBBnALdgaMcgY59KkitGE/nM27YD8gGe1eVm+IjSocj3kfW8H5dUxeOVVfDDVvzaskafiez05gP7Tk8qWN8Dyxh1bpxj0pNMWK80vUZoZreR4sLFukMbvx2UDk+ucViahbyXE0chibkZyRkj2JpbaNrWUvBlHA+cZ4NfKU2lGx+uvDKnZ31LekTtFrNzfyo8MtogWGPdlXDAh+Rz0rlUlzeSyDA3kkjGeK0b2Z4JyVkLO6gsx65rFdtk3Pet6avc6adFUrVJa3N2y0jTJdMu7mU2kd0W8tVb5JFBAwV7svXOOmK870YGz8aTQuxCTjKZ7+3867ZNSzbeTtVnxjceuPSqXibQYtQs4rqxYJdqoMbg4KsK6MPWdKa5zyM6y2OMw8o093extjgCjvxWX4d1EX9mEk+W7i+SZD1Dev0rW6DnpX08JKUVJH4jWpSozdOas0J68UmPejsaQn8KZkIelFJRQUHtSdfYUtJUjEPb17163+zP/yH/F3/AF62H/od1Xkea9c/Zn/5D/i7/r1sP/Q7qsMR8B7GR/70vRnvVFFFcB9qeRftKf8AIt+G/wDsMj/0kua8QA5xmvcP2k/+Rc8N/wDYaH/pJc14kVrvwvwP1PmM6V8RH0X5sz78wtGRLcNGqPt8qNNztyNzc4AGM455IrEs4S0m5xzWzfW0jXEhVSykb8+1FhZ+ahbv156V4Net70m9z9UyzCUqOHpcj92yf6ix2eIWkfOB0A70sdnIxDKvDcqPUVsW9ubnEJUMjdT6V6N4A8KwtMbme1jnjC7Fjc8c9+e4rmpRlUPSr41UIts8ulnW2t9qcSkcAdfxqGJzLIC4BIGWPrXf+M9AW0vV2wxrE7SLGChXoch/oemevA7VwU0TwlRHgGTI69xSnT5DKlVhWjddSG9jBAK8Ed6xb6DMR3L1OQRW86MNoZtxPPSql/Gvl7fyBopTtoY1YJo464jKZx2rY8OapOrJDA3zhgQMAg4ORkHg8gHmqV6mCR3pPDEMkNzcXMIc+XkscEhQf5V3S1iefG8aqS2Z1RmnR3SNQXkG2Uj5t5znJ9+aLpXt5YmZF8zaC25t2WznNW4tStUtwVhbzu5wBmqMh+1Tlo4m57DmuBSlfVH0FNvqrIA53FwCScnHYZoDmY8s+cchTV+HSsxfvCwYjnFSWlqtsrtuwfUjmodSPQylXjrbczjbyP8AJHEd3XJ5Jos50WIzQjLRswK+4xVjV3FvbTC1kYXDLgYPPuayfDUUlva3FwkyvCjJ5kbfwknAb1PPBx261rTjzxbOSeLfMovY6Jp7iCW4+2yCOSFVZlfAPzAYAA6k8ew7kVW1K/3LC9tbxwwyJuRpWDyyLnGWHRckHAx09etQ6nIPLiEscWzcw8yEhmYn5iAPbIHpnjNY8kcnlbmOTj8BVqCS1RjVrKMlyP8AyNgeK9U3u4nAYp5X+qU4XIIwMcdOoqodTuZ1WOSV5E7KxGBznj071nQQOyFwxVe7HOM/hyaS7nEIVQBI75y7KR34wPoP1rW19DFygt9yO6l4by8gd6pXMu4fNyaWR2IBd8j09PrVSaTJwK0hGxjzWWgSSwiPGW3d65nXkaJhcQt8ko2OBzgitufrzWDqrFQ8YfIPOwjj659a2irHDiHeJL4WnIkeL5t33lcfw16hpssc9r2Eq9cHINeZaZYy2sUNzHJy/wArr7V3Wk2beWk46gd6xxFtww0WrX3L+pWhMBZcbT1rx7V4/K1O5TGMOeAe1etatfLDbnzSETqWJryTVp0uNRuJY/uM3y/Snhb21DMJXjG+53fhLUTdWKBs70+Rvc16h8Hufi54TPHNxcf+kdxXifgYv9onA+5x+de1/Bz/AJKz4S4/5eLj/wBI7ivSi702fDzpKnmEVHudn8cv+Spv/wBgW0/9H3VcSeeK7b45f8lTf/sC2n/o+6riR0r0sJ/CX9dTwM9/36p8vyQAUuPWkxS10nkidaU0etVLq/igYpy0mPurWdSpCmuabsjowuErYuoqWHi5S7ItE4qN5kXqQKp6ncNFOY7ZhcKAMuinAJ7fhWHcpf3DYjYKCe4PFcMszo/ZZ9CuEMyXLzU9+zX4nRG8QtwaUXKYGf51yM1pfwqphuVlk3YKFSuB65qKQa2F3RwI4HpJ/wDWrOOZQeppV4Rx1N2cDt1nViMEU7zF7EVwkd5rCkq9kxI5O11NRHxWbaQx3cM8TjqGQ1rHHwZw1eHsXT1cGehZHrTJJViUsxwOlYXh3VU1PDO5jh6b2U8+wFbF1JFDJmMCYkY+foK58VmsKUeWnrI9fIuDsRjqqliE40/xfp/mWLY+ciyA4I7HsO1adtC0US5yXc8sB1rCsbwoVRo8ADIAPWtVJpp4wUk2oTkgV8ziK1SvPnqO7P1fCZXQy2l7DDxUY/n6vqXJ98RTzEwoB74rCjczuxYEFumO1T6neyLKsblmYKAMjGabZWs8cXmltrNyRjNZQVldnROio07y6mLeBTKx3Dd9OtYOrzmN4x0Jrr1sDJclpCG5yfWub8Y2j24iuc5Qvg8YxXbRmudI58VVTw9k9ULoVlcXsuIVLMRn8K625tUt4Ayq3yJhlZflBqh4MuLVrIgyCOce+Mit652/2ezCUMBnK561FVtzszONTlior/hzzy9smTUTd2bmCf1U8H2I7irP9rXqRqHtonkH3sNgH6Zqy8JeTKYHpUc9nIpziuyjip01ZM87McgwONnzVIrm8mWdI1KHU4GeEMjqdrxvwyH3q9iua+wRrMZ4WkhmIwWjbGR79jVhTdgBftLn3IHNelDMYW99anxGK4IxiqP6vZx6XepuEelFc3PPrEDl4JIriMf8s3Xaf++h/hTofEsKMqajDJZueMuMrn/eHFdFPF057M8TGcPY/B/xIaeWp0J6UnU0yGeOZQ0TqwPQg08cV0XvseK007MOMivWv2Z/+Q/4u/69rD/0O6ryTivW/wBmf/kP+Lv+vXT/AP0O6rDEfAexkf8AvS9Ge9UUUVwH2p5H+0kM+HPDX/YZH/pJc14rXtX7SP8AyLvhr/sND/0kua8Wzz0rvwvwP1Pmc5/jr0/VjWiWNXnRwC2dyseCafYwZtvl6Ux0WVCj96ZZzS2sMiABypyM8ZFeLjsKqU3JbM+44ezSWMoRpv4o2Xy6M2NGRY5vmJBY8nPSvRNI1uTSIIhFj72xiRnOeAy4446nPavLILx5Jk2LhgMtgZPXpW5aXssABEmT3xxgelctCdlZHvYuk5azOo+Jmpx3VtH5G55IyW8wg9DgYGfX8q8xkCsA8rHepyPatrU55booWdSoPJbJJ/Gsi6MeMZAx0xSrPmdxYW0IqKK8s0eEbdk9SM4rPu3DvuB/WmyLK+c5x71EwHl4HfvUwglqdVRWRj3gHmNk/TFQ6FPImrlY3aOMAEsP1+tWL9dhHc4qPw0yvrABAIRSfqe1dl7QbPLbXtY+p28ZtWtGFtbbnfgtIMDp1FPjv47cBEgRFUYwvOfqe9PRW+z/ADYGBWdPbsQSSBtzx7VxxgaV8Q3p0N6wvre4c+Yh6dV6irVxbadNaO804QZHy7Tub6dq5rTiElHzYP8AOt66ikSxiZVWdWk+ZVfBA9cYqlRUnojklWcVe5zMsvlXrPbW8gcthWkAJPaoZNNRnYBSjxLlhjpXYQ2UTwOXJjkXhd69PY1mw2bi+iiILtMwQjGS2ela+ycLIxjiby50chNEIZyPmAH54rRiUSJ++G2MAfL3Y+n5fzFT+ILbyrstEoY8ZU9sGlsv3xVtmFOMqeTnuSfUnJJ/wp8vM7M2rV04KS3LVrp6SwR+aGDPgLt4APrVLUtFuGuVhUQ5QfKVfHt6Z7V21gsAtgNjZPrUd21pa3EclwRslfZG+e+DweP881uqCWrOJ4iTWh5tqmg3umQ28t5EqJcBjGQ4Y8HByByv41jtGR8p5A5HtXZeK7stMyq/mRqcBic/hXKSPu7DA9qTdpNI7aT9pBORnzJ8pPcVxurMRfPgk49a7e62YbbnHauP1m2Im8xQcEZNawOTFx00NTR7xXiWN+xCg+tdrDqDQWuwn5Av415bp8rJOg3YQMGb8KvarrdxPI0cDlIR8vy9WpTpKbsFHFqnC73J/EuunUP3ER/dKeT61gxo0sipGpZ2OAB3ptdn4R0gIq3M4xI/3QewraELe6jx8Zi1Ti6kzX8MaYLK0Csv7w8sfevTfg+MfFrwj0/4+Lj/ANI7iuSiQIoC5z3rrvhF/wAlc8Jcf8vFx/6R3FdjhywZ8rhq0q2MjOXVnYfHH/kqb/8AYFtP/R91XE123xx/5Km//YGtP/R91XFL16V3YT+Cv66nlZ7/AL9U+X/pKE7UyWRIU3SMAPepHZY1LMcKOpNYM8z3d2EClyW2pGOMVjjsYsOrR1kz0eG+HZ5vU56j5aUd338l/WhJNqMkpYJiNOx7mp9JWSKYyLaCVz0Mh2r/AI1saD4UuJUadmUMvALjjPt/jVu5sZ9NYzCHzZOnHUV8zXqTrPmm7n61gqWEwFL6vhIJfm/VmfM1+xPmT29tGvURJ0/OqBuLghvJ1GOQDnDqK0bqeS4iAeDKv94Djb9axp9JUK0sLeUVQt1NZRijSVaSV/8AIS9knVE+12sAZyQJEGP5VLbTOsDv9kjuIgCrSxn/AA6VyJ1e5gnALsVRsr7GtJr43bC6tH+z3X8Ww7QfwrSVFpDjmEoqzVzbik06RVWRJIznnuKpXkcK3RFsxePpkjNZ8epSXd032wKJifmYDAz9BXc+B77RLe3vE1iF2uGK/Z5FQMvfcG/TFZSjKnqd/tKNSn7SMbvsc+sarCFgR2c8A+WQa1dP8N394GaOCUAAHp/M1u+IdUvrIKdPtIpLEjHmxKGx3wR1BpBrd/raeUtzJb2xh2hYY+Wb3I7VleTV2ef/AGpKKcKUbMsaT4QuLyNljMKsF5ZnGRirEmhWtm7RXOoRefG21liIPP0FULK3s9Pun+1RO5aXcIEO1Vz1HXmuysdIivCbiOzeGPGY0wMj34qYxdR2h95lPE1kr1WcpdaHamUOX2t2klBG3/69UtR0+8sZBuZHjK5BxxjtXVatcJYzLLdu0qIc7ZOR9MVWGv2GpaaZ/sbtMj7UjbhWHr/9ak4Ti7PUccZJpdUcDbyu9wbiQhQpwQRg4+lVfENrpuqRGOMXisDnKDjP410kutXQaTZaaegzgAx5H69654NfazcqLp0gtk4You0fTFa03d3XQ0n713JaPzOVh8P3Kyf6LM5jHXPUflUl9YataRkwOT7OeD+NdRdX1jpwZIHLEDHA4/OsuXXYJQVuJML9OldKnOWtrmfsFFaSscgviO806423ttImD94jI/A1p2/iJ5X3kBlPap9W1CxlgZY2SQEY5Fc/baekp3pIIyecA4FbpRkrtWOJupCXuu51gv4biKMfMNgIUE8KCcnH4k1LC0ZYbiSv+ya4+X7XZZJBdB3Wrun6wrKA5BqJUbq6PTw2ZKHuVFY63CMzLB8ykcA9azbm3WQsrgVNZsZQrxkYxnOav2toJZhvGcck1zr93dnoVa9OslHdHLS2C2oZ7Rmt2PeM4rU8MX817aTJdsHmt5NhbGN4xkE1paxp6+S7plSc4HrXOeEHYanqsZHy5Rhjtx0r08vrucrXPgOLsDRjh3VhFJq2p1PIGO1et/s0f8h/xd/166f/AOh3VeS44r1r9mj/AJD/AIu/69dP/wDQ7qvSxHwHxmRf72vRnvVFFFcB9qeR/tI/8i74a/7DQ/8ASS5rxYA817V+0hz4d8Nf9hkf+klzXiuMda9DC/A/U+Zzn+OvT9WKeD0qtdXQingVwCD1FWeaytcgkJSYDKhcEjtzWOYx5qR28L1FDGpN2umdJZmJo/3W0HHzADHNSYJU+vTJrntFu5HmENx8hVSwO3k+x/xrZspUuHYPMI5VBIjYdR6g96+e1TsfpUou12JODg72xgYHNYt0qI8bYaSMHJCnGfxrW1GJ/LKEcGs6KNsKi9Oh9M1EpO+ppRSiua5RMolGCOW56YxULnYh4BwK0ZrILwvHrisrUJFjDquPQ1cNdETVqK3unPaxc+XE8nJ7Ae9XfBMDPqQbAzt6etYF2z32oIqKTDF3xwzGu28PwvYyWjKFDP0O8Ege47d+vrXXU92Fjz6S9pVutkdnDbNdyRxxJlnO0Ad62z4aI0t5JECSBTtVu59BWVBemzlSSJxG8Z3qQean1DxC11b7pnwwHBXjcf8A9Qooygl7xzV4zl8Jxdy5SdUVjsi4UenOT+tejeFFt59GlS5yXAygGM9f8RXnt2VkfzA+5mJyMYxWzpF5JGqDeQAM4qIVVCpdjnQc6Vjp9ejhhR1UgjbnI71xMUpgvYZXIZUcHYD2B7flW3qU8sjM2/hlHUZA+tYT+XG5UjcdvB7E1pVrqcro5IYf2cbD/FEqyarcyR4CM7EDGOM5HFU9OmicvGSBKRu64/IU+4iM0Py5BVQCc5J9z+NZqW/kO3HOOD1xWSnaXMzV0uaPKjbTVvJjU+aq55BPpWRrGqyfZ5Ymud1u3zCNhyj8cj07/Wq9zAdodU+YD16Vm6hHJKQCmPfOcVpKpzPcijTcHqiqbiSZmaSQuSc57VGqmRuuF9abtMbbQQx4HFX9UkgsLLyjBvnmXJdnyRx+lNvsdE6yS5YmHfuBIwQ/KKxtXLm0fPpjPtWqke/73bnHtWJr1ypY20JDbeWI6VrHexyVZpR1Mm0lSGTe6ByBwD0zUJOSfU0VLa28tzMsUClmPYVscDlZaljSLNr28SNRlQctn0r1LT4RHGq+n6Vl+HdJWzt0UgFupOOprokj2qB+eOtdVGn1Z8pmeNVafLHZDwCPXpiup+EP/JWvCR55ubj/ANI7iuXbnpwMZrqPhFn/AIW34S5yPtFx/wCkdxWtX4GcmXf7zD1Ow+OH/JU3x/0BrT/0fdVxXAWu1+N//JU3/wCwNaf+j7quKrswf8GP9dThz3/f6ny/9JRQ1QPLDKkckQ8mMzuHcKSoIGFz1POcDmuh8DeHxNNDLJHmSUg/N0Rf8axrfT21PxHb25jUKQDkLjKjuff/AAr3vRNHht4o5AgA24A9q+YxM5Vasm97n65g4Qy7L6NCk7pxT+bVys9lFb2oURfdXpisS/0wTIrBd2Oa63UOyNkg5wFGOKrQQK65AOB1zxXNLcITsuY8/uvD0cKM8e7c5yc9qyJNHaTzIivYghh1FerTQwuCMAv6msu802KcNhQSOcj1pqzL9tLZnzt4k8NC1nIg3qmT94d/aucSCWIFAx5NfROv6Qk1iUkVWBB7civK9Q0F3QtGMRq23GOSa1VRrRlQ5ZK7MbQbUeZFMfmkDbQvrWjp1v5utCIyOqNJ06VWAewnjUDaM7gDXUeEytsZtQmjEkr5EZddwX1bmspy6s6aEXFSqr0XqbQuru9k8l55TBuwRGuWYYxitOW/TSbNba202S3ZjgTSkbh+AqbwRcW4SS4mbbuTfl8Ank8/SsHxl4i/tG6+y6YNyxnLyY44rllSTWr1DD0uapy8ui3ZuadDHAUuFQTvjJD8c1pWHjwaffsL7ThNAQFISbaV54PTmvP4ZrqVFSfU1iU8Yj60up6e1rZxuZDOkh4ljb5mPoc1cZSgtDWWDp1JWqSvf1O88TatbeMGWOGxgsoIW8z7xMkhxzz0A9q5icwxhbaN0wvXPb2rgpNRNszR+fKwz8wR8A0RagkkUiIrhiOpOeauUJzVw+r0qT5YSuibVopW1ElphgHKnOAB61l6x4hSGMQo/mbRtLDjP/1qz9Yun3NbqTleZD6n0/CuX1KGaW2YD72cjB6CuqlQVlzHLisW3pAtXWoXV84IcKnQD2+lNeAshJY7sVTAeO2REP7zjOO9WbSZyWyOFPU966rW2PP5nJ+8N+x+YNjPtXHY1DJFd2BUwTeYCfutxV6aNy5ZDjI/CoPmdhkEkDjNAnG3qa+k6kJCI5RtbuDVbX9OMY+1WQAfqwArMuHVWD7groRyeK1NJ1dLndE4PHHPeocbO6N1UVSPs579GR6DrTwSxq2Vye/QV6Rp1zFdBH7qMjFeT65bCC5yjlVb5gf5Gum8LXMrW4ZXKt3FY16alHmRnhq0qdTkb1O51Ro1spACVYgnJPArh/AeGutXkBypuCBWvrF5O9rhmA4xgd/rXKfD28EeoXlu/DM5bFa5dD2crs4eK3OphOX5nopHFes/s0/8jB4v/wCvaw/9Duq8lXkda9a/Zp/5D/i7/r1sP/Q7qvYxPwHwmRf72vRnvNFFFeefbHkv7RuP7A8NZ6f2yP8A0kuq8aYd+3bFezftG/8AIA8M/wDYaH/pJc14y3UZJFehhPgfqfO5uv3y9P1Yzr9aGRHUq6hlPUGnt+f1oxniuhrmVmeXFuDUouzRDDawpIXy2duApPFQXMDGTepJ5+uKt475pdh61xPAUL3se1/rBmHIoqexmyTSqiqWYYJ4XOKqPqbxkoFZT2BGa2NqseevSleFHXEiKw9xXPPLIvWLPRocW1krVYJ+hzV9q7Bf3rDB7KeW/CsSaWe+lACGKHvnqa7V9NtmkDmIBh0Ipt1pVrdoFnjEgHZhmpjlso7NFPiiEneUGcxa2UUR+8CfQGtS3kEToRwoIJrbt7OCHaEiRQo4wvSsktFFqEqzKTGsnIXAOM847dK5sXhnRSbd7n0eQ51DMHOmqfLZfebkkhlVkGDJt7dD71nRF0+RiQuenYVnrqf2SRXkfYinAc84GcAGug+327A+fCY5B6DIrk5NLm1SXsqnJIqLBGGGSeehNWIJBHcqoOBg5HbFVri7tmXAZc1mvqccTKFbcVPUH/61ZcjbNPaK1jqrkNFDucBo2AYMD09qxArmJptyiHJADNz+Heol8TxvZ+Q1sm37oCnA/HNZlxeS4xCd8Y5APf8ACq5GYbbtG7bSf6YsTuDuXYcHIq01igIA6+lceNQliO54mTHOa07DxK0lyEkKM4HAznI71ag7WZmqkFLdGjdW/l5BHB5rIvEG73x0Nbc+qxzfIU2OfxFZM0kLkl3QDHPNRZpm91a8jm3hDzHIbb1qMw7Sxbkepq7qepWtrGxMkceB/Gefy6muTv8AXPPkMdssl0D0wCq/kOa6oKUjy6+ISbsO1S+DxzRW5KoPvSdF+g965iRweEyR3J6mtxNG1TVJFaVPLjA4HZR7Cug0vwfDGQ1wWlbryOB+FdtOk9kjx6+Y0qes5fJHHaZpVxqDgRLhM4LGvQdE0CGxjGFyx6k962bXTo4FVUUBR7VdCBVIH5V108PbWR87jc0nX92OiIY4do4Apdvy46AehqUj1PFRsOc7vrmum1jyrt7iYwOvH5YrqfhJ/wAlb8I9OLi4/wDSO4rlmAJya6n4R8fFrwlzn/Sbj/0juKyq/Czty7/eYep2Hxu/5KnJ/wBgW0/9H3dcWB65rtPjb/yVR/8AsC2n/o+7rjB1/rXZg/4Mf66nBnv+/wBT5f8ApKOm8Cxxvfs8yLwu0Njnr0/WvYrdTJEY1U/Kuc+2O1eFeH7w2mp253YiZwHHtmvcLBy0KRCQIJCFb3z2r5/MKHsazfSWp97kOYLG4KMdnTtF/LZ/cQPcrLjC5cDkdKzJ7spJJG8nVugHSt/VbRI5z9hRpERNr7edre9cXdidx5Kvkbywzzgn3615s04uzPoaKjPVF0ThgGWQKVOPrUrTRrGuX6nFU7SyRiFZzx1qW60+NTuUEkHPXrQrlSSvYZf24cY3AhhXBXVsU1DUIrgkgbXjPopH+INdRLcTpcSIVCICNhzyRjnIrmvEuoGOaO6VQVjG2Qf3kPX8utU31KpQbfL3PPtciI1MKrbgRhc/WuojRoNMVFgdYkXBkI4Y/Sq8qW9zqJu4QrxWyjnPVj/gKk1fX31G9htLRcW5dRnGC3TIxWM23oj1aVGU0oJaLVlJdJvL6bzAWEO3kBsbR24rM1e6Wyf7JanbGowx7sfUmu21rVRplg6Wnypgbv8Aab615ZdzPcXTM3JJzV0oXD2smrvbojT02QtcAsT1rT167eLR4o2YglydvoKzNDgaS5iQDO5sc1a8YWsqyMADtjAyPSr5VzCq1NFfc5UgsSexqzZtsjMjDgdaZFDuAyR70+aNhZTNj90B27mt276HDzWdzn7u4DM0h5LEk1Rjd5pHVeVHQ4oXczsDygzVu2VEVmJwv8q6Njz7ubC0tEVuT8x6k1HLCFn3bRtYcr/tetWoGLdADgbagfDE5bkNtP1pdRtK2gpI8ra3B9P8KZG5YbgMAHaakEYZiOQQeaVICQ4B9xxzRcWu5n3kHnYGevbtVTyfshWWMkkdVHNbMtvscBuRk81FcBsds56jvVJkON9SG/cXtgpAyycZ7ipPDF68WDt+T7pqpbuF85GI5PNbnhSwSWObzgAFJ4P1qZtKLuYqPNVua+oSiSDOeeuPSuF8OTG38THachnZf1rpdevo9OiDk7iTtCf3qpeD9Hd7k3tyuGc7gPTPNPDxfQ5s6xVP2LUn0seiW5LRivXv2av+Rg8Xf9eth/6HdV5DCCFwOK9e/Zq/5D/i7/r10/8A9Duq9Sv/AAz4rJP98+TPeaKKK4D7Q8l/aP8A+Rf8Nf8AYZH/AKSXNeOA5xkYxXsv7RX/ACAvDP8A2GR/6SXVePADOSPzrvwvwP1PAzWN6y9P1ZGAM57e1KR9aey4AwB19KMgjHODXTc83k7kLpycn/61GDkA5NSHgdM9hSBSRjmkJx7DFH6mlI+XAwMetKFIIOeKOcg/5NFyXHQjbtkEDHrSYHvTipKgUD06U7mbiJ04HWs/UNO+0zebHIEc8MCOD71oBe2SPpSY7dazqUo1VaRvhcZWwc/aUXZmLa6IovvtF5IkyJgxRbcBWH8R9T6dq1Z4o5uXUH3NSFfoaTB9M0oUYQjypaCxGPxGIq+2nJ8xmz6cjg4Zl+hzWbLoIlcF7u52/wBxWwD+VdCe+aRx0IxU/VqW/KTLMcVtzsxpNFtpI9km9xjGSxzVW28NWNu2QsjEf33J/DrW/g5AxkdzQFzn0601QproYyxuIas5szxp1uOkQ9MnmnrZwLyI1H4VcIP49qa445zzVqEexzupU7lcW0IJYIN2MZ9arz2Uco7gegq9/D6UhH1pOnBq1ivrVa93J39THOiWhydgJPcgUsOj28LZVBWr065oPUUvZQ7CeIqvdleK2ROB6dMVJgKeBTs88ZoHt9eau1jJtvcT1HXFJxSgcZ5ppJAzQFhjnAOOKZnBHapSMgf1qPI578Ui0MPOBzXU/CMY+LXhLP8Az8XH/pHcVzA6DOcc8YrqfhIP+LseEcn/AJeLj/0juKyq/Azuy/8A3mHqdf8AGv8A5KpJ/wBga0/9H3dcbjA4rtPjV/yVOT/sDWf/AKPu647HHFduD/gx+f5nBnq/2+p8vyQzp9a9r8K38F/p9nI7YBA3nuD0P5V4vt4rZ8Na5/ZNyIrsuLCRvncDIRj0/lz+dcOcRXsoye6Z7PBrqSxM6UdnG7+X/Dn0TaGFoJobTGYjsYgY+bAPXv1HNcnqeiyWiRzEAlslx/dbNcvp/jWS31lUikY2LYCyZyrnOMD29667VvEdne26xCKQsGJ2sOM445/OvAdWFSOujR+gLD1qEl1TMgLskyQBxTdRDTW5VGKkgjjtUFzMJygRiD1NKJCcDOPesrnQ1bUy9WtCbZQmWcDmuV1OySa3eIHGVIOa7K5lBYqSMjt7Vyuv6hDYwymQKWIwgz1p6IcJSbstziNUZNPsxaQYUt19T7mpdJ0maz1WIXa7XNqt0q9wHHy598c/jXPztLcO0szKWckden/1ua9Hu9VstZ1vULyzt5PLOn28aAj5g0YCtgDtUWR7s5To0kkr3vd/cch4ol8y2ID5JYDaO1c/p9k0rOZMqydsYya7fxdZ6VHqbQ6ReG9t/kPmldvzEcr74P8Anis5rRQ6BRyRgVSfIuU4oy50mS+DbJJdUjd1LrGCStP8ZW6xarLCwZYcKWx6Y9a6HwrZ/ZU+1Eck44Fc94kkN5r160gONwQY9hSuZzblU8kjj9StPsp2rgxyDcjjjjH86imP/EomiC8KB09a3dTsFkgfyiUMUbSHK8EDrzWJpEEl9mGD5mZHcKT97ahc/jhTW0bs5G0t2cvLavbTmM5JIBx6U5Ym3ruYqjHnArbv7A3FzLMX+RAFXHGeOKpRwSSMYztHpnvW6ndGDpNaGdcM8U5ESckjPPSojsaRHOQBkFR35q/NbPCTuXB6c1C8Gwb1zn34NUmjNxZE0mSqAHdzzU0KMFLY5UZ5NIFyzZwOM4zip8KsCgli5Genak2BDMrSqGA428c9qi8pmj5AJI/Or0aDA2dM9M+tVpPlVuduP88UJhayMaO3Md1dMw4GMZ5Gepp8GqHTYWy6mUAlVJ6k9Kluv3cAJ5LHn61zVvBJf3pROdx5PoK25brU8iNZ88pJ6GzpEU+r3ourxt4U4Udvyr0bTYBHCoArH8P6WsMSLtwq100EW0AAYHpXXQp9T5DNcZ7adk9ETL0Ga9c/Zp/5GDxdj/n10/8A9Duq8lA4zXrX7NX/ACMHi7/r10//ANDuq3xH8MjI3/ta9Ge80UUV559qeT/tFcaF4Z/7DI/9JLqvJIEM9wkcYyzEKvvk4r1z9ogZ0Pwxxn/icj/0kuq8+8HWhu/EdlGBwrbz9AM124d2g2ePjoc9eK8l+bOu07wFaeUhvZpZH/i2HAz6Cm6l4E02O3xby3aSO6or7gduT6Ec13kY2IAAcDpVO/O67tIx/fL/AJA1l7STe52/VqSXwnnkHhOwhihW5luJyZJg0i4UFUHHHOOe9UpfB4kkjMF86qFi8xTFu3GRux4xha70aTcrbeXujLiCSMNn+N2yT+VJNbvDqUKlgRNcK6j0WOPj9afO+5Dw8Hq4o5AeDbNWVGuZ5EInZpQyrtCfd+XHPPX6e9VU8FbJwst5vQtBGNqbW3PyxPUdOgrujpdy1uyHy95t2izk4JZ8t+lSNA66lAHUEvcmVR/spHgUlUkupTw1N/ZOJXwfp7Hcbm5Vf35/h+7HwD07mnJ4Hs3ZE+1XIJMK9F6vgkdOwrrDpd4LHygE3i1eEYb+J3y34YqR1kj1OAbNpku/NQf7KRYH60/aS7kPCUusTk28CWnls4vJ9ginkGQv8BwPzOKH+H9o05RL64X95DGAVBwXXLc+1dcLS7Np5WwCT7IIM7uCzSZb9KuyRSJqkZKMGlvHlUZ6okWFP50e0l3D6lRf2TzmXwJAse8X8pxHNJ/q1IwjYHfvSt4BiE3l/b5gfNjiy0Q/iXcT17V3a6befY1jaLD/AGNYjyPvNJuf8hVl1lXU0Dxn95eSzKDg5VYsKaftZdyfqFDrE8ri8GrNFK4vWUxRu7BoeMggAA98561ZbwC3n+WdRXHnLD/qvVck9a6/R0vtRsr6KfS5rOS2C2SbyP32HBaQe2D+lX57aVNRiypDPeyyIv8AeVY8A0e1l3J/s+hvynmv/CDzGAyfbo8GEy4MZ7Ntx171IfANz5xjXUIOJfJz5Z67d2a7hba4FqsbQyZ+yxJ0/iMmW/IdasFWXUI96MC93LIo9QI8A0/ay7kf2dh/5TzhvA12YhIt7bf6sy/cYcA4pG8BXwkZTe2eVkEedr9Su6vQhb3H2MBYnD/ZETGP4i+SPwFTOh+3LvXAa8ZlBHUCLij2su4nluH/AJTzP/hBNQMW8XVmR5RkA+bpnHp1pD4D1USEeZaEiTywA55OM56dK9JEMv2UDymDfZY1+6fvF8kflUgJ+2gFW5umIJHUCOj2siXleHf2TyW88Harb2puFjiuAF8wRwtliM4PXA4rNm8P65EyKdGvXLvs/d7GKnGefm4yDXr8iSiwKBH3fY8cjuX6fWpwCL35lwDdgD3Aj60/ayIeVYft+J5PD4O1eWxS4MMUe6Iy+XJJh1A4IIxwfbNLJ4K1lFIFvExVguFlGSSMjivTQCLXJU7vsj9u5eppmJuwhRtr3SDI7YTPWj2shf2Vh+z+88fi8NavJGjfYJVDBjhiAQFOCTzxT5fCmsxsw+wsxDBDtdTyenevUZJdkHIJzby4wOc76tSMDcEL1+0Rgf8AfNHtZA8qw/RP7zx4eGtZKkjT5CuC2VdDwDyetMbwzrKyf8gu5yCBwV6np/F3r1YTn7P8wLEQTk4GBjdUjb2c7sK6yW+QORR7WQv7Ko+Z5C3h7V1wDpl3kkj7gPTr0Pat74Y6Ze2XxV8JSXVpcQo11PhpFwObK4IA/I/lXoCsCyk92uOfoai0o58d+CRz/wAfhPP/AF4XlTOo3Fo1oZdTp1IzTehlfGn/AJKnL/2BbP8A9H3dceAM57etdj8aP+Spy/8AYGs//R93XIgfnXp4P+DH5/mfK55/v1T5fkgxlTnr61lamzveJbeckSYVsSuVQk5APHpzz9a1gOnSqeqWtvMkLzt5K+YsbzEEhFJwMj6n9axzOm6mHdump38JYuGFzOEqjspXX3/8Eo6PqGoWV68NgPORSWeA/Ony9WyPzyK7/S/GOnXsz2cxeC9UbtrjKOO5Vv8AHBrhJZYNJiktbV7eeadhl4VbeFHRcdueSaXSbF47mS6mXYSuyND1C9ST7n0r57B4OWJqWt7vc/SOI88oYKjzwadTou/qettcwBi8LqxIxkHOaYdQQRFnZY1XuxxmvPFYjoxX6HFRuWbqe/evT/sVX+PT0PjHxo+X+Fr6/wDAN/WfEG2RktVEkhyN/RV9MmuOvbS4u5nkvLlXkY5wvzAD2rSIHcUm3ngD61qsmpX1k2YLjbGQu6UIp99WYj6Z+7kkMgXb2K4FXvCN62napA9wQLR8xOx/hDcZ/PFXRbJPFMHmWN9nyhwdjH0JHKn3wR61hapDcQ4hlikUNjAUBgfoy5Bry8bgJ0qn7qPu/efbZDxVRxuDccdVSqa3vZaeR7Po/g3QfE+jZspZLTWLb5bhS+7DZOCynsexFQJ8J9UDEtfWPH3cBsH/AArgPCGq6vprJdrP9mvY1KJJt3bk/uuvRhXqGn/EvVJYxJcadYOuMbUd1J/PNKeGlCKdWFjChm9PETawtZPyb1/Hdehqap4VTSPBCRIhnu0kDyyIM9sHHfaP/r1nTfDGO7n0m/geMZ2tfRyZ/eqSG+XHQ4yv5VtD4jWMtlN/oU0NwIiUSTG1z3GR9e/WuM/4Tu9hdLSDV/JjUYwYlbaD74yaybhF3tc6FKs003Y1fjToxlsdPi0awXzfmiZY1VRs2gAE+3avI7bw9qXgrxXpsuqWoQQvHdBFYMrx7sMAe/GQRXSa866jM1zcai15Jnbu8wkY9h2+lU3F5deX/aF00pjXy4vMm3hV64GTxUSqJu9h048q5W9DlfFGjnR9V1XS0+eO3nHkyZyGiIzG34oVru9c+Fdre+FbHXPBjS3KyW6yyWrtvdjjkofUHOVPpx6VzqWLT6lJLLcCVWjWLDnPCjAGfQDiut8EeKbvwVO1o8ZutJlO/wAnOGjY9Sh/mOh60o1Fd32Z31FJwi6Uvej+J4xd6RPI0iYZWUkFWGCCOxHY+1ZkylEMc4O5Rtr6q8SJ4H8Y27Ti+t7HU2XCXDqY2U/7YOA3+ea8K8S+HpIQ4kERkViqPHIrB8emD05Bq2+XrdGcZqturM8+MeWJPBFKu8R4/hzxU8iBZcMDkZBU8c1rW+nrLD51zItnaDAJblm+i9TWjkY1HGCvJ2MWIs6bFUtJ3IqO4AjBUkFsZJ7LWo5wjRWKOIScbyBvf/Cmx6M867ZAAnUj1raFGUuh87j85pxXJBnG3EN1q9yEgVktF4BP8XvXWeH/AA8lrGPlOTySeprfs9LjgAwg49q0o4scAV308N1kfL4zN5VI+zp6IghgCqABVhVxUm3HrzSHgeldiioniObkIBnPFer/ALNXPiDxd/166f8A+h3VeTk8+1esfs1f8jB4u/69bD/0O6rDE/AexkX+9r0Z7zRRRXnH2x5R+0P/AMgTwx/2GR/6R3Vcx8L7cPrk8zZxFCRn3JxXUftDf8gXwx/2GR/6R3VUvhXbBdLvbkjO+UKD/uj/AOvXTTdqTPPqx5sVH0/zO2xjvVaSEvexzZG1UK49zj/CrGTSHIrFHaGKoq9ldOl9HNHIsG9RIr/KvZs/lV18hTgZOK4CbQr2WUajLo8Rhmule40hJQVYDgStyFLj7xHQ+5FNEydjvQQygqQQeQR0qk/z67CMYEUDHPuzAf0q+qhUwMbRwAO1ZNms51y/ZzL9nCRiPd93PJOP0oRTNQ5yarTWyvdQ3BJ3RBgo7fNjP8qtbcge1NPJ64oCwxm6Z6VSad/+Egs06qkEr4J6ZKgfTvV11PfpXMWFy9x4kLRzyIqSMrCU8uo42qmOBnncTk00S3Y7CS62uMxMyEc7fWqzhZdQt7kiRBCjrswMEtjnOe2P1p7MBzjqKhZx09aVirlw3Sf3W/Ssq7ud2vWCqp+WKZ+T/uj+tWgRj+lcxcXrnxdZQW8+UJaOZMAuvGcYIyE4BJz1xTSJkzpGAzVeWAyX1vPuG2EONuOpIAqy/UetA56ck0wI3B4IJXB9OtUrk/8AEzsF6keY3/juP61oE+tc/LqSN4ngtpInQoGRGKH52IBJHbaAAM+po6iZ0A6CqdzbNLd20ofCRFiR65GKt9hik6EetAMaQMc9qzdQ3fbdOCjJMrH0/gNaRByawdXuZIdSt32D7Pbje7jBKljt5GQcYPoaBM12XK++KqXMEkktqygfu5d7fTBH8zV7HJFA5zmmFrlc/NljwOhyOtUb4gPaELnM6j9DWi4JIwBjuawdZvlS/ig8s/6OBdSSYO1RkqM4B9/yoFI1WVVHQYNV76JpY4hGgLCVGb6A5NW2GO2R9aQ525A5x0oEM8tP7qg89qpKir448EkY/wCQnKOB/wBOF3V8HrkGqRz/AMJx4I4+X+0pufT/AEC7pS2Kjucx8aP+Spy/9gWz/wDR93XJZ49a634z/wDJU5f+wLZ/+j7uuSB4zXr4P+DH5/mfCZ5/v1T5f+koFwRx2p6kDG4BipDKf7rA5DD3BqMGnHviulq6szyoycZKUd0JbxRwBhEgUsSWI6sSeSTStyOeMelA6nPUUMQAMUkraIJScndvUTaCM00/pTse9IelMkaRnrxSHI6U8Hg0hHTmmIQE/hSqxVvl4pB3pDgcUCZIr84xzTw4BPNVs9/5UE5GKLisWJJCyYLMR6ZqDdghhjcDxkZFICeopp4PFKy7F88u5l32mSS6k11a3BhQqEEXJCqMAAfQDHPX1qaTTrUsGEW09flYj8+au/lTO5rnWFoxvaO52zzXGVLXqPTtp+RXjgSPmJSp9VY5q6NSnRVDqJQvqcGocDHFNKg9RzWdbCUqkbOJrhM4xeFnzwm/Ru6LcmpQyc+S24DOAOtULu5WQ/uYQWHcjmnFFGSBgn0pMY9K4XlNK+7PcXGOM5bWV/mYjWM7ytIAkZY5JAyc0iaQu/MrNI3+1W2QOwFNZcng10wwdKnsjyMTnOLxT/eSKUdmqAYUDFTCEA44xUoBzSE8EZrZRSPPc5PcQKFHcU0gE470/r+X50h+tMVxnB9qaRwfSnHkDmm881JSGt0r1j9mn/kYPF3/AF62H/od1Xk5IyevtXrH7NX/ACMHi7/r10//ANDuq5sT8B7eRf72vRnvNFFFecfbHHfE7wdP400rTrW11KPTprK9F2sklsZ1b91LGVKh07S5znt0rH0TwP4p0fTxZ2viXQ2jDFtz6HKWJP0uxXpNFPmdrE8kebmtqcIPDXjAf8zJ4f8A/BFN/wDJdH/CNeMD/wAzJ4f/APBFN/8AJdd3RRcqxwf/AAjPjD/oZNA/8EU3/wAl0n/CMeL/APoZNA/8EU3/AMl13tFFwscEfDHjA/8AMy6B/wCCKb/5LpB4X8XjP/FSaBz/ANQOb/5LrvqKLiscEPDHi8DH/CS6B/4Ipv8A5LpD4W8Xnr4k0D/wRTf/ACXXfUUXYWOC/wCEX8X4x/wkugY/7AU3/wAl0x/Cni5wobxLoPBDD/iRzdR/2916BRRdhZHAnwv4vPXxLoH/AIIpv/kumf8ACJ+Ls5/4SXQc+v8AYU3/AMl16DRRdhZHn/8Awivi7GP+El0H6/2FN/8AJdH/AAini7Of+Ek0DPr/AGFN/wDJdegUUXYWR5+fCni4/wDMy6D/AOCOb/5LpD4T8XY48S6CO/Ghzf8AyXXoNFF2Fkef/wDCKeLv+hl0H/wRTf8AyXTT4R8WFgT4k0AkdD/YU3H/AJN16FRRdhZHn3/CJ+Lv+hl0H/wRTf8AyXR/wifi7/oZdB/8EU3/AMl16DRRdhZHn3/CJeLu/iXQf/BHN/8AJdVpvAviSeaOabXvDryx/cdtBlJX6f6XXpVFF2HKjzz/AIRDxb/0Muhf+COX/wCS6D4P8Wk/8jNoX/gjl/8AkuvQ6KOZhyo87Pg7xYf+Zm0L/wAEc3/yXVK8+HfiG9kSS51/QZHUYBOiTDIznB/0vkZ7GvUaKOZi5UecHwX4rP8AzM2h/wDgjl/+S6Q+CfFZGP8AhJtD/wDBHL/8l16RRRzMfKjzf/hCvFf/AEM2h/8Agjl/+S6l0vwNrcfiPRtS1XX9OuYNNne4WC20t4GdmglhwXa4cAASk/d7dq9Doouw5UeZ/EL4aXvinxSNZsddtrDNlFZvDNp7XGfLeVwwYSpjPmkYwenWud/4UvrWf+Rs07/wSv8A/JNe3UVpGvUgrRehyVcvw1abqVIJtniX/Cl9a/6GzTv/AASv/wDJNH/CmNb/AOhs07/wSv8A/JNe20VX1qr/ADGX9k4P/n2jxL/hTGt/9DZpv/glf/5Jo/4Uvrf/AENmnf8Aglf/AOSa9too+s1f5g/snB/8+0eJf8KY1r/obNN/8Er/APyTQfgvrRPPizTv/BM//wAk17bRR9Zq/wAwf2Tg/wDn2jxH/hS2tf8AQ2ad/wCCZ/8A5Jpf+FL63/0Nunf+CZ//AJJr22ij6zV/mD+ycH/z7R4ifgtrX/Q2ad/4Jn/+SaQ/BXWj18Wad/4Jn/8Akmvb6KPrNX+YP7JwX/PtHiH/AApXWv8AobdO/wDBM/8A8k0n/ClNZ5/4qzTv/BK//wAk17hRR9Zq/wAwf2Rgv+faPD/+FKa1/wBDbp//AIJn/wDkml/4UprP/Q26d/4Jn/8Akmvb6KPrVX+YP7IwX/PtHh5+Cesn/mbdO/8ABM//AMk0n/CktY/6G3T/APwTP/8AJNe40UfWav8AMH9kYL/n2jw7/hSWs/8AQ26f/wCCZ/8A5JpD8EdYPXxbp/8A4Jn/APkmvcqKPrNX+YP7Jwf/AD7R4Z/wpDWP+ht0/wD8Ez//ACTR/wAKQ1j/AKG3T/8AwTP/APJNe50UvrFX+YP7Jwf/AD7R4X/wo/WP+htsP/BM/wD8k0f8KO1f/obdP/8ABM//AMk17pRR9YqfzD/srB/8+0eFf8KN1fH/ACNth/4Jn/8Akmk/4UZq+c/8JbYZ/wCwM/8A8k17tRR7ep3D+ysH/wA+0eE/8KM1f/obrD/wTP8A/JNH/CjNW/6G2w/8Ez//ACTXu1FL29TuH9lYT/n2jwj/AIUVq3/Q3WP/AIJn/wDkmk/4UTq3/Q3WP/gmf/5Jr3iij21TuP8AsvCf8+0eDf8ACiNV/wChusf/AATP/wDJNdt8Kvh3ceB7zWLm71iLUn1CO3jAiszbiMRGU95HznzfbGK9DoqZVJSVmzWlgqFGXPTgkwoooqDqP//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multinodular pheochromocytoma: General view and cross section. A rim of cortical tissue can be seen at the top.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Expert Review of Endocrinology &amp; Metabolism, September 2009, Vol. 4, No. 5, Pages 443-465 with permission of Expert Reviews Ltd.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5457=[""].join("\n");
var outline_f5_21_5457=null;
var title_f5_21_5458="Anthrax CSF gram stain";
var content_f5_21_5458=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F56832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F56832&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gram stain of cerebrospinal fluid containing Bacillus anthracis, displaying the characteristic \"boxcar- shaped\" morphology",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 323px; height: 375px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Sejvar, JJ, Tenover, FC, Stephens, DS. Management of antrax meningitis. Lancet Infect Dis 2005; 5:287. Copyright &copy;2005 Elsevier.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5458=[""].join("\n");
var outline_f5_21_5458=null;
var title_f5_21_5459="Patient information: Pelvic fracture (The Basics)";
var content_f5_21_5459=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/83612\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/13/41173\">",
"         Pelvis",
"        </a>",
"        <li>",
"         <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/13/18647\">",
"          Foods and drinks with calcium and vitamin D",
"         </a>",
"        </li>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?35/12/36034\">",
"         Patient information: Calcium and vitamin D for bone health (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?29/34/30243\">",
"         Patient information: Fractures (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?35/21/36179\">",
"         Patient information: Giving your child over-the-counter medicines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?14/33/14867\">",
"         Patient information: Hip fracture (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?39/15/40178\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?41/4/42050\">",
"         Patient information: Preventing falls (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?17/46/18146\">",
"         Patient information: Quitting smoking (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?22/60/23491\">",
"         Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?2/13/2262\">",
"         Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?19/13/19670\">",
"         Patient information: Quitting smoking (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Pelvic fracture (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/pelvic-fracture-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H867668125\">",
"      <span class=\"h1\">",
"       What is a pelvic fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A &ldquo;fracture&rdquo; is another word for a broken bone. A pelvic fracture is when a person breaks his or her pelvis (",
"      <a class=\"graphic graphic_figure graphicRef83511 \" href=\"UTD.htm?40/13/41173\">",
"       figure 1",
"      </a>",
"      ).",
"     </p>",
"     <p>",
"      There are different types of pelvic fractures, depending on the part of the pelvis that breaks and how it breaks.",
"     </p>",
"     <p>",
"      Some pelvic fractures happen after falls or sports injuries. But most pelvic fractures happen from car accidents or other severe injuries. In these cases, the injury causing the pelvic fracture can also damage organs, nerves, and blood vessels near the pelvis.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668140\">",
"      <span class=\"h1\">",
"       What are the symptoms of a pelvic fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Symptoms of a pelvic fracture can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Pain",
"       </li>",
"       <li>",
"        Swelling",
"       </li>",
"       <li>",
"        Bruising",
"       </li>",
"       <li>",
"        Trouble walking or pain when walking",
"       </li>",
"       <li>",
"        Weakness or loss of feeling in the legs",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668155\">",
"      <span class=\"h1\">",
"       Is there a test for a pelvic fracture?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. Tests to check for a pelvic fracture can include:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        An X-ray of the pelvis",
"       </li>",
"       <li>",
"        An imaging test of the pelvis, such as a CT scan &ndash; Imaging tests create pictures of the inside of the body.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668170\">",
"      <span class=\"h1\">",
"       How is a pelvic fracture treated?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Treatment depends on the type of pelvic fracture you have and how severe it is.",
"     </p>",
"     <p>",
"      A mild pelvic fracture is usually treated with:",
"     </p>",
"     <p>",
"      <ul class=\"bullet-block\">",
"       <li>",
"        Rest",
"       </li>",
"       <li>",
"        Ice &ndash; You can put a cold gel pack, bag of ice, or bag of frozen vegetables on the area every 1 to 2 hours, for 15 minutes each time. Put a thin towel between the ice (or other cold object) and the skin. Use the ice (or other cold object) for at least 6 hours after the injury. Some people find it helpful to ice up to 2 days after an injury.",
"       </li>",
"       <li>",
"        Crutches or a walker to help with walking",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Right after an injury, doctors usually treat a severe pelvic fracture by putting a splint or other binding material around the pelvis to hold it in place.",
"     </p>",
"     <p>",
"      Then a severe pelvic fracture is treated with surgery to put the pelvis back in the correct position. During surgery, the doctor might:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Use screws, pins, rods, or plates to fix the bone inside the body",
"       </li>",
"       <li>",
"        Put pins or screws through the skin and into the bone, and then attach the pins or screws to a bar that is outside the skin",
"       </li>",
"      </ul>",
"     </p>",
"     <p>",
"      Treatment for a pelvic fracture also includes medicine to treat the pain. Doctors can prescribe a strong pain medicine if people have a lot of pain or a severe fracture. For mild fractures, doctors usually recommend that people take an over-the-counter pain medicine. Over-the-counter medicines include",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?19/35/20021?source=see_link\">",
"       acetaminophen",
"      </a>",
"      (sample brand name: Tylenol&reg;),",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?14/17/14614?source=see_link\">",
"       ibuprofen",
"      </a>",
"      (sample brand names: Advil&reg;, Motrin&reg;), and",
"      <a class=\"drug drug_patient\" href=\"UTD.htm?43/35/44597?source=see_link\">",
"       naproxen",
"      </a>",
"      (sample brand names: Aleve&reg;, Naprosyn&reg;).",
"     </p>",
"     <p>",
"      After surgery and after your bones are mostly healed, you will work with a physical therapist (exercise expert). He or she will teach you exercises to make the muscles around your pelvis stronger. He or she will also work with you on bending, walking, and climbing stairs so you can move normally again.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668185\">",
"      <span class=\"h1\">",
"       How long does a pelvic fracture take to heal?",
"      </span>",
"      &nbsp;&mdash;&nbsp;A pelvic fracture usually takes months to heal, depending on the fracture.",
"     </p>",
"     <p>",
"      Healing time also depends on the person. Healthy children usually heal much more quickly than older adults or adults with other medical problems.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668200\">",
"      <span class=\"h1\">",
"       Can I do anything to improve the healing process?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. It&rsquo;s important to follow all of your doctor&rsquo;s instructions while your fracture is healing. Plus, doctors usually recommend that people with a fracture:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        Eat a healthy diet that includes getting enough calcium, vitamin D, and protein (",
"        <a class=\"graphic graphic_figure graphicRef79375 \" href=\"UTD.htm?18/13/18647\">",
"         figure 2",
"        </a>",
"        ).",
"       </li>",
"       <li>",
"        Stop smoking. A fracture can take longer to heal if you smoke.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668238\">",
"      <span class=\"h1\">",
"       When should I call my doctor or nurse?",
"      </span>",
"      &nbsp;&mdash;&nbsp;After treatment, your doctor or nurse will tell you when to call him or her. In general, you should call him or her if:",
"     </p>",
"     <p>",
"      <ul class=\"bulletCompact-block\">",
"       <li>",
"        You get a fever.",
"       </li>",
"       <li>",
"        You have severe pain, or your pain or swelling gets worse.",
"       </li>",
"       <li>",
"        Your leg gets swollen or you see red streaks on your leg.",
"       </li>",
"       <li>",
"        You have chest pain, trouble breathing, or dizziness.",
"       </li>",
"       <li>",
"        Fluid or pus drains out of the cut from your surgery.",
"       </li>",
"       <li>",
"        You get an open sore on your skin.",
"       </li>",
"      </ul>",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H867668253\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30243?source=see_link\">",
"       Patient information: Fractures (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?14/33/14867?source=see_link\">",
"       Patient information: Hip fracture (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=see_link\">",
"       Patient information: Giving your child over-the-counter medicines (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=see_link\">",
"       Patient information: Quitting smoking (The Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?41/4/42050?source=see_link\">",
"       Patient information: Preventing falls (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=see_link\">",
"       Patient information: Quitting smoking (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=see_link\">",
"       Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"      </a>",
"      <br/>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=see_link\">",
"       Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 14, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?5/21/5459?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 83612 Version 1.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-79.122.249.114-555B9DE994-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5459=[""].join("\n");
var outline_f5_21_5459=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668125\">",
"      What is a pelvic fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668140\">",
"      What are the symptoms of a pelvic fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668155\">",
"      Is there a test for a pelvic fracture?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668170\">",
"      How is a pelvic fracture treated?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668185\">",
"      How long does a pelvic fracture take to heal?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668200\">",
"      Can I do anything to improve the healing process?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668238\">",
"      When should I call my doctor or nurse?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H867668253\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/83612\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?40/13/41173\">",
"      Pelvis",
"     </a>",
"     <li>",
"      <a class=\"graphic graphic_figure\" href=\"UTD.htm?18/13/18647\">",
"       Foods and drinks with calcium and vitamin D",
"      </a>",
"     </li>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?22/60/23491?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/12/36034?source=related_link\">",
"      Patient information: Calcium and vitamin D for bone health (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?29/34/30243?source=related_link\">",
"      Patient information: Fractures (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?35/21/36179?source=related_link\">",
"      Patient information: Giving your child over-the-counter medicines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?14/33/14867?source=related_link\">",
"      Patient information: Hip fracture (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?2/13/2262?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?39/15/40178?source=related_link\">",
"      Patient information: Nonsteroidal antiinflammatory drugs (NSAIDs) (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?41/4/42050?source=related_link\">",
"      Patient information: Preventing falls (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?19/13/19670?source=related_link\">",
"      Patient information: Quitting smoking (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?17/46/18146?source=related_link\">",
"      Patient information: Quitting smoking (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_21_5460="Incisions for mastectomy";
var content_f5_21_5460=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F59388&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F59388&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 609px\">",
"   <div class=\"ttl\">",
"    Incisions for mastectomy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 589px; height: 405px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    (A) A practical incision based on that of Stewart is planned by choosing two points, in line with the nipple, to either side of the breast, with the lateral site along the posterior axillary fold, under the hairline.",
"    <br>",
"     (B) The breast skin is pulled down orthogonal to that imaginary line and a straight line drawn between the points.",
"     <br>",
"      (C) The breast is pushed up orthogonal to the imaginary line between the two points and a lower straight line drawn between the points below the nipple.",
"      <br>",
"       (D) With the breast relaxed, an ellipse has formed, which will close relatively ���������at against the chest.",
"       <div class=\"footnotes\">",
"       </div>",
"       <div class=\"reference\">",
"        Reproduced with permission from: Shaughnessy EA. Simple mastectomy. In: Master Techniques in General Surgery: Breast Surgery, Bland KI, Klimberg SV (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"       </div>",
"       <div class=\"contractual\">",
"        <br/>",
"        <a href=\"file://www.lww.com\">",
"         file://www.lww.com",
"        </a>",
"       </div>",
"      </br>",
"     </br>",
"    </br>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5460=[""].join("\n");
var outline_f5_21_5460=null;
var title_f5_21_5461="Cefdinir: Drug information";
var content_f5_21_5461=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Cefdinir: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?16/40/17028?source=see_link\">",
"    see \"Cefdinir: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=see_link\">",
"    see \"Cefdinir: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F147178\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Omnicef&reg; [DSC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F147198\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Antibiotic, Cephalosporin (Third Generation)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F147182\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute exacerbations of chronic bronchitis, pharyngitis/tonsillitis:",
"     </b>",
"     Oral: 300 mg twice daily for 5-10 days",
"     <b>",
"      or",
"     </b>",
"     600 mg once daily for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Acute maxillary sinusitis:",
"     </b>",
"     Oral: 300 mg twice daily",
"     <b>",
"      or",
"     </b>",
"     600 mg once daily for 10 days",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Community-acquired pneumonia, uncomplicated skin and skin structure infections:",
"     </b>",
"     Oral: 300 mg twice daily for 10 days",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F147192\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=see_link\">",
"      see \"Cefdinir: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <i>",
"      Children 6 months to 12 years:",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Acute bacterial otitis media, pharyngitis/tonsillitis:",
"     </b>",
"     Oral: 7 mg/kg/dose twice daily for 5-10 days",
"     <b>",
"      or",
"     </b>",
"     14 mg/kg/dose once daily for 10 days (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Acute maxillary sinusitis:",
"     </b>",
"     Oral: 7 mg/kg/dose twice daily",
"     <b>",
"      or",
"     </b>",
"     14 mg/kg/dose once daily for 10 days (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <b>",
"      Uncomplicated skin and skin structure infections:",
"     </b>",
"     Oral:  7 mg/kg/dose twice daily for 10 days (maximum: 600 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <i>",
"      Children &gt;12 years:",
"     </i>",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F147183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F147184\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: 7 mg/kg once daily (maximum: 300 mg/day)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 300 mg once daily",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     Hemodialysis removes cefdinir; recommended initial dose: 300 mg (or 7 mg/kg/dose) every other day. At the conclusion of each hemodialysis session, 300 mg (or 7 mg/kg/dose) should be given. Subsequent doses (300 mg or 7 mg/kg/dose) should be administered every other day.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F5219912\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No adjustment necessary.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F147161\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Capsule, oral: 300 mg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Omnicef&reg;: 300 mg [DSC]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Powder for suspension, oral: 125 mg/5 mL (60 mL, 100 mL); 250 mg/5 mL (60 mL, 100 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Omnicef&reg;: 125 mg/5 mL (60 mL [DSC], 100 mL [DSC]); 250 mg/5 mL (60 mL [DSC], 100 mL [DSC]) [contains sodium benzoate, sucrose 2.86 g/5 mL; strawberry flavor]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F147146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F854709\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Twice daily doses should be given every 12 hours. May be administered with or without food. Manufacturer recommends administering at least 2 hours before or after antacids or iron supplements. Shake suspension well before use.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F147162\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of community-acquired pneumonia, acute exacerbations of chronic bronchitis, acute bacterial otitis media, acute maxillary sinusitis, pharyngitis/tonsillitis, and uncomplicated skin and skin structure infections.",
"    </p>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F147196\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &gt;10%: Gastrointestinal: Diarrhea (8% to 15%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     1% to 10%:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Central nervous system: Headache (2%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Dermatologic: Rash (&le;3%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Endocrine &amp; metabolic: Bicarbonate decreased (&le;1%), hyperglycemia (&le;1%), hyperphosphatemia (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Gastrointestinal: Nausea (&le;3%), abdominal pain (&le;1%), vomiting (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Genitourinary: Vaginal moniliasis (&le;4%), urine leukocytes increased (&le;2%), urine pH increased (&le;1%), urine specific gravity increased (&le;1%), vaginitis (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hematologic: Lymphocytes increased (&le;2%), eosinophils increased (1%), lymphocytes decreased (1%), platelets increased (&le;1%), PMN changes (&le;1%), WBC decreased/increased (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Hepatic: Alkaline phosphatase increased (&le;1%), ALT increased (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Renal: Proteinuria (1% to 2%), microhematuria (&le;1%), glycosuria (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Miscellaneous: GGT increased (&le;1%), lactate dehydrogenase increased (&le;1%)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     &lt;1%, postmarketing, and/or case reports: Allergic vasculitis, amylase increased, anaphylaxis, anorexia, asthma, AST increased, bilirubin increased, bleeding tendency, bloody diarrhea, BUN increased, cardiac failure, chest pain, cholestasis, coagulation disorder, conjunctivitis, constipation, cutaneous moniliasis, disseminated intravascular coagulation (DIC), dizziness, dyspepsia, enterocolitis (acute), eosinophilic pneumonia, erythema multiforme, erythema nodosum, exfoliative dermatitis, facial edema, fever, flatulence, fulminant hepatitis, granulocytopenia, hemoglobin decreased, hemolytic anemia, hemorrhagic colitis, hepatic failure, hepatitis (acute), hyperkalemia, hyperkinesia, hypertension, hypocalcemia, hypophosphatemia, idiopathic thrombocytopenia purpura, ileus, insomnia, interstitial pneumonia (idiopathic), involuntary movement, jaundice, laryngeal edema, leukopenia, leukorrhea, loss of consciousness, maculopapular rash, melena, moniliasis, monocytes increased, myocardial infarction, nephropathy, pancytopenia, peptic ulcer, pneumonia (drug-induced), pruritus, pseudomembranous colitis, renal failure (acute), respiratory failure (acute), rhabdomyolysis, serum sickness, shock, somnolence, Stevens-Johnson syndrome, stomatitis, stools abnormal, thrombocytopenia, toxic epidermal necrolysis, upper GI bleed, urine specific gravity decreased,  weakness, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Additional reactions reported with other cephalosporins: Agranulocytosis, angioedema, aplastic anemia, asterixis, encephalopathy, hemorrhage, interstitial nephritis, neuromuscular excitability, PT prolonged, seizure, superinfection, and toxic nephropathy",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F147166\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to cefdinir, any component of the formulation, other cephalosporins, or related antibiotics",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F147150\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Penicillin allergy: Use with caution in patients with a history of penicillin allergy, especially IgE-mediated reactions (eg, anaphylaxis, angioedema, urticaria).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Superinfection: Prolonged use may result in fungal or bacterial superinfection, including",
"     <i>",
"      C. difficile",
"     </i>",
"     -associated diarrhea (CDAD) and pseudomembranous colitis; CDAD has been observed &gt;2 months postantibiotic treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;30 mL/minute); dosage adjustment may be required.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13298986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F147155\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aminoglycosides: Cephalosporins (3rd Generation) may enhance the nephrotoxic effect of Aminoglycosides.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     BCG: Antibiotics may diminish the therapeutic effect of BCG.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the serum concentration of Cefdinir. Red-appearing, non-bloody stools may also develop due to the formation of an insoluble iron-cefdinir complex. Management: Avoid concurrent cefdinir and oral iron when possible.  Separating doses by several hours may minimize interaction.  Iron-containing infant formulas do not appear to interact with cefdinir.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Cefdinir. Specifically, Iron Salts may decrease the serum concentration of Cefdinir. Red-appearing, non-bloody stools may also develop due to the formation of an insoluble iron-cefdinir complex. Management: Avoid concurrent cefdinir and oral iron-containing multivitamins when possible. Separating doses by several hours may minimize interaction. Iron-containing infant formulas do not appear to interact with cefdinir.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Probenecid: May increase the serum concentration of Cephalosporins.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Vaccination with live attenuated typhoid vaccine (Ty21a) should be avoided in patients being treated with systemic antibacterial agents.  Use of this vaccine should be postponed until at least 24 hours after cessation of antibacterial agents.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Vitamin K Antagonists (eg, warfarin): Cephalosporins may enhance the anticoagulant effect of Vitamin K Antagonists.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F147157\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     B (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F854704\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Teratogenic events have not been observed in animal reproduction studies. An increase in most types of birth defects was not found following first trimester exposure to cephalosporins.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F147187\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F854705\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Cefdinir is not detectable in breast milk following a single cefdinir 600 mg dose. If present in breast milk, nondose-related effects could include modification of bowel flora.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F147168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Capsules",
"     </b>",
"     (Cefdinir Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     300 mg (60): $306.83",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Suspension (reconstituted)",
"     </b>",
"     (Cefdinir Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     125 mg/5 mL (60 mL): $51.00",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     250 mg/5 mL (60 mL): $99.48",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F147159\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Monitor renal function. Observe for signs and symptoms of anaphylaxis during first dose.",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F147169\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Adcef (IN);",
"     </li>",
"     <li>",
"      Anicef (KP);",
"     </li>",
"     <li>",
"      Anycef (KP);",
"     </li>",
"     <li>",
"      Cefnaxl (PH);",
"     </li>",
"     <li>",
"      Cefnir (PK);",
"     </li>",
"     <li>",
"      Cefralin (PE);",
"     </li>",
"     <li>",
"      Cefzon (CL, JP);",
"     </li>",
"     <li>",
"      Nirocef (PH);",
"     </li>",
"     <li>",
"      Omicef (PH);",
"     </li>",
"     <li>",
"      Omnicef (AE, BB, BH, BM, BS, BZ, CY, EG, GY, ID, IL, IQ, IR, JM, JO, KP, KW, LB, LY, NL, OM, PR, QA, SA, SE, SR, SY, TH, TT, YE);",
"     </li>",
"     <li>",
"      Omnicef R (MX);",
"     </li>",
"     <li>",
"      Onicef (PH);",
"     </li>",
"     <li>",
"      Samnir (TH);",
"     </li>",
"     <li>",
"      Sefdin (IN)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F147149\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F147165\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Distribution: V",
"     <sub>",
"      d",
"     </sub>",
"     :",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 6 months to 12 years: 0.29-1.05 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Adults: 0.06-0.64 L/kg",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Protein binding: 60% to 70%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Minimal",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability: Capsule: 16% to 21%; suspension 25%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life elimination: ~100 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak, plasma: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Primarily urine (7% to 25% as unchanged drug)",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Bradley JS, Byington CL, Shah SS, et al.  &ldquo;The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America&rdquo;,",
"      <i>",
"       Clin Infect Dis",
"      </i>",
"      , 2011, 53(7):e25-76.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/21/5461/abstract-text/21880587/pubmed\" id=\"21880587\" target=\"_blank\">",
"        21880587",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Marshall WF and Blair JE, &ldquo;The Cephalosporins,&rdquo;",
"      <i>",
"       Mayo Clin Proc",
"      </i>",
"      , 1999, 74(2):187-95.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/21/5461/abstract-text/10069359/pubmed\" id=\"10069359\" target=\"_blank\">",
"        10069359",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8602 Version 39.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-61.234.146.186-EA4EE1DDAC-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5461=[""].join("\n");
var outline_f5_21_5461=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147178\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147198\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147182\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147192\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147183\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147184\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5219912\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147161\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147146\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F854709\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147162\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147196\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147166\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147150\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298986\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147155\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147157\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F854704\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147187\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F854705\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147168\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147159\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147169\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147149\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F147165\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8602\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/8602|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?16/40/17028?source=related_link\">",
"      Cefdinir: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?6/2/6181?source=related_link\">",
"      Cefdinir: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_21_5462="Management of the fetus in occiput posterior position";
var content_f5_21_5462=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of the fetus in occiput posterior position",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Cynthia Holcroft Argani, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Andrew J Satin, MD, FACOG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Susan M Ramin, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5462/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/21/5462/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 8, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Over 95 percent of fetuses are in cephalic presentation at term. The position of the fetal occiput can be anterior, transverse or posterior (",
"    <a class=\"graphic graphic_figure graphicRef63528 graphicRef73262 graphicRef52247 \" href=\"UTD.htm?42/5/43093\">",
"     figure 1A-C",
"    </a>",
"    ). Fifteen to 20 percent of term fetuses are in occiput posterior (OP) position before labor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Most of these fetuses rotate intrapartum: the incidence at vaginal birth is approximately 5 percent. Persistence of the OP position is important because it can be associated with labor abnormalities and maternal and neonatal complications (eg, birth trauma, neonatal acidosis) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It had been assumed that the OP position at birth resulted from failure of an OP fetus to spontaneously rotate to occiput anterior (OA) position. Sonographic studies of fetal position have challenged this assumption and suggested that the OP position is actually often the result of malrotation from an OA position. As an example, a study that performed ultrasounds on 270 cephalic fetuses &ge;36 weeks of gestation prior to induction found that 17 of 25 fetuses delivered from the OP position had been in a non-OP position prior to labor [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISK FACTORS AND CONSEQUENCES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for OP position at delivery include [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/4-9\">",
"     4-9",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Nulliparity",
"     </li>",
"     <li>",
"      Maternal age greater than 35 years",
"     </li>",
"     <li>",
"      Obesity",
"     </li>",
"     <li>",
"      African-American race",
"     </li>",
"     <li>",
"      Previous OP delivery",
"     </li>",
"     <li>",
"      Decreased pelvic outlet capacity",
"     </li>",
"     <li>",
"      Gestational age &ge;41 weeks",
"     </li>",
"     <li>",
"      Birthweight &ge;4000 g",
"     </li>",
"     <li>",
"      Prolonged first",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      second stage of labor",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Because the OP position can prolong the first and second stages of labor, these labors are more likely to undergo interventions, such as artificial rupture of membranes,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?5/0/5125?source=see_link\">",
"     oxytocin",
"    </a>",
"    augmentation, and operative delivery (vaginal, abdominal), and the mothers experience more delivery-related complications, such as anal sphincter injury [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/4,5,9-17\">",
"     4,5,9-17",
"    </a>",
"    ]. In a series of 16,781 nulliparas, the rate of operative vaginal delivery was almost twice as high for the OP position compared with the OA position (44 and 24 percent, respectively); the rate of cesarean delivery was three-fold higher for OP position than OA position (42 and 14 percent, respectively) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Neonatal complications associated with delivery in the OP position include a higher risk of five-minute Apgar score less than 7 (OR 1.5, 95% CI 1.17-1.91), umbilical artery acidemia (OR 2.92, OR 1.84-4.62), meconium-stained amniotic fluid (OR 1.29, 95% CI 1.17-1.42), birth trauma (OR 1.77, 95% CI 1.22-2.57), and neonatal intensive care admission (OR 1.57, 95% CI 1.28-1.92) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/3\">",
"     3",
"    </a>",
"    ]. Vaginal delivery of the OP fetus is associated with a lower rate of shoulder dystocia than other cephalic positions; however, in the event of a shoulder dystocia, there is a higher rate of brachial plexus injury in the neonate [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Epidural analgesia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Whether epidural analgesia has a causative role in OP position at delivery is controversial. Most studies, but not all [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/15,19\">",
"     15,19",
"    </a>",
"    ], have observed that epidural analgesia is more likely to be in place when the position at birth is OP than when it is OA [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/4-7,15,16\">",
"     4-7,15,16",
"    </a>",
"    ]. It is possible that the effect of the epidural anesthetic on the pelvic musculature either promotes fetal rotation to OP or inhibits rotation from OP; alternatively, more painful and prolonged labors associated with OP position may cause women to request epidurals more often than with the OA position.",
"   </p>",
"   <p>",
"    The relationship between epidural analgesia and fetal position was evaluated in a prospective cohort study including 1562 nulliparous women in labor with term singleton cephalic presentations [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/7\">",
"     7",
"    </a>",
"    ]. Serial ultrasound examinations of fetal position were performed at study enrollment, at epidural administration or at four hours after the initial sonogram if no epidural was administered, and after 8 cm dilation. Position at delivery was also assessed [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/7\">",
"     7",
"    </a>",
"    ]. Overall, 92 percent of women received a labor epidural. Major findings of the study were:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The OP position did not appear to cause more painful labors or \"back labor.\" At the time of the request, women who requested epidurals were no more likely to have a fetus in the OP position than women who did not request epidurals: the proportion of fetuses in the OP position was the same at the time of epidural placement and four hours after study enrollment if an epidural was not placed.",
"     </li>",
"     <li>",
"      Although women who requested epidurals and those who did not receive labor epidurals had a similar proportion of fetuses in OP position in early active labor, at delivery the epidural group had a significantly higher proportion of OP fetuses (all deliveries: 12.9 versus 3.3 percent; all vaginal births: 10.2 versus 1.9 percent).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These data suggest that pelvic musculature relaxation associated with epidural analgesia leads to malpositioning of the fetal head, and this is an important mechanism for OP position at delivery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnosis of OP position is generally made by digital examination, but if there is uncertainty, ultrasound examination is both useful and accurate [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/1,20-22\">",
"     1,20-22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Digital or sonographic [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/23\">",
"     23",
"    </a>",
"    ] assessment of occipital position is a poor predictor of eventual need for cesarean delivery. Expectant management of OP position is appropriate in the presence of a reassuring fetal heart rate, favorable clinical pelvimetry, and continued progress in the second stage. Multiparous women with persistent OP fetuses are more likely to achieve spontaneous vaginal delivery than nulliparas (55 to 57 versus 26 to 29 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/4,8,15\">",
"     4,8,15",
"    </a>",
"    ]. Asking the laboring woman to assume a position, such as knees on bed with",
"    <span class=\"nowrap\">",
"     chest/arms",
"    </span>",
"    on an exercise ball, does not enhance anterior rotation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The management of a definite arrest of descent of the OP fetus is less clear. No randomized trials comparing the various approaches have been conducted. Options include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Rotation to OA position manually or with forceps [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/25-28\">",
"       25-28",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Operative delivery from OP position",
"     </li>",
"     <li>",
"      Cesarean delivery",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Manual rotation",
"    </span>",
"    &nbsp;&mdash;&nbsp;We avoid performing manual rotation in the first stage of labor because it may disengage the fetal head, which could lead to prolapse of the umbilical cord or small parts. Rotation before full dilatation is also less successful than rotation in the second stage [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/25\">",
"     25",
"    </a>",
"    ]. The optimum time for rotation during the second stage has not been studied, but prophylactic manual rotation is more likely to be successful than a procedure performed after arrest of descent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We define prophylactic rotation as rotation at the beginning of the second stage, regardless of the station of the fetal head. We do not routinely perform prophylactic rotations, but consider its use in two main scenarios: first, if there is a need for more expeditious delivery, and second, if there has been minimal or slow descent after a trial of pushing.",
"   </p>",
"   <p>",
"    The maternal bladder is emptied prior to the procedure.",
"   </p>",
"   <p>",
"    A hand is inserted into the vagina with the palm upward. Digital rotation is performed by placing the tips of the index and middle fingers in the anterior segment of the lambdoidal suture near the posterior fontanelle (",
"    <a class=\"graphic graphic_figure graphicRef79764 \" href=\"UTD.htm?10/54/11104\">",
"     figure 2",
"    </a>",
"    ). The fingers are used to flex and slightly dislodge the vertex, rotating the fetal head to the OA position via rotation of the operator's hand and forearm. The thumb may also be used with gentle downward pressure more anteriorly on the parietal bone to aid in this rotation. The fetal head may need to be held in place for a few contractions to prevent rotation back toward the posterior position [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Manual rotation can also be performed by placing the operator's four fingers behind the posterior parietal bone with the palm up and the thumb over the anterior parietal bone. The right hand is used for left OP position and the left hand is used for right OP position. The head is grasped with the tips of the fingers and thumb. During a contraction, the patient is encouraged to push and the operator attempts to flex and rotate the fetal head anteriorly (",
"    <a class=\"graphic graphic_figure graphicRef61902 \" href=\"UTD.htm?11/33/11796\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/25,31\">",
"     25,31",
"    </a>",
"    ]. Occasional, mild upward pressure may help to slightly displace the station and facilitate rotation.",
"   </p>",
"   <p>",
"    A study in which manual rotation from the OP or occiput transverse position was attempted in 796 patients reported 90 percent of fetuses were successfully rotated to an anterior position, although multiple attempts were sometimes required [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Manual rotation is more successful in multiparous women and women less than 35 years of age [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/32\">",
"     32",
"    </a>",
"    ]. Cesarean delivery is common after a failed manual rotation (cesarean delivery rate 34 to 59 percent versus 2 to 4 percent if rotation is successful [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/25,32\">",
"     25,32",
"    </a>",
"    ]). However, if prompt delivery is indicated, failed manual rotation may be followed by vacuum or forceps delivery from the OP position, in an appropriately assessed patient. Manual rotation performed prior to instrumental birth has little or no increase in risk to the pregnant woman or to the fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/29,30\">",
"     29,30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Forceps rotation",
"    </span>",
"    &nbsp;&mdash;&nbsp;The performance of rotational forceps should be reserved to those experienced and skilled in their art, due to the high risk of potential complications. These procedures are beyond the scope of this topic review.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Operative vaginal delivery from the OP position",
"    </span>",
"    &nbsp;&mdash;&nbsp;Forceps or vacuum can be used to deliver the fetus from the direct OP position. Delivery from OP position rather than rotation is probably preferable in woman who on clinical examination have ample room between the fetal occiput and maternal",
"    <span class=\"nowrap\">",
"     sacrum/coccyx",
"    </span>",
"    and when the pelvis is too narrow to permit anterior rotation (women with an anthropoid pelvis with a narrow transverse diameter and women with an android pelvis with a narrow arch). The usual criteria for operative vaginal delivery also apply to the OP position; we do not perform elective operative vaginal deliveries for fetuses above +2 station.",
"   </p>",
"   <p>",
"    OP position is associated with a significantly higher rate of failed operative vaginal delivery than OA position [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/14\">",
"     14",
"    </a>",
"    ]. Because the flexion point on OP presentations is positioned more posterior and higher in the vagina than with OA presentations, certain adjustments must be employed when performing vacuum extraction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42903?source=see_link&amp;anchor=H6#H6\">",
"     \"Procedure for vacuum assisted operative vaginal delivery\", section on 'Instrumentation'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There is no demonstrated advantage to forceps over vacuum delivery for OP fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/14\">",
"     14",
"    </a>",
"    ]. We make our choice based on individual patient factors. As an example, for a tired nulliparous woman with an edematous perineum and fetus at or near the outlet, we prefer a vacuum delivery. For a multiparous patient at +2 station with fetal bradycardia, we would perform a forceps delivery.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     AVOIDANCE OF OP POSITION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pregnant women are often advised to perform exercises to facilitate anterior rotation of the fetus, but there is no high quality evidence that these maneuvers are effective. The lack of benefit was best illustrated by a large, multicenter, randomized trial that assigned 2547 women at 36 to 37 weeks of gestation to one of two exercise programs [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5462/abstract/33\">",
"     33",
"    </a>",
"    ]. Group 1 was told to take a daily walk and Group 2 was asked to assume a hands and knees position with slow pelvic rocking for 10 minutes twice a day until labor began. The incidence of persistent OP position at birth or before instrumental rotation was similar (8 percent) in both groups. x",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Fifteen to 20 percent of term cephalic fetuses are in occiput posterior (OP) position before labor and approximately 5 percent are OP at delivery. Most fetuses rotate to occiput anterior (OA) position, some maintain a persistent OP position, and others rotate from OA to OP position. (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Occiput posterior position is associated with labor abnormalities and a variety of maternal and neonatal complications. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Risk factors and consequences'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The effect of epidural analgesia on the pelvic musculature may promote fetal rotation to OP or inhibit rotation from OP; alternatively, more painful and prolonged labors associated with OP position may cause women to request epidurals more often than with the OA position. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Epidural analgesia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Expectant management of OP position is appropriate in the presence of a reassuring fetal heart rate, favorable clinical pelvimetry, and continued progress in the second stage. More than 50 percent of multiparous women and more than 25 percent of nulliparous women with persistently OP fetuses achieve spontaneous vaginal delivery. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We do not routinely perform prophylactic rotation at the beginning of the second stage, although we do consider manual or digital rotation if there is a need for more expeditious delivery or if there has been minimal or slow descent after a trial of pushing. We have no preference for manual versus digital rotation. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We suggest delivery from OP position rather than rotation in women who, on clinical examination, have ample room between the fetal occiput and maternal",
"      <span class=\"nowrap\">",
"       sacrum/coccyx",
"      </span>",
"      and when the pelvis is too narrow to permit anterior rotation (women with an anthropoid pelvis with a narrow transverse diameter and women with an android pelvis with a narrow arch) (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Operative vaginal delivery from the OP position'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      Operative vaginal delivery should not be attempted above +2 station.",
"     </li>",
"     <li>",
"      There is no effective method to facilitate rotation from occiput posterior to occiput anterior before labor. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Avoidance of op position'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/1\">",
"      Gardberg M, Laakkonen E, S&auml;levaara M. Intrapartum sonography and persistent occiput posterior position: a study of 408 deliveries. Obstet Gynecol 1998; 91:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/2\">",
"      Peregrine E, O'Brien P, Jauniaux E. Impact on delivery outcome of ultrasonographic fetal head position prior to induction of labor. Obstet Gynecol 2007; 109:618.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/3\">",
"      Cheng YW, Shaffer BL, Caughey AB. The association between persistent occiput posterior position and neonatal outcomes. Obstet Gynecol 2006; 107:837.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/4\">",
"      Ponkey SE, Cohen AP, Heffner LJ, Lieberman E. Persistent fetal occiput posterior position: obstetric outcomes. Obstet Gynecol 2003; 101:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/5\">",
"      Cheng YW, Shaffer BL, Caughey AB. Associated factors and outcomes of persistent occiput posterior position: A retrospective cohort study from 1976 to 2001. J Matern Fetal Neonatal Med 2006; 19:563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/6\">",
"      Le Ray C, Carayol M, Jaquemin S, et al. Is epidural analgesia a risk factor for occiput posterior or transverse positions during labour? Eur J Obstet Gynecol Reprod Biol 2005; 123:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/7\">",
"      Lieberman E, Davidson K, Lee-Parritz A, Shearer E. Changes in fetal position during labor and their association with epidural analgesia. Obstet Gynecol 2005; 105:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/8\">",
"      Floberg J, Belfrage P, Ohls&eacute;n H. Influence of the pelvic outlet capacity on fetal head presentation at delivery. Acta Obstet Gynecol Scand 1987; 66:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/9\">",
"      Sen&eacute;cal J, Xiong X, Fraser WD, Pushing Early Or Pushing Late with Epidural study group. Effect of fetal position on second-stage duration and labor outcome. Obstet Gynecol 2005; 105:763.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/10\">",
"      Wheeler TL 2nd, Richter HE. Delivery method, anal sphincter tears and fecal incontinence: new information on a persistent problem. Curr Opin Obstet Gynecol 2007; 19:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/11\">",
"      Lowder JL, Burrows LJ, Krohn MA, Weber AM. Risk factors for primary and subsequent anal sphincter lacerations: a comparison of cohorts by parity and prior mode of delivery. Am J Obstet Gynecol 2007; 196:344.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/12\">",
"      Fitzgerald MP, Weber AM, Howden N, et al. Risk factors for anal sphincter tear during vaginal delivery. Obstet Gynecol 2007; 109:29.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/13\">",
"      Wu JM, Williams KS, Hundley AF, et al. Occiput posterior fetal head position increases the risk of anal sphincter injury in vacuum-assisted deliveries. Am J Obstet Gynecol 2005; 193:525.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/14\">",
"      Ben-Haroush A, Melamed N, Kaplan B, Yogev Y. Predictors of failed operative vaginal delivery: a single-center experience. Am J Obstet Gynecol 2007; 197:308.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/15\">",
"      Fitzpatrick M, McQuillan K, O'Herlihy C. Influence of persistent occiput posterior position on delivery outcome. Obstet Gynecol 2001; 98:1027.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/16\">",
"      Sizer AR, Nirmal DM. Occipitoposterior position: associated factors and obstetric outcome in nulliparas. Obstet Gynecol 2000; 96:749.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/17\">",
"      Mazouni C, Porcu G, Bretelle F, et al. Risk factors for forceps delivery in nulliparous patients. Acta Obstet Gynecol Scand 2006; 85:298.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/18\">",
"      Cheng YW, Norwitz ER, Caughey AB. The relationship of fetal position and ethnicity with shoulder dystocia and birth injury. Am J Obstet Gynecol 2006; 195:856.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/19\">",
"      Yancey MK, Zhang J, Schweitzer DL, et al. Epidural analgesia and fetal head malposition at vaginal delivery. Obstet Gynecol 2001; 97:608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/20\">",
"      Rouse DJ, Owen J, Hauth JC. Active-phase labor arrest: oxytocin augmentation for at least 4 hours. Obstet Gynecol 1999; 93:323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/21\">",
"      Akmal S, Kametas N, Tsoi E, et al. Comparison of transvaginal digital examination with intrapartum sonography to determine fetal head position before instrumental delivery. Ultrasound Obstet Gynecol 2003; 21:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/22\">",
"      Chou MR, Kreiser D, Taslimi MM, et al. Vaginal versus ultrasound examination of fetal occiput position during the second stage of labor. Am J Obstet Gynecol 2004; 191:521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/23\">",
"      Verhoeven C, Ruckert M, Opmeer B, et al. Ultrasonographic fetal head position to predict mode of delivery: a systematic review and bivariate meta-analysis. Ultrasound Obstet Gynecol 2012; 40:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/24\">",
"      Desbriere R, Blanc J, Le D&ucirc; R, et al. Is maternal posturing during labor efficient in preventing persistent occiput posterior position? A randomized controlled trial. Am J Obstet Gynecol 2013; 208:60.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/25\">",
"      Le Ray C, Serres P, Schmitz T, et al. Manual rotation in occiput posterior or transverse positions: risk factors and consequences on the cesarean delivery rate. Obstet Gynecol 2007; 110:873.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/26\">",
"      Hawkins JL, Hess KR, Kubicek MA, et al. A reevaluation of the association between instrument delivery and epidural analgesia. Reg Anesth 1995; 20:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/27\">",
"      GRIFFIN RJ. MANAGEMENT OF THE OCCIPUT POSTERIOR. J Ky Med Assoc 1964; 62:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/28\">",
"      Reichman O, Gdansky E, Latinsky B, et al. Digital rotation from occipito-posterior to occipito-anterior decreases the need for cesarean section. Eur J Obstet Gynecol Reprod Biol 2008; 136:25.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/29\">",
"      Cargill YM, MacKinnon CJ, Arsenault MY, et al. Guidelines for operative vaginal birth. J Obstet Gynaecol Can 2004; 26:747.",
"     </a>",
"    </li>",
"    <li>",
"     Dennen, PC. Dennen's forceps deliveries, 3rd ed, FA Davis Company, Philadelphia 1989.",
"    </li>",
"    <li>",
"     Tarnier, S, Chantreiul, G, Lauwergus, H. Trait&eacute; de l'art des accouchements (Tome 2), Paris 1982.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/32\">",
"      Shaffer BL, Cheng YW, Vargas JE, et al. Manual rotation of the fetal occiput: predictors of success and delivery. Am J Obstet Gynecol 2006; 194:e7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5462/abstract/33\">",
"      Kariminia A, Chamberlain ME, Keogh J, Shea A. Randomised controlled trial of effect of hands and knees posturing on incidence of occiput posterior position at birth. BMJ 2004; 328:490.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4471 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-200.131.240.2-5115C1355F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5462=[""].join("\n");
var outline_f5_21_5462=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H10\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISK FACTORS AND CONSEQUENCES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Epidural analgesia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Manual rotation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Forceps rotation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Operative vaginal delivery from the OP position",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      AVOIDANCE OF OP POSITION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/4471\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/4471|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?27/30/28143\" title=\"figure 1A\">",
"      Occiput anterior position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?31/52/32590\" title=\"figure 1B\">",
"      Occiput posterior position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?32/0/32783\" title=\"figure 1C\">",
"      Occiput transverse position",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?10/54/11104\" title=\"figure 2\">",
"      Three finger rotation from occiput posterior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?11/33/11796\" title=\"figure 3\">",
"      Five finger rotation from occiput posterior",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/57/42903?source=related_link\">",
"      Procedure for vacuum assisted operative vaginal delivery",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_21_5463="Role of inhaled glucocorticoid therapy in stable COPD";
var content_f5_21_5463=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Role of inhaled glucocorticoid therapy in stable COPD",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5463/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5463/contributors\">",
"     Marcia L Erbland, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5463/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5463/contributors\">",
"     James K Stoller, MS, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5463/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5463/contributors\">",
"     Helen Hollingsworth, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/21/5463/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 28, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic obstructive pulmonary disease (COPD) is an inflammatory disorder that is characterized by both airway and systemic inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/1\">",
"     1",
"    </a>",
"    ]. Inhaled glucocorticoid (also called inhaled corticosteroid or ICS) therapy appears to reduce this inflammation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/2-6\">",
"     2-6",
"    </a>",
"    ]. Thus, it has been hypothesized that ICS therapy may also improve clinical outcomes.",
"   </p>",
"   <p>",
"    Clinical evidence that ICS therapy is beneficial to patients with COPD is limited. Despite this, 40 to 50 percent of patients with COPD receive ICS therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/7,8\">",
"     7,8",
"    </a>",
"    ]. The likely reason for the widespread use of ICS therapy is the clinician's recognition that COPD can have an asthmatic component and the desire to offer the patient maximal therapy.",
"   </p>",
"   <p>",
"    In this topic review, the beneficial and adverse effects of ICS therapy in patients with COPD are discussed. An approach to ICS therapy is also described. Discussions about the management of stable COPD and the role of systemic glucocorticoids in COPD are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/7/10360?source=see_link\">",
"     \"Role of systemic glucocorticoid therapy in COPD\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL EFFICACY",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of studies have examined the impact of inhaled glucocorticoids (ICS) on lung function, respiratory symptoms, exacerbations, mortality, lung cancer, and airway inflammation. These studies have reported conflicting data for several different outcomes. However, taken together, the data suggest that ICS therapy decreases exacerbations and modestly slows the progression of respiratory symptoms, but has minimal or no impact on lung function and mortality.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Lung function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The impact of ICS therapy on disease progression, as measured by the annual rate of decline of forced expiratory volume in one second (FEV",
"    <sub>",
"     1",
"    </sub>",
"    ), has been examined in several randomized trials and three meta-analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/9-16\">",
"     9-16",
"    </a>",
"    ]. The largest randomized trial [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/17\">",
"     17",
"    </a>",
"    ] and a meta-analysis found that ICS therapy slightly slowed the decline in lung function, whereas several other studies and a different meta-analysis found no beneficial effect on lung function. As examples:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      TORCH trial &ndash; The Toward a Revolution in COPD Health (TORCH) trial randomly assigned 6112 patients with moderate to severe COPD &ndash; mean FEV",
"      <sub>",
"       1",
"      </sub>",
"      was 44 percent of predicted &ndash; to one of four treatment arms for three years:",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/63/34806?source=see_link\">",
"       salmeterol",
"      </a>",
"      alone (50 mcg twice daily),",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      alone (500 mcg twice daily), combination therapy (salmeterol plus fluticasone), or placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13,17\">",
"       13,17",
"      </a>",
"      ]. All active treatments slowed the lung function decline compared to placebo, including fluticasone (-15 versus -62 mL per year). The clinical importance of this small difference is unknown.",
"     </li>",
"     <li>",
"      In a meta-analysis of trials longer than two years that included the TORCH trial, the mean difference in the rate of decline in postbronchodilator FEV",
"      <sub>",
"       1",
"      </sub>",
"      between ICS and placebo was 6.88",
"      <span class=\"nowrap\">",
"       mL/year",
"      </span>",
"      (95% CI 1.80 to 11.96, 4823 participants) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/16\">",
"       16",
"      </a>",
"      ]. On the other hand, a separate calculation in the same report based on pooled difference found a nonsignificant reduction in the rate of decline in post-bronchodilator FEV",
"      <sub>",
"       1",
"      </sub>",
"      with ICS (5.80",
"      <span class=\"nowrap\">",
"       mL/year,",
"      </span>",
"      95% CI -0.28 to 11.88; 2333 participants).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The reason for the conflicting data is uncertain but may be a function of different doses and formulations of inhaled glucocorticoids, length of study, or other confounding factors that influence studies over longer periods of time.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Symptoms",
"    </span>",
"    &nbsp;&mdash;&nbsp;Respiratory symptoms were predetermined secondary outcomes in four out of the five randomized trials and one of the meta-analyses [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/9,11-13,16\">",
"     9,11-13,16",
"    </a>",
"    ]. Most demonstrated that ICS therapy slowed the progression of respiratory symptoms modestly [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/11-13\">",
"     11-13",
"    </a>",
"    ], although one trial found that ICS therapy had no impact on respiratory symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/9\">",
"     9",
"    </a>",
"    ]. ICS slowed the rate of decline in quality of life compared with placebo, as measured by a standard respiratory disease questionnaire [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Exacerbations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Glucocorticoid-responsive inflammatory factors appear to play an important role in the initiation and severity of exacerbations of COPD. Thus, it has been hypothesized that ICS therapy may prevent or reduce the severity of COPD exacerbations. Many studies support this theory [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/11-13,16,18-22\">",
"     11-13,16,18-22",
"    </a>",
"    ], as illustrated by the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A meta-analysis of 12 randomized trials (5618 patients with COPD) demonstrated that ICS therapy decreased the risk of exacerbation compared to placebo (RR 0.67; 95% CI, 0.59 to 0.77) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/20\">",
"       20",
"      </a>",
"      ]. Three other meta-analyses reported similar results [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/16,18,22\">",
"       16,18,22",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The TORCH trial (n = 6112) described above demonstrated that ICS therapy decreased the rate of moderate or severe exacerbations (RR 0.82; 95% CI, 0.76 to 0.89) and the rate of exacerbations requiring systemic glucocorticoids (RR 0.65; 95% CI, 0.58 to 0.73) compared to placebo [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13\">",
"       13",
"      </a>",
"      ]. However, it did not reduce the rate of severe exacerbations that required hospitalization.",
"     </li>",
"     <li>",
"      A trial randomly assigned 449 patients with moderate or severe COPD to receive",
"      <a class=\"drug drug_general\" href=\"UTD.htm?26/34/27173?source=see_link\">",
"       tiotropium",
"      </a>",
"      plus placebo, tiotropium plus",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/63/34806?source=see_link\">",
"       salmeterol",
"      </a>",
"      , or triple therapy (tiotropium plus",
"      <span class=\"nowrap\">",
"       salmeterol/",
"       <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"        fluticasone",
"       </a>",
"       )",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/19\">",
"       19",
"      </a>",
"      ]. Only triple therapy decreased hospitalizations, implying additive benefit due to the fluticasone.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The notion that ICS therapy decreases exacerbations is not universally accepted. One report criticized the second systematic review described above on the basis of its statistical methods [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/23\">",
"     23",
"    </a>",
"    ]. When similar data were analyzed using alternative statistical methods, ICS therapy had no effect on COPD exacerbations.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Mortality",
"    </span>",
"    &nbsp;&mdash;&nbsp;ICS therapy has not been shown to reduce mortality [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13,16,24\">",
"     13,16,24",
"    </a>",
"    ]. In a meta-analysis of eleven randomized trials (14,426 patients) that included the TORCH trial, long-term ICS therapy had no significant effect on mortality (RR 0.86; 95% CI, 0.68 to 1.09) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/24\">",
"     24",
"    </a>",
"    ]. However, the actual effect on mortality may be larger than reported; in the intention to treat analyses, sicker patients in the placebo group may have left trials, seeking active treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Lung cancer",
"    </span>",
"    &nbsp;&mdash;&nbsp;A prospective cohort study followed 10,474 patients with COPD for approximately four years [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/25\">",
"     25",
"    </a>",
"    ]. ICS therapy using doses of 1200 mcg per day or higher was associated with a dose-dependent decrease in the incidence of lung cancer (HR 0.39; 95% CI, 0.16 to 0.96). Smaller doses had no effect. These findings require confirmation using controlled trials. Until then, ICS therapy can not be recommended for the prevention of lung cancer among patients with COPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Airway inflammation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Data are conflicting regarding the effect of ICS therapy on airway inflammation. This can be illustrated by the following contrasting studies:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A double-blinded trial randomly assigned 30 patients with mild chronic bronchitis to receive inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?33/7/33904?source=see_link\">",
"       beclomethasone",
"      </a>",
"      or placebo, then performed spirometry and bronchoalveolar lavage before and after six weeks of therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/26\">",
"       26",
"      </a>",
"      ]. ICS therapy improved both spirometry and subjective bronchial inflammation, but placebo did not.",
"     </li>",
"     <li>",
"      Administration of inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      (800 mg twice daily) for two weeks to 13 patients with severe but stable COPD did not change the inflammatory indices measured in induced sputum [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/27\">",
"       27",
"      </a>",
"      ]. These indices included total and differential cell counts, concentrations of TNF alpha, concentrations of eosinophil activation markers (ECP and EPO), and concentrations of neutrophil activation markers (MPO and HNL). In addition, there was no improvement of pulmonary function or symptoms.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     ADVERSE EFFECTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled glucocorticoid therapy has a few well-described adverse effects in patients with COPD. They include dysphonia, skin bruising, and oral candidiasis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/10,12,28\">",
"     10,12,28",
"    </a>",
"    ]. Dysphonia has been described in up to 50 percent of patients, skin bruising in up to 10 percent, and oral candidiasis in up to 20 percent (usually asymptomatic). In general, these effects have not been severe enough to alter management, but appear to increase at higher doses and with cumulative exposure. A more detailed discussion of adverse effects associated with inhaled glucocorticoids is provided separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=see_link\">",
"     \"Major side effects of inhaled glucocorticoids\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Additional adverse effects in patients with COPD are suspected, but conflicting data exist:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Subcapsular cataracts. In a meta-analysis, subcapsular cataracts were more common among patients receiving ICS therapy, although the possibility that intermittent systemic glucocorticoid therapy was the actual culprit could not be excluded [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/29\">",
"       29",
"      </a>",
"      ]. However, a large randomized trial found no increase in the incidence of cataracts [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Diminished bone density and risk of fracture. A randomized trial demonstrated that lumbar spine and femur bone density was decreased among patients who received ICS therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/12\">",
"       12",
"      </a>",
"      ]. However, a similar trial did not find decreased bone density among patients who received ICS therapy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13\">",
"       13",
"      </a>",
"      ]. A meta-analysis examined the risk of fracture among 17,513 participants in 17 trials that compared inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"       fluticasone",
"      </a>",
"      or",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      to placebo in COPD [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/30\">",
"       30",
"      </a>",
"      ]. Inhaled glucocorticoids were associated with a small increased risk of fracture (Peto OR 1.27, 95% CI 1.01 to 1.58), such that 83 patients would need to be treated with ICS for one to develop a fracture. A limitation of the study is that the studies were not designed to assess fracture risk and did not record whether the fractures were osteoporotic or not. In addition, the use of oral glucocorticoids was not fully detailed in the individual trials.",
"     </li>",
"     <li>",
"      Mild hypothalamic-pituitary-adrenal axis suppression has been identified at doses greater than 800 mcg per day, although it can be absent at even higher doses [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/31\">",
"       31",
"      </a>",
"      ]. Clinical adrenal crisis has not been reported.",
"     </li>",
"     <li>",
"      Pneumonia. An area of ongoing concern is whether inhaled glucocorticoids increase the risk of pneumonia in patients with COPD [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13,24,32-34\">",
"       13,24,32-34",
"      </a>",
"      ]. A meta-analysis of 18 randomized trials (16,996 participants) with at least 24 weeks of follow-up found a slight increase in risk of pneumonia among patients taking inhaled glucocorticoids (RR 1.60, 95% CI 1.33-1.92) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/33\">",
"       33",
"      </a>",
"      ]. In the individual studies, pneumonia was uncommon, often poorly defined, and not always a predetermined endpoint. Neither pneumonia-related mortality nor overall mortality was significantly increased.",
"      <br/>",
"      <br/>",
"      In a study that pooled data from seven clinical trials with 7042 COPD patients of whom 3801 were on inhaled",
"      <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"       budesonide",
"      </a>",
"      , the risk of pneumonia was NOT increased among those on budesonide [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/35\">",
"       35",
"      </a>",
"      ].",
"      <br/>",
"      <br/>",
"      Among 6353 patients with COPD and pneumonia hospitalized at US Veterans Affairs hospitals, mortality at 30 and 90 days was not increased in those taking outpatient inhaled glucocorticoids compared with those who were not [",
"      <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     GENERAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Inhaled glucocorticoids are part of the stepwise approach to management of stable COPD, which is intended to control symptoms, decrease exacerbations, and improve patient function and quality of life. COPD patients being considered for treatment with inhaled glucocorticoids will usually have moderate to severe airflow obstruction. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    ICS therapy is not recommended as monotherapy for patients with stable COPD because inhaled bronchodilators have greater benefits with fewer adverse effects. However, ICS therapy is indicated as an additional therapy for patients with COPD who have symptoms, repeated exacerbations, or severe exacerbations despite an optimal inhaled bronchodilator regimen. This is based on the observation that combination therapy using an ICS and a long-acting beta agonist has greater impact than either agent alone in decreasing the incidence of exacerbations and slowing the progression of symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An optimal inhaled bronchodilator regimen usually includes one or more long-acting inhaled bronchodilators &ndash; a long-acting inhaled beta agonist",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    a long-acting inhaled anticholinergic. One acceptable approach to initiating ICS therapy is to add an ICS when the existing long-acting inhaled bronchodilator regimen includes a long-acting inhaled beta agonist, or to add the combination of an ICS plus a long-acting inhaled beta agonist when the existing long-acting inhaled bronchodilator regimen does not include a long-acting inhaled beta agonist. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"     \"Management of stable chronic obstructive pulmonary disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    An inhaled glucocorticoid may be warranted earlier (ie, at the same time that the long-acting inhaled bronchodilator is initiated) if there are signs of an asthmatic component to the COPD.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Dose",
"    </span>",
"    &nbsp;&mdash;&nbsp;The optimal formulation, dose, and schedule of ICS are unknown. Large clinical trials evaluating the impact of ICS in patients with COPD used relatively high doses of ICS, including",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/7/32880?source=see_link\">",
"     budesonide",
"    </a>",
"    at 400 mcg twice daily or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?38/45/39632?source=see_link\">",
"     fluticasone",
"    </a>",
"    at 500 mcg twice daily [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. Although small clinical benefits were achieved at these doses, adverse systemic effects were also detected (eg, cataracts, possible pneumonia) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/13,29\">",
"     13,29",
"    </a>",
"    ]. In patients with asthma, significantly lower doses of ICS provide most of the obtainable benefits with less toxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5463/abstract/37\">",
"     37",
"    </a>",
"    ]. It is unknown if the same is true for patients with COPD. Clinical trials are necessary to compare the benefits and risks of different doses of ICS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Trial of systemic glucocorticoids",
"    </span>",
"    &nbsp;&mdash;&nbsp;It has been hypothesized that patients with COPD who respond favorably to a trial of systemic glucocorticoid therapy are more likely to benefit from ICS therapy. There is little evidence to support this theory; thus, selection of patients based on their response to a trial of systemic glucocorticoid therapy is not recommended. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/7/10360?source=see_link&amp;anchor=H10#H10\">",
"     \"Role of systemic glucocorticoid therapy in COPD\", section on 'Clinical implications of prednisone response'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topics (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=see_link\">",
"       \"Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)\"",
"      </a>",
"      and",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=see_link\">",
"       \"Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In patients with COPD, inhaled glucocorticoids (also known as inhaled corticosteroids or ICS) decrease exacerbations and modestly slow the progression of respiratory symptoms, but appear to have little impact on lung function and mortality. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical efficacy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Adverse effects of ICS therapy include dysphonia, skin bruising, and oral candidiasis. These adverse effects appear to be more common at higher doses. In addition, ICS therapy may increase the incidence of pneumonia, increase the incidence of cataracts, and diminish bone density. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Adverse effects'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For most patients with COPD, we recommend that other therapies &ndash; inhaled bronchodilators, smoking cessation, pulmonary rehabilitation &ndash; be initiated prior to ICS therapy&nbsp;(",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H10\">",
"       'General approach'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=see_link\">",
"       \"Management of stable chronic obstructive pulmonary disease\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      For patients who have symptoms, repeated exacerbations, or severe exacerbations despite an optimal long-acting inhaled bronchodilator regimen, we suggest initiating ICS therapy (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). This can be achieved by:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Adding an ICS alone when the existing long-acting inhaled bronchodilator regimen includes a long-acting inhaled beta agonist.",
"     </li>",
"     <li>",
"      Adding the combination of an ICS plus a long-acting inhaled beta agonist when the existing long-acting inhaled bronchodilator regimen does not include a long-acting inhaled beta agonist.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Inhaled glucocorticoid therapy may be warranted earlier (ie, at the same time that the long-acting inhaled bronchodilator is initiated) if there are signs of an asthmatic component to the COPD. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'General approach'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/1\">",
"      Sin DD, Paul Man SF. Cooling the fire within: inhaled corticosteroids and cardiovascular mortality in COPD. Chest 2006; 130:629.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/2\">",
"      Pinto-Plata VM, M&uuml;llerova H, Toso JF, et al. C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61:23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/3\">",
"      Gan WQ, Man SF, Sin DD. Effects of inhaled corticosteroids on sputum cell counts in stable chronic obstructive pulmonary disease: a systematic review and a meta-analysis. BMC Pulm Med 2005; 5:3.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/4\">",
"      Ozol D, Aysan T, Solak ZA, et al. The effect of inhaled corticosteroids on bronchoalveolar lavage cells and IL-8 levels in stable COPD patients. Respir Med 2005; 99:1494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/5\">",
"      Sin DD, Lacy P, York E, Man SF. Effects of fluticasone on systemic markers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2004; 170:760.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/6\">",
"      Siva R, Green RH, Brightling CE, et al. Eosinophilic airway inflammation and exacerbations of COPD: a randomised controlled trial. Eur Respir J 2007; 29:906.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/7\">",
"      Niewoehner DE, Erbland ML, Deupree RH, et al. Effect of systemic glucocorticoids on exacerbations of chronic obstructive pulmonary disease. Department of Veterans Affairs Cooperative Study Group. N Engl J Med 1999; 340:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/8\">",
"      Van Andel AE, Reisner C, Menjoge SS, Witek TJ. Analysis of inhaled corticosteroid and oral theophylline use among patients with stable COPD from 1987 to 1995. Chest 1999; 115:703.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/9\">",
"      Vestbo J, S&oslash;rensen T, Lange P, et al. Long-term effect of inhaled budesonide in mild and moderate chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 1999; 353:1819.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/10\">",
"      Pauwels RA, L&ouml;fdahl CG, Laitinen LA, et al. Long-term treatment with inhaled budesonide in persons with mild chronic obstructive pulmonary disease who continue smoking. European Respiratory Society Study on Chronic Obstructive Pulmonary Disease. N Engl J Med 1999; 340:1948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/11\">",
"      Burge PS, Calverley PM, Jones PW, et al. Randomised, double blind, placebo controlled study of fluticasone propionate in patients with moderate to severe chronic obstructive pulmonary disease: the ISOLDE trial. BMJ 2000; 320:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/12\">",
"      Lung Health Study Research Group. Effect of inhaled triamcinolone on the decline in pulmonary function in chronic obstructive pulmonary disease. N Engl J Med 2000; 343:1902.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/13\">",
"      Calverley PM, Anderson JA, Celli B, et al. Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease. N Engl J Med 2007; 356:775.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/14\">",
"      Highland KB, Strange C, Heffner JE. Long-term effects of inhaled corticosteroids on FEV1 in patients with chronic obstructive pulmonary disease. A meta-analysis. Ann Intern Med 2003; 138:969.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/15\">",
"      Sutherland ER, Allmers H, Ayas NT, et al. Inhaled corticosteroids reduce the progression of airflow limitation in chronic obstructive pulmonary disease: a meta-analysis. Thorax 2003; 58:937.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/16\">",
"      Yang IA, Clarke MS, Sim EH, Fong KM. Inhaled corticosteroids for stable chronic obstructive pulmonary disease. Cochrane Database Syst Rev 2012; 7:CD002991.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/17\">",
"      Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008; 178:332.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/18\">",
"      Alsaeedi A, Sin DD, McAlister FA. The effects of inhaled corticosteroids in chronic obstructive pulmonary disease: a systematic review of randomized placebo-controlled trials. Am J Med 2002; 113:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/19\">",
"      Aaron SD, Vandemheen KL, Fergusson D, et al. Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial. Ann Intern Med 2007; 146:545.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/20\">",
"      Gartlehner G, Hansen RA, Carson SS, Lohr KN. Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes. Ann Fam Med 2006; 4:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/21\">",
"      Macie C, Wooldrage K, Manfreda J, Anthonisen NR. Inhaled corticosteroids and mortality in COPD. Chest 2006; 130:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/22\">",
"      Agarwal R, Aggarwal AN, Gupta D, Jindal SK. Inhaled corticosteroids vs placebo for preventing COPD exacerbations: a systematic review and metaregression of randomized controlled trials. Chest 2010; 137:318.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/23\">",
"      Suissa S. Statistical treatment of exacerbations in therapeutic trials of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 173:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/24\">",
"      Drummond MB, Dasenbrook EC, Pitz MW, et al. Inhaled corticosteroids in patients with stable chronic obstructive pulmonary disease: a systematic review and meta-analysis. JAMA 2008; 300:2407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/25\">",
"      Parimon T, Chien JW, Bryson CL, et al. Inhaled corticosteroids and risk of lung cancer among patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2007; 175:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/26\">",
"      Thompson AB, Mueller MB, Heires AJ, et al. Aerosolized beclomethasone in chronic bronchitis. Improved pulmonary function and diminished airway inflammation. Am Rev Respir Dis 1992; 146:389.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/27\">",
"      Keatings VM, Jatakanon A, Worsdell YM, Barnes PJ. Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD. Am J Respir Crit Care Med 1997; 155:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/28\">",
"      Selroos O, Backman R, Fors&eacute;n KO, et al. Local side-effects during 4-year treatment with inhaled corticosteroids--a comparison between pressurized metered-dose inhalers and Turbuhaler. Allergy 1994; 49:888.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/29\">",
"      Cumming RG, Mitchell P, Leeder SR. Use of inhaled corticosteroids and the risk of cataracts. N Engl J Med 1997; 337:8.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/30\">",
"      Loke YK, Cavallazzi R, Singh S. Risk of fractures with inhaled corticosteroids in COPD: systematic review and meta-analysis of randomised controlled trials and observational studies. Thorax 2011; 66:699.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/31\">",
"      Barnes PJ, Pedersen S, Busse WW. Efficacy and safety of inhaled corticosteroids. New developments. Am J Respir Crit Care Med 1998; 157:S1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/32\">",
"      Ernst P, Gonzalez AV, Brassard P, Suissa S. Inhaled corticosteroid use in chronic obstructive pulmonary disease and the risk of hospitalization for pneumonia. Am J Respir Crit Care Med 2007; 176:162.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/33\">",
"      Singh S, Amin AV, Loke YK. Long-term use of inhaled corticosteroids and the risk of pneumonia in chronic obstructive pulmonary disease: a meta-analysis. Arch Intern Med 2009; 169:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/34\">",
"      Crim C, Calverley PM, Anderson JA, et al. Pneumonia risk in COPD patients receiving inhaled corticosteroids alone or in combination: TORCH study results. Eur Respir J 2009; 34:641.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/35\">",
"      Sin DD, Tashkin D, Zhang X, et al. Budesonide and the risk of pneumonia: a meta-analysis of individual patient data. Lancet 2009; 374:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/36\">",
"      Malo de Molina R, Mortensen EM, Restrepo MI, et al. Inhaled corticosteroid use is associated with lower mortality for subjects with COPD and hospitalised with pneumonia. Eur Respir J 2010; 36:751.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5463/abstract/37\">",
"      Powell H, Gibson PG. Initial starting dose of inhaled corticosteroids in adults with asthma: a systematic review. Thorax 2004; 59:1041.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 1449 Version 12.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-200.215.4.194-785DB895A1-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5463=[""].join("\n");
var outline_f5_21_5463=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H14\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL EFFICACY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Lung function",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Symptoms",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Exacerbations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Mortality",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Lung cancer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Airway inflammation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ADVERSE EFFECTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      GENERAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Dose",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Trial of systemic glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?6/60/7114?source=related_link\">",
"      Major side effects of inhaled glucocorticoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/26/39338?source=related_link\">",
"      Management of stable chronic obstructive pulmonary disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?13/52/14148?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD) treatments (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?1/13/1236?source=related_link\">",
"      Patient information: Chronic obstructive pulmonary disease (COPD), including emphysema (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/7/10360?source=related_link\">",
"      Role of systemic glucocorticoid therapy in COPD",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_21_5464="Management of pregnancy complicated by Rhesus (Rh) alloimmunization";
var content_f5_21_5464=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Management of pregnancy complicated by Rhesus (Rh) alloimmunization",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5464/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5464/contributors\">",
"     Kenneth J Moise Jr, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5464/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5464/contributors\">",
"     Charles J Lockwood, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/21/5464/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/21/5464/contributors\">",
"     Vanessa A Barss, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/21/5464/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 20, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Despite the development and implementation of Rh(D) immune globulin prophylaxis, maternal rhesus (Rh) alloimmunization is still a cause of hemolytic disease of the fetus and newborn. However, with appropriate monitoring and intervention, this disorder can be treated successfully in almost all cases, with no long-term sequelae in offspring.",
"   </p>",
"   <p>",
"    This topic will provide an approach to management of pregnant women with Rh(D) alloimmunization. Alloimmunization to other Rh antigens (c, C, e, E, G) is managed in a manner similar to that described below for Rh(D) alloimmunization, although data supporting this approach are sparse and primarily consist of case reports and small series [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/1-3\">",
"     1-3",
"    </a>",
"    ]. Related topics, including a discussion of the Rhesus system, diagnosis and prevention of Rhesus alloimmunization, in utero transfusion, and neonatal issues, are reviewed in detail separately:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32982?source=see_link\">",
"       \"Overview of Rhesus (Rh) alloimmunization in pregnancy\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13210?source=see_link\">",
"       \"Intrauterine fetal transfusion of red blood cells\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40648?source=see_link\">",
"       \"Prevention of Rh(D) alloimmunization\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10665?source=see_link\">",
"       \"Postnatal diagnosis and management of alloimmune hemolytic disease of the newborn\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INITIAL APPROACH",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideally, alloimmunized pregnant women should be monitored by a Maternal-Fetal Medicine specialist with experience managing this now rare complication and who is credentialed to perform the invasive diagnostic and therapeutic procedures that may be needed. An algorithm describing our approach to managing pregnancies complicated by alloimmunization is provided in the figure (",
"    <a class=\"graphic graphic_algorithm graphicRef86945 \" href=\"UTD.htm?27/37/28240\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An Rh(D)-negative fetus is not at risk of complications from maternal anti-D antibodies; therefore, the first step in antenatal management of maternal alloimmunization is to test paternal blood, which will help predict the fetal Rhesus type.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Test paternal blood to predict whether fetus is at risk",
"    </span>",
"    &nbsp;&mdash;&nbsp;The biologic father of the baby is tested for his Rh(D) type and, if Rh(D)-positive, zygosity is determined early in the course of evaluation. Homozygotes always pass the Rh(D) antigen to their offspring; heterozygotes have a 50 percent chance of having Rh(D)-negative offspring. Obviously, certainty as to paternity is imperative.",
"   </p>",
"   <p>",
"    Quantitative polymerase chain reaction (PCR) DNA testing reliably identifies the presence of one or two paternal",
"    <em>",
"     RHD",
"    </em>",
"    genes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/5\">",
"     5",
"    </a>",
"    ]. Zygosity testing will reveal a heterozygous paternal phenotype in approximately 40 percent of Caucasians. In the past, blood banks employed anti-sera to the Rh antigens (D,",
"    <span class=\"nowrap\">",
"     C/c,",
"    </span>",
"    <span class=\"nowrap\">",
"     E/e),",
"    </span>",
"    along with gene frequency tables based upon",
"    <span class=\"nowrap\">",
"     race/ethnicity",
"    </span>",
"    to estimate paternal zygosity at the Rh(D) locus. Although useful, these estimates are less reliable than direct genetic testing. The test is commercially available from one vendor in the United States",
"    <span class=\"nowrap\">",
"     (file://www.bcw.edu/cs/groups/public/documents/documents/mdaw/mda0/~edisp/rhd_zygosity_desc.pdf)",
"    </span>",
"    and costs approximately USD$250.",
"   </p>",
"   <p>",
"    If the biologic father of the baby is Rh(D)-negative, maternal alloimmunization occurred as a result of a pregnancy with a different partner or from some other source of Rh(D)-positive blood (eg, incompatible blood transfusion, needle sharing). Thus, the current fetus is not at risk for hemolytic disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23486190\">",
"    <span class=\"h2\">",
"     Cell free fetal DNA testing to determine fetal Rh(D) type",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cell free fetal DNA (cffDNA) may be detected in the maternal circulation as early as 38 days of gestation; the amount of DNA increases with advancing gestational age and disappears soon after delivery. Fetal Rh(D) status can be determined by evaluation of cffDNA sequences in maternal plasma using a reverse transcriptase PCR. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1448?source=see_link\">",
"     \"Prenatal diagnosis using cell-free fetal nucleic acids in maternal blood\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Assays for the",
"    <em>",
"     RHD",
"    </em>",
"    exon 4; exons 5 and 7; exons 4, 5, and 7; or exons 4, 5, 7, and 10 have been recommended, ideally after 8 weeks of gestation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/5-10\">",
"     5-10",
"    </a>",
"    ]. The presence of these",
"    <em>",
"     RHD",
"    </em>",
"    exons in maternal plasma indicates cffDNA is present and the fetus is Rh(D) positive. If",
"    <em>",
"     RHD",
"    </em>",
"    exons are absent, the fetus is Rh(D)-negative if it can be proven that cffDNA and not maternal DNA was tested. The presence of Y chromosome gene sequences in the plasma sample confirms that fetal DNA was present and validates the test results. If the fetus is female, single nucleotide polymorphisms (SNPs) that are not common to the general population can be used to confirm the presence of cffDNA in the sample [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/11\">",
"     11",
"    </a>",
"    ]. Maternal SNPs are identified in the white cells (maternal) of the buffy coat of the sample. A significant difference in the types of SNPs between the buffy coat and the plasma indicates the presence of paternally-acquired SNPs in the plasma, thereby confirming that cffDNA was present and validating the test result.",
"   </p>",
"   <p>",
"    Although widely used in the United Kingdom and Europe, cffDNA for Rh(D) has only recently become available in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/10\">",
"     10",
"    </a>",
"    ]. A protocol consisting of a multiplex analysis designed to detect exons 4, 5, and 7 of the",
"    <em>",
"     RHD",
"    </em>",
"    gene and three Y chromosome gene sequences (SRY, DBY, and TTTY2) results in the detection of",
"    <em>",
"     RHD",
"    </em>",
"    with accuracy 97.1 percent, sensitivity 97.2 percent, and specificity 96.8 percent using a serotype Rh(D) reference (",
"    <a class=\"graphic graphic_algorithm graphicRef86944 \" href=\"UTD.htm?0/15/254\">",
"     algorithm 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/10\">",
"     10",
"    </a>",
"    ]. A 2006 meta-analysis of 31 studies using 37 protocols for noninvasive fetal Rh(D) genotyping reported overall diagnostic accuracy of 94.8 percent, with higher accuracy in the four series including at least 200 cases (accuracy 98.7 to 100 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    False-positive results have been attributed to phenotypically Rh(D)-negative mothers who carry the Rh(D) pseudogene or another",
"    <em>",
"     RHD",
"    </em>",
"    gene variation and pass this gene on to their fetus [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/13\">",
"     13",
"    </a>",
"    ]. These can often be detected by using primers targeting exons 4 and 10 of the",
"    <em>",
"     RHD",
"    </em>",
"    gene. Such false positives, if not detected, could result in unnecessary invasive interventions.",
"   </p>",
"   <p>",
"    False negative results would be more serious as appropriate monitoring and interventions might be withheld. Similar to the analysis of amniotic fluid for fetal Rh(D) typing, more than one Rh(D) region (eg, exons 7 and 10, intron 4) should be examined to ensure that negative results reflect true Rh(D) negativity and not the presence of Rh(D) variants.",
"   </p>",
"   <p>",
"    False negatives can be due to a low level of fetal DNA in a maternal sample because it was drawn too early in gestation or to insensitive laboratory techniques [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/14\">",
"     14",
"    </a>",
"    ]. At least 10 to 15 mL of maternal blood should be collected at &ge;8 weeks of gestation to ensure there is adequate cffDNA. Various techniques are available to make sure cffDNA was not overlooked in the maternal blood sample.",
"   </p>",
"   <p>",
"    The test is commercially available from only one vendor in the United States",
"    <span class=\"nowrap\">",
"     (file://www.sequenomcmm.com/Home/Health-Care-Professionals/Fetal-RHD-Genotyping)",
"    </span>",
"    and costs approximately USD$250.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Testing amniocytes to determine fetal Rh(D) type",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the paternal phenotype is heterozygous for Rh(D) or unknown and cffDNA testing is not available, then amniocentesis can be performed at approximately 15 weeks of gestation to obtain amniocytes. The fetal blood genotype is determined by PCR on uncultured amniocytes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/15\">",
"     15",
"    </a>",
"    ]. Transplacental amniocentesis is avoided, if possible, as it may worsen alloimmunization (chorionic villus biopsy is avoided for the same reason).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7289512\">",
"    <span class=\"h1\">",
"     FIRST VERSUS SUBSEQUENT PREGNANCIES COMPLICATED BY ALLOIMMUNIZATION",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     First alloimmunized pregnancy with Rh(D) positive fetus",
"    </span>",
"    &nbsp;&mdash;&nbsp;The first pregnancy complicated by alloimmunization is managed differently from subsequent pregnancies because the fetal effects of alloimmunization tend to be less severe in the first affected pregnancy, but worsen with each subsequent affected pregnancy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Follow maternal anti-D titers",
"    </span>",
"    &nbsp;&mdash;&nbsp;The indirect Coombs titer is used to detect not only the presence, but also the degree, of alloimmunization. Antibody titers should be interpreted as screening tests, just as serum alpha-fetoprotein is a screening test for the detection of fetal neural tube defects. A positive anti-D titer means that the fetus is at risk for hemolytic disease, not that it has occurred or will develop. Variation in titer results between laboratories and intra-laboratory is common. A truly stable titer should not vary by more than one dilution when repeated in a given laboratory. As an example, a titer of 8 that increases to 16 may not represent a true increase in the amount of antibody in the maternal circulation, but a rise to 32 is likely real.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h4\">",
"     Critical titer",
"    </span>",
"    &nbsp;&mdash;&nbsp;A critical titer refers to the titer associated with a risk for fetal hydrops. The critical titer will vary among institutions and methodologies; however, in most centers, an anti-D titer between 8 and 32 is considered critical. In Europe and the United Kingdom, a threshold value of 15",
"    <span class=\"nowrap\">",
"     IU/mL",
"    </span>",
"    based upon comparison to an international standard is recommended to begin invasive testing [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/16\">",
"     16",
"    </a>",
"    ]. Below the critical titer, there is a risk of mild to moderate, but not severe, fetal or neonatal hemolytic anemia.",
"   </p>",
"   <p>",
"    In the first affected pregnancy, serial antibody titers are determined every two to four weeks after 20 weeks of gestation as long as the titer remains below the critical titer. If the critical titer is reached or exceeded, then further assessment to determine whether severe fetal anemia is present is required and checking maternal titers can be discontinued (see",
"    <a class=\"local\" href=\"#H10\">",
"     'Assessment for severity of fetal anemia'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    Maternal administration of anti-D immune globulin after the primary immune response to the D antigen has occurred will not prevent a rise in titer [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/17,18\">",
"     17,18",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7289621\">",
"    <span class=\"h2\">",
"     Subsequent pregnancies with Rh(D) positive fetus",
"    </span>",
"    &nbsp;&mdash;&nbsp;In general, pregnancies after the first affected pregnancy will involve a greater severity of",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    hemolytic disease due to an anamnestic maternal antibody response from the entry of fetal cells into the maternal circulation at delivery. Therefore, if the patient has had a prior significantly affected pregnancy (eg, fetal hydrops, intrauterine fetal transfusion, preterm delivery because of fetal anemia, neonatal exchange transfusion), then severe fetal anemia in subsequent pregnancies with an Rh(D)-positive fetus is almost certain. For this reason, the severity of fetal anemia is assessed beginning at 16 to 18 weeks of gestation and maternal antibody titers are not routinely evaluated, as they do not reliably predict the severity of fetal anemia. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Assessment for severity of fetal anemia'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ASSESSMENT FOR SEVERITY OF FETAL ANEMIA",
"    </span>",
"    &nbsp;&mdash;&nbsp;A systematic review of well-designed observational studies provided compelling evidence that Doppler assessment of the fetal middle cerebral artery (MCA) peak systolic velocity is the best noninvasive tool for predicting fetal anemia in at-risk pregnancies [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/19\">",
"     19",
"    </a>",
"    ]. Although several other ultrasonographic parameters have been used to predict the presence of severe fetal anemia (placental thickness, umbilical vein diameter, hepatic size, splenic size, polyhydramnios), none have proven to be sufficiently reliable for clinical practice [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/20-23\">",
"     20-23",
"    </a>",
"    ]. Two-dimensional sonography reliably detects fetal hydrops, however, hydrops is not observed until the fetal hemoglobin deficit is at least 7",
"    <span class=\"nowrap\">",
"     g/dL",
"    </span>",
"    below the mean for gestational age [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/24\">",
"     24",
"    </a>",
"    ]; ideally, intrauterine transfusions are initiated before this late stage of fetal anemia.",
"   </p>",
"   <p>",
"    Invasive techniques can be used to estimate the severity of fetal anemia (eg, amniocentesis with spectral analysis of amniotic fluid [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]) or sampling of fetal blood directly to determine fetal hematological values [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/27\">",
"     27",
"    </a>",
"    ], but these techniques are more hazardous to the mother and fetus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Middle cerebral artery-peak systolic velocity",
"    </span>",
"    &nbsp;&mdash;&nbsp;Doppler assessment of the fetal MCA peak systolic velocity (PSV) in alloimmunized pregnancies was based on the principle that the anemic fetus preserves oxygen delivery to the brain by increasing cerebral flow of low viscosity blood. However, under physiologic circumstances, it appears that the relationship between fetal hemoglobin and viscosity is the primary factor determining MCA-PSV [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a seminal study, the hemoglobin concentration in blood obtained by cordocentesis and MCA-PSV were measured in 111 fetuses at risk for anemia due to maternal red cell alloimmunization and compared to values for 265 normal fetuses [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/29\">",
"     29",
"    </a>",
"    ]. The sensitivity of increased MCA-PSV (above 1.5 multiples of the median [MoMs]) for the prediction of moderate or severe anemia was 100 percent (95% CI 86-100), either in the presence or absence of hydrops, with a false positive rate of 12 percent (",
"    <a class=\"graphic graphic_figure graphicRef76467 \" href=\"UTD.htm?8/31/8702\">",
"     figure 1",
"    </a>",
"    ). The same authors performed a follow-up prospective study of 125 fetuses at risk for alloimmune anemia and reported overall sensitivity to detect moderate to severe anemia (hemoglobin below 0.65 MoMs) of 88 percent, with specificity 87 percent, positive predictive value 53 percent, and negative predictive value 98 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/30\">",
"     30",
"    </a>",
"    ]. One of nine fetuses with severe anemia was missed, possibly due to a screening interval longer than two weeks. Multiple subsequent studies by different investigators have confirmed these findings [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Ideally, MCA-PSV is measured when the fetus is in a quiet behavioral state, as results are higher when the fetus is active [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. Conversion calculators, such as the one found at www.perinatology.com, can be used to convert the actual MCA-PSV in",
"    <span class=\"nowrap\">",
"     cm/sec",
"    </span>",
"    to multiples of the median to correct for gestational age. Because MCA-PSV increases across gestation, results should be adjusted for gestational age. Measurements can be initiated as early as 16 weeks of gestation if there is a past history of early severe fetal anemia, otherwise Doppler evaluation is begun later since intrauterine intravascular transfusions are very difficult before 20 weeks of gestation. The optimal interval between examinations has not been determined, but should be one to two weeks based on clinical experience and what is known about progression of fetal anemia in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/29\">",
"     29",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7289715\">",
"    <span class=\"h2\">",
"     Other methods",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Spectral analysis of amniotic fluid",
"    </span>",
"    &nbsp;&mdash;&nbsp;In the past, amniocentesis to determine amniotic fluid bilirubin levels was the usual method for indirectly estimating the severity of fetal anemia. Bilirubin present in amniotic fluid derives from fetal pulmonary and tracheal effluents and correlates with the degree of fetal hemolysis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. However, Doppler velocimetry is as, or more, sensitive and specific for detection of severe fetal anemia and has the advantage of being noninvasive [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Fetal blood sampling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ultrasound-directed fetal blood sampling (ie, percutaneous umbilical blood sampling, cordocentesis, funipuncture) allows direct access to the fetal circulation to obtain important laboratory values such as hematocrit, direct Coombs, fetal blood type, reticulocyte count, and platelet count. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=see_link\">",
"     \"Fetal blood sampling\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Because this procedure is associated with a 1 to 2 percent rate of fetal loss, fetal blood sampling is usually reserved for patients with increased MCA-PSV. Most centers attempt to lower the fetal risk of the procedure by having blood available (O Rh(D)-negative) for intrauterine transfusion at the time of fetal blood sampling. An intrauterine transfusion is initiated if fetal anemia is detected (ie, hematocrit less than 30 percent or below two standard deviations for gestational age) and the fetus is remote from term. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13210?source=see_link\">",
"     \"Intrauterine fetal transfusion of red blood cells\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     MANAGEMENT OF WOMEN WITH MULTIPLE ANTIBODIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some women develop antibodies to more than one red blood cell antigen. There are no specific guidelines for management of these pregnancies; they are typically followed as described above. The presence of anti-D antibody with another antibody (especially anti-C) appears to increase the need for intrauterine fetal transfusion [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/2,34\">",
"     2,34",
"    </a>",
"    ]. These pregnancies warrant closer observation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     ANTEPARTUM FETAL SURVEILLANCE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, alloimmunization has been considered an indication for antepartum fetal surveillance, although no well-designed studies have evaluated the utility, type, or frequency of testing [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/35\">",
"     35",
"    </a>",
"    ]. We begin weekly nonstress testing or determining the biophysical profile score at 32 weeks of gestation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?29/26/30121?source=see_link\">",
"     \"Overview of fetal assessment\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR FETAL TRANSFUSION OR DELIVERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe fetal anemia can be defined as a hematocrit below 30 percent or two standard deviations below the mean hematocrit for the gestational age. Severe fetal anemia is an indication for intervention because fetal cardiac failure will eventually develop. Intrauterine transfusions for severe fetal anemia are generally performed between 18 and 35 weeks of gestation. Before 18 weeks, fetal transfusions are rarely successful due to limited visualization and the small size of the relevant anatomic structures [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/36-38\">",
"     36-38",
"    </a>",
"    ]. Prior to 20 weeks of gestation, intraperitoneal fetal transfusion is technically easier than intravascular transfusion. When technically possible, the intravascular transfusion is preferred because the therapeutic effects are more rapid and reliable. After 35 weeks, the procedure is generally considered riskier than late preterm delivery for neonatal treatment of severe anemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13210?source=see_link\">",
"     \"Intrauterine fetal transfusion of red blood cells\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10665?source=see_link\">",
"     \"Postnatal diagnosis and management of alloimmune hemolytic disease of the newborn\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When severe fetal anemia has required treatment with serial intrauterine transfusions, some centers administer oral",
"    <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"     phenobarbital",
"    </a>",
"    to the pregnant patient for seven days prior to delivery to enhance fetal hepatic maturity [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/39\">",
"     39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5318055\">",
"    <span class=\"h1\">",
"     FUTURE PREGNANCIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Each subsequent pregnancy after the first affected pregnancy is likely to manifest more severe",
"    <span class=\"nowrap\">",
"     fetal/neonatal",
"    </span>",
"    hemolytic disease, and at an earlier gestational age. As discussed above, fetal transfusion is technically more challenging and associated with higher perinatal mortality when performed before 20 to 22 weeks of gestation. Options for patients with a history of early second trimester fetal loss secondary to severe maternal red cell alloimmunization and patients who wish to avoid invasive fetal therapy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Insemination with donor sperm from an Rh(D)-negative donor",
"     </li>",
"     <li>",
"      If the father is heterozygous: in vitro fertilization, preimplantation genetic diagnosis for selection of Rh(D) negative embryos, and transfer of only these embryos",
"     </li>",
"     <li>",
"      Use of a gestational surrogate",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Combined plasmapheresis and intravenous immune globulin therapy to decrease the severity of disease has only been described in case reports and small case series [",
"    <a class=\"abstract\" href=\"UTD.htm?5/21/5464/abstract/38,40-43\">",
"     38,40-43",
"    </a>",
"    ]. The efficacy of this approach is unproven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?3/59/4019?source=see_link\">",
"       \"Patient information: Pregnancy in Rh-negative women (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In general, the fetal effects of alloimmunization tend to be least severe in the first affected pregnancy, but worsen with each subsequent affected pregnancy. (See",
"      <a class=\"local\" href=\"#H7289512\">",
"       'First versus subsequent pregnancies complicated by alloimmunization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Fetal Rhesus status should be determined early in pregnancy since additional monitoring and intervention are not required if both mother and fetus are Rh(D)-negative. Paternal Rhesus typing is performed, and if Rh(D)-positive, quantitative polymerase chain reaction (PCR) DNA testing reliably identifies the presence of one or two paternal",
"      <em>",
"       RHD",
"      </em>",
"      genes. If the father is heterozygous, the fetal Rhesus type is determined using cell free fetal DNA (cffDNA) in maternal plasma (",
"      <a class=\"graphic graphic_algorithm graphicRef86944 \" href=\"UTD.htm?0/15/254\">",
"       algorithm 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Initial approach'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An algorithm describing our general approach to managing pregnancies complicated by alloimmunization is provided in the figure (",
"      <a class=\"graphic graphic_algorithm graphicRef86945 \" href=\"UTD.htm?27/37/28240\">",
"       algorithm 1",
"      </a>",
"      ).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <strong>",
"     First affected pregnancy:",
"    </strong>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      If the maternal titer is &le;8, we suggest repeating the titer monthly until 24 weeks, then every two weeks until delivery. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Follow maternal anti-D titers'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the critical titer is reached (16 or 32 depending on the laboratory), the fetus should be evaluated for the presence of severe anemia. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Critical titer'",
"      </a>",
"      above.)",
"      <br/>",
"      <br/>",
"      We measure middle cerebral artery peak systolic velocity (MCA-PSV) at one- to two-week intervals beginning as early as 16 to 18 weeks of gestation. MCA-PSV &ge;1.5 multiples of the median is predictive of severe anemia. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Middle cerebral artery-peak systolic velocity'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with MCA-PSVs that remain &lt;1.5 MoMs, we induce labor at 37 to 38 weeks of gestation. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Indications for fetal transfusion or delivery'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with MCA-PSV &ge;1.5 MoMs, management depends on gestational age (see",
"      <a class=\"local\" href=\"#H17\">",
"       'Indications for fetal transfusion or delivery'",
"      </a>",
"      above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      For pregnancies &lt;35 weeks of gestation, we perform fetal blood sampling followed by transfusion if severe anemia is confirmed (fetal hematocrit &lt;30 percent or below two standard deviations for gestational age).",
"     </li>",
"     <li>",
"      For pregnancies at 35 to 37 weeks of gestation, we perform amniocentesis to assess fetal lung maturity. If fetal lung maturity is documented, we induce labor (or perform cesarean delivery if obstetrically indicated). If fetal lung test results suggest immaturity and antenatal testing (nonstress test [NST]",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      biophysical profile [BPP]) are reassuring, we continue to monitor fetal well-being and delay delivery until fetal lung maturity is likely. At the author&rsquo;s institution, women who have undergone several fetal transfusions are given oral",
"      <a class=\"drug drug_general\" href=\"UTD.htm?28/40/29321?source=see_link\">",
"       phenobarbital",
"      </a>",
"      for seven days prior to delivery to enhance fetal hepatic maturity.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <strong>",
"     Previously affected",
"     <span class=\"nowrap\">",
"      fetus/infant:",
"     </span>",
"    </strong>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The management of the second (or more) affected pregnancy is similar, except maternal antibody titers are",
"      <strong>",
"       not",
"      </strong>",
"      helpful in following the degree of fetal anemia. (See",
"      <a class=\"local\" href=\"#H7289621\">",
"       'Subsequent pregnancies with Rh(D) positive fetus'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/1\">",
"      Hackney DN, Knudtson EJ, Rossi KQ, et al. Management of pregnancies complicated by anti-c isoimmunization. Obstet Gynecol 2004; 103:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/2\">",
"      Spong CY, Porter AE, Queenan JT. Management of isoimmunization in the presence of multiple maternal antibodies. Am J Obstet Gynecol 2001; 185:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/3\">",
"      Joy SD, Rossi KQ, Krugh D, O'Shaughnessy RW. Management of pregnancies complicated by anti-E alloimmunization. Obstet Gynecol 2005; 105:24.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/4\">",
"      Moise KJ Jr, Argoti PS. Management and prevention of red cell alloimmunization in pregnancy: a systematic review. Obstet Gynecol 2012; 120:1132.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/5\">",
"      Pirelli, K, Pietz, B, Johnson, S, Pinder, H, et al. Molecular determination of RhD zygosity. Am J Obstet Gynecol 2006; 195:S172.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/6\">",
"      Wikman AT, Tiblad E, Karlsson A, et al. Noninvasive single-exon fetal RHD determination in a routine screening program in early pregnancy. Obstet Gynecol 2012; 120:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/7\">",
"      Singleton BK, Green CA, Avent ND, et al. The presence of an RHD pseudogene containing a 37 base pair duplication and a nonsense mutation in africans with the Rh D-negative blood group phenotype. Blood 2000; 95:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/8\">",
"      Tynan JA, Angkachatchai V, Ehrich M, et al. Multiplexed analysis of circulating cell-free fetal nucleic acids for noninvasive prenatal diagnostic RHD testing. Am J Obstet Gynecol 2011; 204:251.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/9\">",
"      Daniels G, van der Schoot CE, Olsson ML. Report of the First International Workshop on molecular blood group genotyping. Vox Sang 2005; 88:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/10\">",
"      Bombard AT, Akolekar R, Farkas DH, et al. Fetal RHD genotype detection from circulating cell-free fetal DNA in maternal plasma in non-sensitized RhD negative women. Prenat Diagn 2011; 31:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/11\">",
"      Finning KM, Martin PG, Soothill PW, Avent ND. Prediction of fetal D status from maternal plasma: introduction of a new noninvasive fetal RHD genotyping service. Transfusion 2002; 42:1079.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/12\">",
"      Geifman-Holtzman O, Grotegut CA, Gaughan JP. Diagnostic accuracy of noninvasive fetal Rh genotyping from maternal blood--a meta-analysis. Am J Obstet Gynecol 2006; 195:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/13\">",
"      Moise KJ. Fetal RhD typing with free DNA in maternal plasma. Am J Obstet Gynecol 2005; 192:663.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/14\">",
"      Bianchi DW, Avent ND, Costa JM, van der Schoot CE. Noninvasive prenatal diagnosis of fetal Rhesus D: ready for Prime(r) Time. Obstet Gynecol 2005; 106:841.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/15\">",
"      Goebel JC, Soergel P, Pruggmayer M, et al. Prenatal diagnosis of the Rhesus D fetal blood type on amniotic fluid in daily practice. Arch Gynecol Obstet 2008; 277:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/16\">",
"      Nicolaides KH, Rodeck CH. Maternal serum anti-D antibody concentration and assessment of rhesus isoimmunisation. BMJ 1992; 304:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/17\">",
"      de Silva M, Contreras M, Mollison PL. Failure of passively administered anti-Rh to prevent secondary Rh responses. Vox Sang 1985; 48:178.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/18\">",
"      Bowman JM, Pollock JM. Reversal of Rh alloimmunization. Fact or fancy? Vox Sang 1984; 47:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/19\">",
"      Pretlove SJ, Fox CE, Khan KS, Kilby MD. Noninvasive methods of detecting fetal anaemia: a systematic review and meta-analysis. BJOG 2009; 116:1558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/20\">",
"      Nicolaides KH, Fontanarosa M, Gabbe SG, Rodeck CH. Failure of ultrasonographic parameters to predict the severity of fetal anemia in rhesus isoimmunization. Am J Obstet Gynecol 1988; 158:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/21\">",
"      Bahado-Singh R, Oz U, Mari G, et al. Fetal splenic size in anemia due to Rh-alloimmunization. Obstet Gynecol 1998; 92:828.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/22\">",
"      Roberts AB, Mitchell JM, Lake Y, Pattison NS. Ultrasonographic surveillance in red blood cell alloimmunization. Am J Obstet Gynecol 2001; 184:1251.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/23\">",
"      Dukler D, Oepkes D, Seaward G, et al. Noninvasive tests to predict fetal anemia: a study comparing Doppler and ultrasound parameters. Am J Obstet Gynecol 2003; 188:1310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/24\">",
"      Nicolaides KH, Thilaganathan B, Rodeck CH, Mibashan RS. Erythroblastosis and reticulocytosis in anemic fetuses. Am J Obstet Gynecol 1988; 159:1063.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/25\">",
"      LILEY AW. Liquor amnil analysis in the management of the pregnancy complicated by resus sensitization. Am J Obstet Gynecol 1961; 82:1359.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/26\">",
"      Queenan JT, Tomai TP, Ural SH, King JC. Deviation in amniotic fluid optical density at a wavelength of 450 nm in Rh-immunized pregnancies from 14 to 40 weeks' gestation: a proposal for clinical management. Am J Obstet Gynecol 1993; 168:1370.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/27\">",
"      Weiner CP, Williamson RA, Wenstrom KD, et al. Management of fetal hemolytic disease by cordocentesis. I. Prediction of fetal anemia. Am J Obstet Gynecol 1991; 165:546.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/28\">",
"      Picklesimer AH, Oepkes D, Moise KJ Jr, et al. Determinants of the middle cerebral artery peak systolic velocity in the human fetus. Am J Obstet Gynecol 2007; 197:526.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/29\">",
"      Mari G, Deter RL, Carpenter RL, et al. Noninvasive diagnosis by Doppler ultrasonography of fetal anemia due to maternal red-cell alloimmunization. Collaborative Group for Doppler Assessment of the Blood Velocity in Anemic Fetuses. N Engl J Med 2000; 342:9.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/30\">",
"      Zimmerman R, Carpenter RJ Jr, Durig P, Mari G. Longitudinal measurement of peak systolic velocity in the fetal middle cerebral artery for monitoring pregnancies complicated by red cell alloimmunisation: a prospective multicentre trial with intention-to-treat. BJOG 2002; 109:746.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/31\">",
"      Sallout BI, Fung KF, Wen SW, et al. The effect of fetal behavioral states on middle cerebral artery peak systolic velocity. Am J Obstet Gynecol 2004; 191:1283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/32\">",
"      Shono M, Shono H, Ito Y, et al. The effect of behavioral states on fetal heart rate and middle cerebral artery flow-velocity waveforms in normal full-term fetuses. Int J Gynaecol Obstet 1997; 58:275.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/33\">",
"      Oepkes D, Seaward PG, Vandenbussche FP, et al. Doppler ultrasonography versus amniocentesis to predict fetal anemia. N Engl J Med 2006; 355:156.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/34\">",
"      Nordvall M, Dziegiel M, Hegaard HK, et al. Red blood cell antibodies in pregnancy and their clinical consequences: synergistic effects of multiple specificities. Transfusion 2009; 49:2070.",
"     </a>",
"    </li>",
"    <li>",
"     American College of Obstetricians and Gynecologists. Antepartum fetal surveillance. ACOG practice bulletin #9. American College of Obstetricians and Gynecologists, Washington, DC 1999.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/36\">",
"      Canlorbe G, Mac&eacute; G, Cortey A, et al. Management of very early fetal anemia resulting from red-cell alloimmunization before 20 weeks of gestation. Obstet Gynecol 2011; 118:1323.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/37\">",
"      Yinon Y, Visser J, Kelly EN, et al. Early intrauterine transfusion in severe red blood cell alloimmunization. Ultrasound Obstet Gynecol 2010; 36:601.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/38\">",
"      Fox C, Martin W, Somerset DA, et al. Early intraperitoneal transfusion and adjuvant maternal immunoglobulin therapy in the treatment of severe red cell alloimmunization prior to fetal intravascular transfusion. Fetal Diagn Ther 2008; 23:159.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/39\">",
"      Trevett TN Jr, Dorman K, Lamvu G, Moise KJ Jr. Antenatal maternal administration of phenobarbital for the prevention of exchange transfusion in neonates with hemolytic disease of the fetus and newborn. Am J Obstet Gynecol 2005; 192:478.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/40\">",
"      Ruma MS, Moise KJ Jr, Kim E, et al. Combined plasmapheresis and intravenous immune globulin for the treatment of severe maternal red cell alloimmunization. Am J Obstet Gynecol 2007; 196:138.e1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/41\">",
"      Porter TF, Silver RM, Jackson GM, et al. Intravenous immune globulin in the management of severe Rh D hemolytic disease. Obstet Gynecol Surv 1997; 52:193.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/42\">",
"      Isojima S, Hisano M, Suzuki T, et al. Early plasmapheresis followed by high-dose &gamma;-globulin treatment saved a severely Rho-incompatible pregnancy. J Clin Apher 2011; 26:216.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/21/5464/abstract/43\">",
"      Palfi M, Hild&eacute;n JO, Matthiesen L, et al. A case of severe Rh (D) alloimmunization treated by intensive plasma exchange and high-dose intravenous immunoglobulin. Transfus Apher Sci 2006; 35:131.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 6802 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-200.150.3.100-EF161DC620-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5464=[""].join("\n");
var outline_f5_21_5464=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INITIAL APPROACH",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Test paternal blood to predict whether fetus is at risk",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23486190\">",
"      Cell free fetal DNA testing to determine fetal Rh(D) type",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Testing amniocytes to determine fetal Rh(D) type",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7289512\">",
"      FIRST VERSUS SUBSEQUENT PREGNANCIES COMPLICATED BY ALLOIMMUNIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      First alloimmunized pregnancy with Rh(D) positive fetus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Follow maternal anti-D titers",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Critical titer",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7289621\">",
"      Subsequent pregnancies with Rh(D) positive fetus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ASSESSMENT FOR SEVERITY OF FETAL ANEMIA",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Middle cerebral artery-peak systolic velocity",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7289715\">",
"      Other methods",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Spectral analysis of amniotic fluid",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Fetal blood sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      MANAGEMENT OF WOMEN WITH MULTIPLE ANTIBODIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      ANTEPARTUM FETAL SURVEILLANCE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      INDICATIONS FOR FETAL TRANSFUSION OR DELIVERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5318055\">",
"      FUTURE PREGNANCIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"OBGYN/6802\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6802|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?27/37/28240\" title=\"algorithm 1\">",
"      Algorithm for management of the red cell alloimmunized pregnancy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"UTD.htm?0/15/254\" title=\"algorithm 2\">",
"      Algorithm for cell free fetal DNA testing for fetal Rh status",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"OBGYN/6802|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?8/31/8702\" title=\"figure 1\">",
"      MCA peak velocity",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/31/11768?source=related_link\">",
"      Fetal blood sampling",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/57/13210?source=related_link\">",
"      Intrauterine fetal transfusion of red blood cells",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/13/32982?source=related_link\">",
"      Overview of Rhesus (Rh) alloimmunization in pregnancy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?29/26/30121?source=related_link\">",
"      Overview of fetal assessment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?3/59/4019?source=related_link\">",
"      Patient information: Pregnancy in Rh-negative women (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/26/10665?source=related_link\">",
"      Postnatal diagnosis and management of alloimmune hemolytic disease of the newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?1/26/1448?source=related_link\">",
"      Prenatal diagnosis using cell-free fetal nucleic acids in maternal blood",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/44/40648?source=related_link\">",
"      Prevention of Rh(D) alloimmunization",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_21_5465="Midpontine syndrome";
var content_f5_21_5465=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F68785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F68785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 541px\">",
"   <div class=\"ttl\">",
"    Midpontine syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 521px; height: 598px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAJWAgkDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6pooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKK5q68Vede3Nl4d06fWbq1lMNy8TpFBbyAAlHlY8tg8qgcj+ILmgDo5ZEhieSV1SNAWZ2OAoHUk9hWLofiOHXJ/8AiXWOovYFN6ahLD5UMnTAQOQ7Ag5DBSpH8XTOdH4cvdd/f+MbgvGzZXSLOZhaIuQQspwrTk4+YPhCDjZ1LdbQAUUUUAFFFFABRRRQAUUUUAFME0RVGEiFXOFO4YY+3rT68b8L+EdUsdC8ENcJIbWzaylis/KYSWsjxD7QZARxhgcHt5jg9qAPZKijuIZHdI5o3dGKMqsCVbAOD74IOPevKdNl8VjT5pLq41MX5hj+326Wk52t58XmtC7ZjysRm2rF975TjIp1tFqOnz31zpem6rcw/a72aJZklWWQfZIgnzyAuMsCATySMc4xQB6tLNHE0YlkRDI2xAzAbmwTgepwCce1BmiE4hMiecVLiPcNxUEAnHpkjn3ry/RotYn1OySddQubG31eGaGSe2uE2IbaUPzOS5UNgZY4yeAMgVr+OYdSHiO0udOivPJWyMdxLaoxdYzdW5kCEAnf5YcgD5sA7eQKAO8orz2yg1W/udPtZJdZj0eS6utrs0sU3kBF8vzHOHX592NxDEAZzzWLFqeupp+jXGtvq9vqbtoqRhY5UiIlkgW5EoA2ByWkBV+QMYAoA9bVgwypBGSOD3HBpa8rt9P1Ma0l28OpQzsmsQ27RRuqbzfM0O/aMAMmGDNgNgHJqf8AtTXL1ZGWLWo7FbTS1uT9klilBMk/2kxgqGLY8oNtBIHI5xQB6RFcQykiKaNyGZTtYHBU4YfUHg+lS15A1vrNlod8+j2uqLKsGuy2zPBI029mBgOWG/c3UZ5b3rY1garY3V/YINYm06S7hKXe65lMIMLF2HlESOpdVG1SFBbsOKAPRBNEZzCJE84KHMe4bgpJAOPTIPPtUaXtrJeS2kdzC13EoaSFZAXQHoSvUA1xPw/j1aTVIrvWYrrz20eCF5p4WjLOs8/Bz/FtKkjryD3rLnsb6yOpFItWRb7Wp3edPtLCJAmVYRwkOyscDIIX5Rk8AEA9RpGZVxuIGTgZPU15Zo914lN14fmvV1O6upba3SaF4p7ZYG2ne7kL5T5PLK5DDHy8kA2rH+0JdL0ZgmtS6x9ptn1Bb2GXy0kw28ruXYFDZGY/lAx6gkA9KphmiE4hMiecVLiPcNxUEAnHpkjn3rznTbvULbTtGupP+Eie9WeE6yk1vO4yY5A+xNpBXzCvEWVAAPTmqTv4gcWmpi31IXKW1zuY27+YI/7QiO3bjOTCpwuMkDjNAHq1FeXa3fa3cwXt1CNZ8hb6Y29oLa6haePyYtg3xpvjAbfjcu0knPSvTLVna2haVGSQoCyMQSpxyCRxn6UAS0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRUV1cQ2lrNc3UscNvChkklkYKqKBksSeAABnNAEtFZ+g30+pacl7PbtbJOS8MbghxEfuFwQCrEfMVIBXODyDWhQAVV1TULXStPnvtQnWC1gXc7t29gBySTgADkkgDmrVcj4wv8ARLPXNJfxNe29tZ26S3UEd0MJLcKU2sp6GRBuITkkvuUEpkADs+IvEaKpRvDulSqdx3h9QcEcAAZSA985kbHGEPI6DR9Ms9G0y207S7dLaytkEcUSdFH48k9yTySSTzUtjLJcWUE08LQSyRq7RMcmMkZKk+o6VPQAUVl+IvEGleHLEXmt30VpAWCJvyWkY9FRRlnY/wB1QT7Vj/8ACZySu32Dwt4mu4g20SfZEtw30Wd42x7kCgDrKxLnxJawXc1utnqs7xHazQ6fMyZ9A+3a34Eis2Tx1Y2Ku3iDTtX0OJWCme+tswjJwC0sReNB7swFdRbXEN3bxXFrLHNbyqHjljYMrqRkEEcEEd6AOcl8b6bZxebrNtqekQ7wnm3lm4iGehaRQyIPdiKsWvii2NzBDqMMliLqQR2dw7LJb3efu+XKhIBIxhX2sewOM10FclrHgu2le6n0X7PZzXQYXVpPD51je7uvnQZALd96lWzjcWHykA62ivM30zUtOgYSWniu32NmL+ytVS9jixwoUTYZh7MjKO/GK7bwrJqkuhWz69EIdQy4dflB2h2CFgrMocptLBSQGJA4oA1qKKKACiisfxjraeHPC+p6s67zawM6J/z0k6Ig92YqPxoAo+GNXvNY8Q+I23J/Y9lOljbAD5nlRczseOm5lQc/wGumrD8EaK3h7wrp2myuZLiOMvcSE53zOS8jZ93ZjW5QAUUUUAFUpdJ06XUo9RlsLR9QjG1LloVMqjngPjI6nv3NXaKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooqtqV/a6ZZSXd/OkFvHjc7nuTgAepJIAA5JIA5oAsEhQSxAA5JPauWWI+LbuG5d2/4RyB98MYxt1FwciQ8cwgjK44c/Nyu0sn2O88VPHLq0UtloPDrpsgAlu/+vgc7U6ERA5OBv6tGOroAKKKKACisfQri91Ca6v5pEXTZSFsoVXkoM5lZv8AbPIA4ChT1JxsUAFc1eDxfd3E0Nt/Yel2oJCXJeW9lZex8vbEqNj/AGnGfXHPS0UAc5a+Go9Mjur6yK6h4jeF0j1HVDvkJPIQlQNkecHZGFXqcZJNRmy8ZeVldd0DzvQ6PNs+n/Hzn8efpXT0UAcjJr/iTS0b+1vCst8iKP32i3Uc271JjlMbL/urv+prmfD+o6rF4ov73wz4W1iHQ5ozLe6fewpZH7TuH722Dthmdc7lOxSV3FtxIb1SigDkIviHoipGNSi1XS7hlLtBfabOjRgdSWClMcdQxHvWjJcReJLGC88L+IIA0T5We2ZLmCTjlJFB5HQ8MrDHDAEg71c/q/g/RNTvmv3tDa6oQV+32UjW1x0xgyRkFh/stke1AEGoR+I7yyNlc6bpkyOFEk0GrT2jEggkrsiLJ0yAHPpnvUuq3sOgeE4Itd1mSG5kjWzW8ij3TyzsuAYo8MXkJyQoVjx0PNVo9F8U2oMVr4sjngxgNqGmJLMP+BRvGpPp8n1zVvQPDS6ddtqGpX91rGrsvli9vFQNEnGUiRFVY1JGTgZY43E4XABN4SvJrzQ7JprfVY/3I/eanGkc7kErmRF6MQoboOGHQ5Au6vez2NqJbXTLzUpC4XybVolcD+9mV0XA+ueelXaKAMLw94osdbla1EdzYapGhkk06/j8m4RN23ftyQyZ43oWXPGc8Vk+K5DqvjTw3oETfu4HOsXgDYISI4iGO+ZWU/8AbM12BijMyylFMqqVVyOQDgkA+h2j8hXH/D4HVL7XvE8mWGo3JtrQ5yBawEohHpufzX9wwoA7OsDxheanZ2to+lxTNG0+26lt4RPLFFtY7ljz8x3BRxkgE8Htv1S1TTLbU440ujcL5bb1aC4kgYHp96NlOPbOKAOWg8bQW2i308sj6i1hp1xqEsqwG3ZhE7AxtG3KONuDnHIPA6VevfFbWur3NubAtZ2t5bWM9x5wDB59gjKpjkbpUB5GM5GecVta8P8AhRW0/SdQikWS/We0hhjuZ1e4VgZJg5VsuOCxZyeT1y3N+LwpZnxDfatdPLPJPPFcRxGR1jiZI1QEoG2scrkErkcegNAGFbfEmK4sWvItIu5baSJJ7UxkgyI8scahiyqqufNVgNzAjPIwavf8JXeLqsmnHTwdRkliiitnlCqhMTysWkGeAEPRTyQMdSNOPwlo0aPGlvOIGKkQfapjEmJFkGyPdtT5lU4UDpjpxU9/4c0u+nlnngkFxJIkplinkidXRSisrKwKnazL8pGQxBzmgDM03xc2pahYWtlpc7tPC00ztKii3CymJwecsQwPTOcdqv3Os3B159M0+xFybeKKa6kebywiyMwUIMHc3yMSDtGMc5OKtWGi6fp80UtnbCKSKD7MhDMcR7t2OTyc85PPvTbzQ7C81JL+WOZbtVVC8NxJFvVSWVXCMA4BJwGBHJ9TQBylp8SIbjT576PSrp7T7L9st2TOZELooDFlVVc+YpADMCM8jBq1J44eLV1sJdInE0ckUV0qMZGiaQjbt2qVYBWVmJZcA8biMVrR+EtGjhmgW3nFtKu02/2qbylG4NhI921OQPugenSrN1oGn3Opfb3jnjujsDtBcyxCXacrvVGAfGT94HjjpQByGnePZ7HRILnX7QsZoJpYJYHDGYpMsewpgbCTImOSCM5weC698Z300Vube3aykWW5ilBUskmy0eVWRnRSRuAB+UcqR05PRW/g3QoIpohZNJFLE8JSe4llCo7BmVA7HYCwU/LjlV9Bib/hGNLMaJLHcz7Gdla4vJpmG+Mxt8zuTjaxGM45z15oAw7LxqVvdIs7iBJxdCCGWeFmYxzSRBwHUJsQHjguG5BC4rc8J63L4g0mLUG0+SygmUPCJJFdnU98KTj8efp0qOPwjosV3FcR2sqvFIkyILmURiRFCK+zdtLbVAyRk45rV0yxttM0+3srGPyrWBBHGm4ttUdBk5JoA4uP4iIulWl7eaZJCNQs4LyxRZfMMqyuiBXwvyEGRCcbvlORkjbTrjxtdXGmzpp2mFNTSC5mYTOyRIkQX50Zky+TIu0FRnDA4xV/w/4F0nS/Dttplysl88dpBayTyyyFm8oDaUy5MWGG4BCNpxjoDV6fwnpFxEkc8d3IVEiiRr6cyFXADoX37ip2rlScfKOOKAM/TvFyvYRG4gd50nsrSRgQAz3CRtuA7AeZ09qgHj2OKOW5vdOkhsRBeTROkod5Ps0gRwUwAMk/LyffFa7eEtGa6huPssgeIwsqrcyhN0WPLYoG2swwBkgnAwalPhnRzCkL2SPEqXEYR2ZlKztulBBPIY+vTtigDA1rxXqGiXtpLrFmtrbC0up5ILeUTmQp5OwBiq4OXIx0z3I5rc8L66+tx3XnWb2stu4Q/fMbggEFGZVJ9D8owR3GCUHhPRym2e3muh5ckP8ApVzLP8kgUMvzseDsX6Y46mtDS9Mt9MR1tmumDkEm4upZzx0AMjMQPYUAXaKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAoornbq/vtZdrbw5NHBaqds2qMgkUHusCnh2HdjlFPGHIZVALOta9Dp9wllbQyX2rSruis4Pvbc43yHpHHkH5m9MDc2FMWn6CX1BNU1yb7bqS8wp/yws+oxCn97BIMhy5yeVUhBe0PSLTRbM29krku5klmlcvLM56u7nlm4A56AADAAA0KACiiigArL8SSAaU0BLA3ciWnyHDYkYKxGO4Us3tjNXL+9tdOtJLu/uYbW1iGXmmcIijOOSeBzWNpZuNc1CHVbmGS20+DJsbeaNo5mYgqZpFOCuVJCoRkBiW5IVADfjjSKNI4kVI0AVVUYCgdABTqKKACqwvrdtSewWTN2kSzvGFJ2oxKqSegyVbAPJ2tjoawbvxDd393daf4VtI7y4tyY5r24cpZwSDIKbhlpHUjlFHHIZkOK0PDmhx6PFcSPK11qN5J515duMNM+MDAydqKOFQcADuckgGvRRRQAVjeJtafSIrKK1tPtuo39x9ltLcyiJWfYzks5B2qqRuxIBPGACSAdmud8fTaHF4clXxLbG7tZWEcVtHE0k80pBKrCq/P5nBIK4K4LZAUkAHCa98Q9c0zVXsbhrG3ukP7yGPSrm4VBjjbLJJAJO/KrjHvVT/AIWP4sV1/wCJNq1wu0MTa+E53Vhjs5uwPTpmnSWGoS+ZGj6rZQRjd5Or+MpLaePPI3eSsp6Efec8VDJHZuRFcz6LfPnmK48f3smeM8IY9ueD2HT34ACXXPFV+yKyeO4C4LMDp9vaQqecKNkM8nbOd3cd+Kn+3Pb6XDNYa/4oTxazvHY6RqE6SPcuMqPMg2AiAkbjIVRgvzZXiqwn8Owt9nn8DeCXvZOEhOpW08soPTA8su2SegBJz6muh0LWxoSWclp4d8M6dpN9fx6e8el3ZFwLhn2AGIwRgspyWXO5VVm5xigD02iiigDmPiRqlxpnhK6XT2VdUvmTT7HLbf38zCNDn23bvoprZ0LTINF0Ww0yzz9ns4Et489SqqACffiuZvWOtfFCwtF3Gz0C2a9lKkbTczAxxqR6iPzW/wCBLXaUAFB460Vx/j+aTUzaeE7GVo7nWA32qRD80FkuPOfocFtwjU+smf4TQBF4LD+INc1DxbMGFtKpsdJVv+fVWy0o5/5auMjj7iJ612tRWtvDaW0VvbRJDBCgjjjQYVFAwAB2AAp0y7oXXYHypG09G9qAM7S/EGlapcmDT76KeXYZVCk/OgIBZT0ZckDIyOR61oTTxQyQpLIqPM/lxgnl22lsD3wrH8DXlWs2esaV4U1dLWPV7LRoNKmQW99cQSNG42iMQPGxfAAfO9v7uO+NSHQdVF/DPYafLp2nnUmm+xGaMGNPsE0ZchXK/NKyfKCefmPJOAD0WonuIUuI4HljWeUMyRlgGcLjcQOpAyM/UV5pb+FdWtNOSOCzbZJp+nfbYVnUG6mjlLXCE7uWZOCxOG4UnHSzp/hu7j13Rr+fR3+xQXNz5Np5kZaxjkMRQ/f27Q0bthCcbgADigDv9PvbfUbGC8spBLbTKHjcAgMp6Hmie9t4Lu2tZZAs9zu8pMH5toy35CvMbLwprGl6LZx2OlQmZ9KEF9Ezowlk86IkEFgHcR+btyducAkA0WXhzxDa2xNpYMfIlvmtYbx4QFSS3QIpWIhVBff8q4x7ZzQB6tUd1PFa201xcyLFBEhkkdjgKoGST7AV5jpPhXUxOsE1hcR6Q2pQ3DW07W6L5Yt5Fk/dwnZtL7Pl5J6nPNR3PhHWYNBuE02zaO/l0zVbRmWdQzF2H2RdxboFAC84QccUAerVHHcQyTSwxyxtNFjzEVgWTIyMjtkVyuh6ZPbeJb2fUNJkmupLqWSLVfMjKiEj5I8bt4wMLt27c/N1NZHiPwzeXOta/Na6dKz6gbIpeQzrGVRJEEqE7w6naucgdO+eKAPRainuIbdVa4ljiV3WNS7BQWY4VRnuScAd68717w5qf/CRWbaXprpb2d1Ym2uIGh4gWZDOsjyN5v3fM+VMAjGSckVWm8L3c+jQw3fh6S41SC8huLu7M0R+3hZ1ZipL5JK5ID7do+UdqAPUqKZAAIIwIzGAoAQ4yvHTjin0AFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUVhaqp1q+OlI7pZwFJL51yPM7rAD054L8/cIXH7zIAIif8AhKchG/4p44IkjkKtfMCDwR/yw49f3mT/AAf6zfgijghjhgjSOKNQiIigKqgYAAHQCljRY0VI1CooAVVGAAOwp1ABRRRQAVBf3UdlZTXMwYpEpYqgyzegUdyegHcmp6p6tbzXNi6Wrok4ZJEMgypZWDAH2OMZ7ZoAy9L0hrm9i1XXYRJqoRXjjLb4bLIPyRDoWHIaXAZs9lwi9BVPS4LiC1BvpIpbxyXmeKPYpJ6ADrgDCgnnAGauUAFc/wCKJJ72S30LT7mW1ub0F57iH78FspAcqcja7ZCKeoLFgDsIrfZgqlmICgZJPAArB8JxG5F5rcykS6m4eLJOVtlBEIwfu5BMhXs0rUAbFjaW9hZQWdlCkFrBGsUUUYwqIowAB2AAqeiigAoorhfHXiIHRtTggi1C2soW8qfWBJDDBCwZcqTJNE7KSdjGMjqyq4ccAHceYnmeXuXzMbtueceuK5zxhpl/Jc6breixRXOp6WZNtpKQBcxSACSNWPCSfKpVjxkbTgMSPPPDlkL7xJpd3D4ZFvfWFyr208Oky6fD5cg23BnWTILIo+Rg25mcYXaGY+g/Eae4tvDTSxXU1nZieIX9xb5E0NqWAkdGH3MA5Z+qoHIwQCADzqPR/scUlpb6FqQtllZ9914fhu71Hc5Y/aGlKSHLH5ijnHVmPJ0hZam0Qghj8ZXKhcGM6bpMalc42/Oirj2z3qn4k8PaSl/EmnwRDSb60W5j1a5S91Nbl2LEr50c4MQ2hGDEkPv4+6c49vpFtcKhhuXvbfoPI0/Wr+AkdM5uAnHpzQBqTtqmm2sttqms2HhewmlL+XqV/b285Xjny7RYzn/dnyce/HV/Dm28MvcPLp2t2+uatArZcsga2RyNwSIY2BiOXOXcgbnbAxy9taP4ehnv7S0u9IVkw76RpOm6Uhx/eN27Mfz710/hO8uvFes6VqkiQS2mk2jRNqMKkJe3UgCyrASAWgXZnePldmXH+rNAHoFcd4o8aJpV7c21mliy2Ko+oXd7d+RBaBxlE4VmeRgMhAOmMkZUHsHZURndgqKMkk4AFeffFjTbPVrSwsLS3tBrutP/AGbb3/ko80FsQzzsrHB2iMPwDyXHrQBH8F9XGs6bql/cRomo6jcf2nL5c6zJ5UmUiUMOm1YTGVbDBo2yBkV6NXl8Ph27uotOsbjwPZK9pG0D3N7qQltpQSWZmVctcEvl/wB6qnczNkMTm/4ES1t9cVNOgTTRJDcw3umWcwkso7i3khTdEMAJw5yFC5z84DrwAd5d3MNnazXN1KkVvCjSSSOcKigZJJ9ABXKfD22mvlvfFOoRvHea0VeCOTg29mufIjxkgEgl2x/FIR2FQeKpY/FWraf4ZtJFm06RVv8AVJI2yrWyt+7iyOP3rjnnlEf1rt6ACiiigAoorH8V69b+HNIe9uEeaRmWG3to/wDWXMzcJEg7sT+QyTwDQBleONcu4ZrTw94ebPiHUwfLfbvFnAOHuXHTC5woP3mIHrXSabamx062tTcT3LQxrGZ7ht0khAxuY9yep6VgeBtBudNgudU1uQTeIdUKy3rj7sWB8kEf+xGCQD3OWPXjqKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigChrV69lYM1uqvdykRW8bDIaRvu5GQSB95sdFVj2pdG05NMsRApDyszSzyhcebKxy7kZOMkk46AYA4AqBFN7rskj7Wt7ABIx1/fMuWY8dkZQCD/G4NatABRWJ42lvYfCWqyaWZRdrAxQwrukA/iKDuwGSPfFcnqmraPpOkyXPg28t5bhmhiuZY7syrBEzgNLJksoYZPzuCRkk5ANAHo9Fed6Rrmu6hqGkWcWp2EqPBe3Ek1uEuPPWGW3CLvXaociVgxAx7A9Ocm8Tapqfhe5l1HU7CPctpPNGJk82yl+1RBlKBQUQZIIkJYFevWgD2eivKr7xbqsbLBBqkB0s3VxHFrcjwxLMEjhZFLlTHktJMuQo3eQcYJzVT+0NQl1a2u90Ul++pRy7bZi8TSHRJmwnqu7kevFAHsFFeaHxtdXtneyaXfWkvlWOlSCSMCQJNcXEkcoOD/dVeO1W7LV9Yg1qGG41JrmCPWW0tkeGNfMjNuZg7FQPnBIHGBgcgk5oA2talj8QahP4chAls0UHVnB4VGGVt/8AekH3h2jPON6GumAwMDpUFnZ21lHIlpBHCkkrzOEXG53YszH3JJJNT0AFFFcV4h1W/OpapH/aw0jT9PEAxbWv2i8uHl+6VUhhsZjsACFmZG5GMEAs+M7+9h1Cxsra/uNNhngnlE1tarNNNLGoYQx7wU3Fd7bSCzBDt+61cHoY8Sa5Ol9B4dt77Q9TQtIt1fRpbXSsq/NPAGmRGyCxMaZZuDjnOrK3iTWhbyvLdRWlk/nrdalYpYwxsoOZZUMhklKA7lULGhIyzccZt1rN8mjWdt4TvLvT/DChppNdljSWa+d5GLupl2xRoXLszMVYlh5aBcMQD1Hwzp1xpWhWlleXZu54gd0p3d2JCjcWYhQQoLEnAGSTk1z/AIm1HUX8Q3VpZ63BodrpdhHqU089usyTqzyhg4YgrGghy20hj5g+ZcfN59ZXKDX7fTrXW7261GSA3EcB1DVUlKAkCX788JXIPBUqf0rorC51nxBYTrHcxf8ACbeGmV4p4lKxX0Mg3CKUMqgeaqbXGBtkQOAAFFAHL6bL9vkeHwrpVvfhMPOfCviiSxCknlvsblUjznPU5/vHmuw0mw0K61CHS9bj8WW9/MpEdvrOpXDR3GASVBSVoJGxklQScAnGAcU0sLPU9JtfEHhCGeOKGZ1bS5IPJl06U5Wbygil4Zd330w6PySpDbqXUzrjfDaHSfEczzeLdQuC+lW6GM3EbxyiSFpGTCN5W1GkkAVccYJI3AHQ3fh7wD4QigvJtC0KxcyCKBksEaeSQ9EjCqXdzjhVyT6VN/bXifVphHo3h8aZasoP2/WZBnr/AA20bF247O0RrH1xtRg8Va4sV5bWmvXsUMPh+4vR+4EICmaJDtOJi4kYjBJXyjhhGQMzXPDunafc2r+P7m91ayusFY21Gb7Ms6EFII7QyF7h3JPGHztxtUYBAILO/wBE13Ubu48Q3k/iXQNLheW61a7KRaVFNnCxRQKNs5wWO5vMKkKA2WAFj4U6TFceMvEerW2m/wBmaNZS/ZdLsTGIxA0kcTTv5f8AyzLbYjt425YEBtwrcurKO00o+JPFNrHBZ6NCbjT9GiI8qzCL8pYL8rz4wBjKpwEycu/MWXiTUPD2n2ugWYsU1XebjXL+5uII/IuZsTPHHG8iGVwJRhidijbyxBQAHsbAlSAxUkdR1FeSaxax6L4Sig1zwbLdxaFC8aTxXkcVndx5Us0iiTeRIVVmiaN8v/f+8RptWnVLqz13WLp3yUlS7WTbg8qUt7J4SR/wL61V0vxFf6/400fwx4raExWM32lrm3jmiS7uFXfbwSq6JskChpioypKLjH3aALPwwsV065g1FbAaXq+papPZ6tZxsvkLiGSaJUC/KTGqouRzlpA3zZx67Xn+p6fq9g01lZ2F/LAl9JqOn32mtbmSJ5WdpY5UnZVPMsuCMjaw6MuWm0rXV0q5srjV/ErzaRqFvIUk1eKG1eCeNlBjyqxgEhnyjAsDGeetAHdUVU0vU7DVrdrjSr61vYFYoZLaVZFDDqMqSM8jj3q3QBHdXENrbS3F1KkMEKGSSSRgqooGSST0AHOa47wtBP4l1dfFepxlLNVKaLauuDHEw5uHB6SSDoP4U46s1R6iT438QS6THtbwzpcoGoODkXlypBFuP9hDgv6thOzV3I46UAFFFFABWRYeJNJv4Wmtr1DANv711ZEO5gq4ZgAckgDB5zWvXl1z4Y1G40W+sLPSr630pI7VotOvbxJi8kc4d/LPmMFUouMFlBOOF5NAHpNve29xc3VvDKHmtWCTKAfkJUMB+TA/jTbnULO1vLS0ubqGK6uywt4ncBpSoy20d8DmuFPhi6/tafUrbTDbzf2jYSW5aRN8VuscSSrwxAwA6kA/NjjIxWv4w0C51rWtLkt/3a21vcFbnI/cTloWibGcn5oyeOwIPWgDp7S5gu4RNaypLEWZd6HIypKkfgQR+FTVyvgKLVbDRrKz1XSzbSv9puJ3E6OsLtcFlj4OTlXJyOPl5wSBWZreiarJ42+3aZasfMwpu7oRsluoiYZiYOJE+YjKbCrHJ4zkAHe0V5RpnhTV49J+zva6hHcSS6eLsNNAsU3l3UbTSBkbc7FBJlnwzDAwTwHar4W1aNGXTtLM32e6uWsbaQwtZojsjIWUyK0fIOGTLKC3y8gEA9VorzifQNYa/uGhspUvftF9JLqPnJi6gkSUQQD5tw2l4eoAHlEg/NzX1PQbrTofD+naXJLDc6tCdP1FWuHdwm0PJOGJJ3KFdQc9ZR7UAen0Vz/ivSpNTGi28cAltIr5Xuo9wCmERSDBGfmGSvy859MVxUuh+JbTR760trG5ma4sJbOARXMai3K3EzR53OMAxugG3ONuDigD1WivO9Z0HVbifxAIdPkbVbl5DZasJ0VYojEAIs7t6chlwFIy2/rnEWk6NqulXFjd2em6mbeG9Mstiz2sWFa3dMxqkmzG4oTkgk5OPUA9Jory628Pa5E3hiZ9PluL62t7aK4+1PFLDAVlJdlbzA6SbSfmUOGwoIwK9RoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACorqeO1tpbidtsUSF3b0UDJNS1m6zKzPaWMSsz3cmH2kfJEvzOxz2PCcd5B9aAJ9Ijmi06EXUkkk7Au5kxkFiWK8ccZxx6VboooAKKKKACiiovtMH2s2vnxfagnm+TvG/ZnG7b1xnjNAEtFFFAFbUr6202xnvL6VYbaFS7ucnA+g5J9AOSeBTNInurnToZ7+2+yzy5cwEgtGpJKq2CRuC43YJG7OCRg1h2YfxRqUWotLG/h22YSWUajcLuVTxcMehRTgxgcEjzMn92R1FABRRXP3Piq0S/ktLO01HUJYZPKle0tmaKN+6mQ4TI7gE474oA5u/1O+1Gytrz+0bgPqF49hZ6fZzJbRxspfieYqzrIBG24L0I2BSRua34a8Ma1FdSSa3d2qW5mjnMdvLLczTMnKiSeXnYrchEVBnJ4DMpzdQCXv/CQWIhit9Z1xEa20tHSSWB0G1b6YoSIyD5Z3AnAhjCkyELXbSa9pkL6pC1/DJcaTAs98iHLQKysylgOhIUkDrjB7igDhPiPqkmua1N4Xs18+ws4BcatHEskrSF+IYGWFhMqH77MgbHyAgqzA83pT31xqWsSJbxPcLcIZJbG5cTTx7B96S3EcrOjZBWS3bHA3Nmi0x/Yr6hrVxbXVtJIb1pL20Mkf2iRCzmPzQgyuCq+XMCAgBTduzZ0023ifQbd2il1awlkLpMbe4ukcqxBKLdW84UfL0V8HHGOKALFwj3ki3Op2V5dBWx++tbWVFkBCgh5oYX3Ag85zkeorT8DaFH4j8Pp4ltdT1XTtVvGdbeeG4OyK3ikdIIzCWeJ0CZOG3cyOwYEgjAv7W90TR7mLw9Z6np08ube13W32eFJpWEaYWGFUHzMDltvIr2LRdOh0fR7LTbUyNBaQpAjSNudgoABY9ycZJ7mgDzq/j0yDVriTxo03hvV59kTazp15LZ2eoqoOzc4basgGRslyw6IzLzXceH9A0rTCbuwD3NzLGEN9c3D3MzpnIXzXLNtzkhQdoPQVsuqujI6hkYYIIyCK5aX4d+D5JjMPDelwzHOZLe3WFjnrymDQBt67baXeaXNBr0NlPpz4Msd4qtEcHI3BuOCAfwriNJu/AmjXMlx4O0W31G/yYfN0OwE5ycZja4UeWnQcO6it2y+Hng+zlEsHhnSDOGDCWS1SRwR0IZgT+tdTQB5Z4kHiDxZr2keHtUih0jSrtje3Frbz+ZeeRAwOZJVIWPdI0ICpuPDEPxisLRIJ7G1vdOs4NTkS2v7uN5xf6q5kInb528mLBdsgnEh6k9cgeg+Df8AibeIPEPiFgpjkmGmWbYHMFuWDEH3mab6hV9q5jxzanQ/GIvGtGudO10qhVm3Il4iAAMHuIo1EkaKB1JZMHqBQBR0e5g8SaIupKbfWtLwx825sLhoAclThry5UMAVAPy4yCPXHMeB9ItIdFNheXmkQ3txcTPNFpctvvgO/eksYghkfzYyAyp5iqCoAyBVzXrawsXtJ9KXw74cvI5BmSdNJtBGpUgOrfv2yDzjAyMgFe/Q3N1qGpp5kOqy6hCrFPtdlf3lyqHgAeXYwRKx7nL8c/gAeieDdYbXfDdlfTIY7oqYrmMxvHsmQlJBtcBgNytjIBxjisPxLod9pen6tqOh63qFnEizX32JIoZU83BZiheN2UM2SQM8kkDnBpfD5bjRNcuNOu5JWg1mNtTthJA8LJLGUjnVhJI785hkGSSSzntWq/iTU9F1iaHxXZW0GkTz7LLVLWQtEoZsJHcBhmNzwA/KEsBlTgEAoprVnper2Ws395aNYX2mrHdanZwF7aSZGBDNKu4RoA7kFzjDHng1f8YatdXFxbeHfDsyrq1+nmSXKkH7Da5w0+P7x5VB3bnoprF8f3Gj+B9VsPEsenWsFzcyTW8skKiF7yZ4yY45WGAQSpO98hcZ4zUfwm0mXwhL/YGsRQNrV3bfbHvIrszGdIisW0gqpjRAyKijIxnoQRQB3mg6RZaDo9ppelwLBZWqBI0Hp3J9STkk9ySav0UUAFFFYXiPxTp2hSw20xmu9Sn/ANRp9mnm3EvuE7LwcsxCjuRQBu1x2o+Mxd3dxpng61/trVIyY5JVO2ztH4/103TIyTsTc3BBA61D/YWt+KgzeLZzpulP00awmO51K4IuJ1wW6nKJhemS1dfYWVrp1nFaWFvDbWsS7Y4oUCIo9ABwKAMbw1ompWd1LqOvazPqOozJsMUY8q0gXdu2xxD8t7lmIHUdK6GiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAqO5nhtbeW4uZY4YIkMkkkjBVRQMliTwABzmsmWyuU8Y29/AmbSWykt7k78YdXVovl78NNyPUVhzaafFHjNpdTj0rUPDenwK1rA26RjcuEYTMpzGwCZCN1G5sdc0Ab/hTU5tZ0SPUJo40juJJXtimQJLfzG8l8HkFo9jY9+3QGjSLqVzLqwUeQ6+TaMyDJiByzg4zhzgjsVRD3pniFnvJbbRoGAN5ua5bIyluuN+AepYlU7EBywOVrZVQqhVACgYAHAAoAWikdgiMzZwoycDNVbA3cjTS3irEGbEUIIJVR3Y/3j7HA4HPJIBboopk0scMLyzOscUalndzgKByST2FAD6xYxp+peIWmt1hkuNOOyWZUBIkZThN/XKqxJX/bWsq3u5vEurTWsr3tnZ23zSQ27mNiCFKCdxhkdgS4iQ5CbTIRvVK6q2t4bWBILWKOGBBhI41Cqo9ABwKAJawdc8zVNSh0aLH2Qp5+oNzkxZISIcY+dg2f9lGHBZTW9WB4NeS5sr6/uECz3V/cknGMxxytFEf+/caH8TQBvKoVQqgBQMADgAUtFQXt3bWFpLdX1xDbWsKl5JpnCIijuWPAH1oAraxq1vpSQ+ck80077IYLeMySSHqcAdAB1JwB3NcRdaRNPLZXOoWjm0bWC9to9+I5SVl/1rkBmUlSZZl5JVdw4ztSTWvGvgLVtQtrb+2nv7+PPlf2HJczS4bBK7rXJKnYCVJx8oyOBVTS/EWjWGpLLpfg7xld6hIpjW4uNNnLhc52+dcsNqkgHG4DgZoA6LxXdDw1oyWnhewso9Z1OcWlhCEEcZmZSTI+0fdRFZ245CYHJFY/inRrHwf8JNZs7TDebGTd3M5+a6mmZVklmfcvLFuWLKFH8SqoI2vD+mahfa9J4i8RWsVrdLEbbT7JZfMNnCxDOXYHaZXIXdtyFCKoJ+Ysz4j3YbRToscSyXOsJJbhnGUt49v7yd+RkLlQBkbnZFyu7cADipB9l1ONL1RHq8qMqGQp5pC8Ao7SRXD9P4ZJhjjd0oh0+4kui13Z306yfOYpbeeVQVGOs1pI3J55kOO3FFtcXtldXGhLoR1HWolkd5NGvoIYLgBgrPLbSSKiSkNEzLtcDzEJPO2rWn+GvFeuytJqltY6DBMcTvIIbm/UggBoZYUREJTA3NvZSBgcA0Acv4m0y6uob/VtNgjWHwykWrTRiKGMyXcbrN5JIto3BESMzA9TLF6GvebC8t9Qsba9spVmtbmNZopV6OjAFWHsQQai03TLPTNNj0+ygWO0QECMktuySWLE5LMxJLMSSxJJJJJrgU8PeLvBt5MfBcthqvhw5dNDvpGhktj/AHLebDDaTnCuMKOBQB6VRXCWfi7xWqltV+HeqQoqlmNnqNpcHPoAZEJ/n7VteFPGGk+JmuIbGSaDULYL9q0+8haC5tyQCN8bc45HIyp7E0AdDWD451eTRPDF5c2gDX8gW3s04+e4kISIf99MM+wNb1eX+IfEsPiPxTpcPhazn8Sw6LJJdXAsmjFutzsCwhp3YLwJHYhNzAgZHFAHf+HNJh0LQdP0u2JMVpCsIY9XIHLH3JyT7msv4k/YB4G1iTVrxbG2gi+0C5b/AJYyRsHiYDB3ESKhC4OTgYOcVVZfHeoJIC/h3Q1ZcKyCXUXU+vPkqD+Y+tP0nwYiXkGo+I9TvPEGqQsJIpLrCQQOM4aKBMIrcnDEM/P3qAOK0XV9e1KzmWEtp2pI5t7qFYWDWc5jDYdBEvmY3AqQ4VxjBPNNv7+70lCdU1VjcSgx7Z7oQknBBJjk1BF98BRXf+KfCdtrUy6haS/2b4hgiMVrqsMSPLEDk7WDAh0ySdrepI2nBHDara+LtLil+1WV5MBJlZtAijdSu7CgxtLHKDjBIBcD+9QBk2M1jay2Gu6FbadevDqNv5lxaRxyeSjuYpvnt4ipJjkLNvmbBUHjGD7NrU+n22lXUmtSW0em7Cs5uSPKKN8pDZ4IOcYPXOK8NvdQ1S6e002TTfGF/NJPHcXBa18pY4I3WQqBMxO5zHsUeYuSTjOAp6/TL9firqME8KTxeDrBleWGaMxve3SkHy3U/wAEZAyOQW9cHABmfDa0l/4SS2n8RWl6thdWsieGUv5Fk+z25LF4GHaYxhGGSzGMEZOx69S0jQ9J0UTDR9MsbATENKLWBIt5HQnaBmmeJtDtPEWjT6dfGZEkwyTQPslgkU7kljb+F1YBgfUd+lcfB4q8QeErRYvH2lyXdnAh8zX9KjMsTKu4+ZPABviO1QWKh0yTggcAA9EqjresafoWnSX+sXkNnaR/eklbAz2A7knsBye1cuvjWTxDJJb+AYINV8t/Lm1OVytlbttzjI+aVsFflTjkZZavaJ4PgtdQTVtaupta1xc7bu6ACwZABEEQ+WIcdvmOTljQBRe88SeKnMelRTeHdFP3r+6jH2ycZ/5YwtxECAfmkG7kYQda3vDfhvTPD0Mi6dAfPmwbi6mYyT3Df3pJG+ZjyepwM8YHFbFFABRRRQAUUUUAFFZXinWY/D+h3GpTRiRImjUqXCD53VASx4AG7JPoKoW/iy1+1aTa3aBZ9TWRrdrZ/tERCFRkuo77x2xwckUAdJRXP+E/FVj4jtIHty0VzJAJ2gdWGFJwdrEAOAeCVzg8HFVdR8bWNhf65aT29z5mlQeeSAuJxsRmCc9VEiZzj7wxnmgDqqKK5+TxloSPIn20syb+EgkfdsO19uFO7afvbc7e+KAOgorJ/wCEj0g3sNqt6jSzbNhUEplxlAXA2gsOQCcntms+w8b6JeaTBqAmniimZ1SN4HMh2/eO1QTtA5LDgDqRQB01FZcHiDSrjU00+3v4Jb14xKsSHcShXcG47Ecg96SbxDpcOqjTpLoC78xYimxiFdgGVWYDapYHgEjPbNAGrRWYdf0oQpM1/AsTwS3IdmwPKiKiR8nspdQfrVZ/FejpbLPJcTIrFhsa1lEgCgFmKbdwUBlJYjA3DnkUAblFZ6a1prkhLyFsTpbZVsjzHRXVc+pV1I9iKTR9bsNZWRtNmaZECtv8p1V1bO1kZgA6nBwy5B9aANGiiigAooooAKKKKACiiigArDPiSBfEP9lPaXqAyfZ0vDGPIafy/N8oHO7Oz5txXZwV3bvlrcrjbXxFDY2HiSKzja91bTrxlNnkRNJJM+YBuOcI29V8w8Da3900AW/iPr9x4W8LvrVuI2htLi3N0rRs5Nu0qpIVCnIYKxYHn7vQ1W+GOl2Vlo15qGmzXMttq97PfxeaflWJ5GMYiXA2xlcMB/tE968y8R6tdXPiGfVtOv8AULeNre4vZ9MR1kVb2xa3aW0mTDBWKQjZIpB5yNysAfX73VYtT8Ix32myN5WoxxJBJkxsvnFUVumVYb8465GOKAJfDhN6k+ruQwvtpg4xtt1z5Y987mfkAjzMH7orZpsaLGiogwqjAHoKbbx+VHgiPcSWYou0Enqcc0AV7m3F5dQiXa0EDCTZk8yDlcjoQOuDnnaeCBVymRrhpGDE7mzyc44AwPyp9ABXJ+LZp7/UbbSrFl85cTESK3lmTnYWxwyJtZ2QEHPkgkB8nqpZEhieSVlSNAWZmOAAOpNct4LtpJ77V9Yu0lWe6nxCrjASIohHynlXxtV894wP4RQBv6Pp0OlWEdrbl3AyzyyEF5XJyzuQBlick/XtVyiigArg38R6d8P2uLPxM09lps95PPaai8e+3bzXMpiYoCY2DO4AcAMANpJyF7yuL8W2yeKvEFn4aliSbSrUx6jqquAySAMfIgIIwQzoXYf3YgCMOKAMg+JPEnjslPAQXSNByAfEN9blnm4yfs1uwG5fujzHwvLAAlc1s6d8N/DkE8V1qdtNr2oxrtF7rUpvJRhiw2h/lTBP8CqK7IDAwOlFADYo0ijWOJFSNRhVUYAH0p1FFABXE+ItyfEfRZSxXZpd2UO8qMefbbwex3fIPm475BArtq5P4iQywabBrls8qtpLPNcCFtryWrIVmAORyqkSgd2iUcZyADP1G1v7TWtG1aWeWOC2u4bY2roEEcUytCygrnIaZoH2lmA8pR8td5XlVpfaXrWraTp3hO7s7otOLu7/ALOnikghhikgfzJSPmDv5cSKiheTITuCE16rQAUUUUAZPiTWk0Szik+zyXVzPJ5VvBGVXe21nOXYhUUKjMWYjhTjJIU+ZeO7q/vft1/HYW+keOfDlq2pWU1vP9pgvbVciWEvsVmXO5SjKpDlCDgk13fjtJ7eDTtZtYpZW0u4Ms6Qpula3dGjk2DuV3rJjBJ8vABJFZ+p31ve+JPB+o2EyXFteXVxZB0dJI3he2klIBXIILW0bA5OckHHGADlvFfiCPxpFbRQNfDww8ECzWds5hudVurmJZY7IHjaghYPIwbG2TkgKxHZeCb7VIXj0rWPD9logNsJ7SCxuBLFGg2q0J+RQrJuT7oKnccHg15v8NJ7Hwt4I8BtrryW2nJY6krzKrlVumnTaAUyRIUM4XHJ5C8kCvUfC0F1fahca/qEU9ubiGOC1t5wUdIl5aRoyT5bOxzszkKiZw24AA6aiiigAoorB8R+KtO0GSK3m8+71GYAw2FnGZZ5AWChto4VNxA3uVUEgE5NAHDabYQ+IbHVtTukuEk10ZilSWSAzRhybddxXauxPLxt3k7pThiSB0Hwms4rPR9UjtLY2tmuoPDDGUKD9zHHBIwBJOGlilYEnJDZPJNebab46bw/pJ8Oy6ZqWiajZRbBcauI1QFMxJNDFudp8hAdkQKhhgOFbfXZ6FpPiDVtFsdN0/7R4T8LwxCNc4OqXK4HzNxtgLZJJ5fP90mgDpvEXjKx0q/XS7OKfVtdcApp1kA0gBwN0hOFjTkfM5H41Si8Malr8guPHF3FLb53R6NZMwtVw2R5rHDTnG3hgE6/KetdDoGgaV4etGttGsYbSN23OUGWkb+87HLMfckmtOgDjdV+HWhz3Z1DR0l0DV9oVb7SW8hiAQQHQfJKMgZDqeOKz4tX8X+EVVPFFqPEulLtDavpcGy5jBKgtLaDO4AkkmIkhVzt616FXPa3408OaLObfUNXtVvNwT7JETNcEnoBEgL/AKUAaeh6vYa7pNrqej3cV3YXKb4pojkMOh+hBBBB5BBBwRV6vIr8ay2vDxB8PfDOq2tw0rNqMOoFLO21RNv/ADydt6TZA2ylF7htwOK1vDg8R+NtJtdVuPEx0mynjZJLDTLJY5oZAcNHJLNvYOjAqcKvIoA9BvLq3sraS5vJ4re3jGXllcIqj1JPArlJfiJocszwaGL7X7hGCsuk2zToMjPM3EQ/F6ktPh54binS5vbFtWvFUL9p1aZ72TjpjzSwX/gIFdYiqiKiKFRRgKBgAUAcf9v8bamR9i0fS9Eh3nMmpXBuZtvr5UOFB/7amol8DXN+FPifxTreqHaUaGCUWNuwPUFIdpP/AAJjxXbUUAY1noNto2iHT/DMNppiqwZMwGRAcjJZdyliQMZ3Z6c8Vl6d4SmsL2wvYtQi+1Qz3M1x/oxEconZWdUUPlPuDBJbuSDmutooA5rw94X/ALHl0l/tnnfYNOawx5W3zNzo2/qcfcxjnr1qj4m8DLrkGsgagbae/njnjlWHd5OIViZcZ+YMoYdsbh3ANdnRQBWtIrmOS6NzcrMjy7oVWLZ5SbVGwnJ3HcGOePvYxxk89ZeEvsrWR+27vsyXyf6rG77TIH/vcbcY9/auqooA4rT/AARJZQQWi6mraf5tnczxm3O+Sa2SJVZX34VT9niJXB6HnmpLLwlf6eLJrDV7dJ7JbmCB5LMuPImdHKsPMGXDRphhgcfd5rsaKAMDwr4ai8O+altO0kBt7a2jRl5VYY/LGTnkkDPQVDeeF/tF7e3H2zb9p1G1v9vlZ2+SIxsznnPl9e2ehxXS0UAcGfAEssYt7jVlNpFZ3dnbLHa7XjE00UoZmLkMVMQH3QDntVrWPCN5rFza3uoX2nT31uksID6exgMb7Djy/N3bgyZ3b8YJBHQjsqKAOMh8GTQX8bwahbx2IvLe+e3WzIPmRQJDtVt+FQrGvG0kHuelXvCHhmXw/Pdu15E8MyIiWttC0MEW0sSyxtI4Vjuwdu0fKOK6WigAooooAKKKKACiiigAooooAK878SaOdV1jWNMiMltqnkNd2E0chjE0Eiqk0O8D5T5iBsjJVmjfBIwfRKKAOB+H+gR3M2reIdWTTLzUNVVbeSZLQRzeXGixPHNktht0ZDIDtBXHOK1LLQ4NA07w9o8V1f3cCXzt5t3L5srnbNL87EcgNjH0FdDa2FraXF1PbW8cUt04lnZFwZHChQzepwoGfYVWu2Da/p0Lb+IZp1wONymNOTn0kPb+XIBok4BIBJHYd6FAVQMnjAyTVAX0NxNOQ8kdrZnc9xuUROw3BlznPyY+bgDOBkkMBW050102up/6RHZxlntY23R+aCMCV1OD67VPY7iM42gGtCrpCiyP5jhQGfGNx7nHanDOWzjGeMelNkIC7Q4R3yqk+uCeB36Z/CmXdxHZ2sk85bZGuTtXcx9gBySegA5JOBQBzPjO8+0SJpMKyTP+7mmgXI88FiI4Sem1mRy+M4jjfIw2a6LSrP7DYRQGQyuMtJIRje7EszY7ZYk47ZrD8LK2qXEmuSmdY5dwt4ZCdoBwGcA+oVVHspYf6w5va5fXCyw6ZpZVdSulZlldNyW8a4DSsOM4JAC5yxPoGIAJRrVrJrLaXah7m6hx9p8nBW1BXcvmEkYJGMKMthgcbea06q6XYw6bYxWtuG2IOXY5aRjyzse7McknuSTU8riKJ5GPCjPJxQBheK/ENno0JjuXxmGS5mwM+XBGpaRjjuQCo9SfY0/wfptzYaXJNqWP7V1CZr29xghZGAAjBHUIipGD3CA965zXlXVNc0ize3aOXUbwGZdu8CC1xI7ZI+68qwx84ypBxzXoFABRRRQAUUV5j4t+Jdy8+qaT8ONMHiTXdOjMl2yt/o1qACdpYEGSQkYEaHOd2SCpFAHd+I9f0rw1pcmo69f29jZpwZJmxuOCdqjqzYBwoyTjgV4T8SfiXfeKrb+xdF8JXVzpLXK/a0vpxbT3Uccb3BUQD96sbJGHD9XAKgZOKvxeHtMv9RsdQ8SavJ4j0/xPbRw6b4jZ/Kl0695ZUhj6QByAUx8wdCj53Cszxff3d3400Ge+0YXvi7wafN1Ipb8X9qeEliZD94kqyRnlXdhjCsSARfEDxFqOm2elaxP4b02bUZy93pet+GLh5IxcgK5SUbFLLJEoDBidyKcDjj3jwb4ksPF3hmw1zSWY2l3HuAcYZGBwyMPVWBB7ccZGDXy2+v8AheaxvPCOi3sWpab4qzKslxMIZNOvjIPnlZoUXYwSIkLkgowXgqTt/B2W58AfFK28HW2pLPDcXE1rf2YZ5RIyxGSO7jGwLHwBG67mI2NnOAVAPqOiiigArKs/DmiWWqSalZ6PptvqMm7fdRWqJK2Tk5cDJz35rVooA5D4URvD4Jt4ZSN0V3excei3UoH6AV19cp8Mgw8MTBySw1XUwc/9f89dXQAUUUUAFeeeFrpZtX8RXU8622oX2ozRqdodjBbSJAigcnZuByvGTcOQQckdJ461m40Hwzc39mLX7QJIIEe7YrDEZZki8yQjnYu/ceRkKeR1ryhLjxX4NluVt9N/txdQM9/JJqN9a20trKhjjmmJjJQQHehZVwyHdk9GIBsW3hy1074meGL8x3t7qU1zd+Ze3dwJDFH9mbEUagABANjA4GPMx/EQPUtU1Sw0m2Nzqt9a2VuDjzbmZY1z6ZYgV4RrVxrZ1nRdZ8a6tNoVrcPLZ28WlzhFtw7IJoprl1/13ybsKAp8h9h3MM+vab4F8N6feG8j0qG4vywY3d4Wup8jofMlLMPwNAFNfH9hevs8N6fquvtll8yxttsAI/6byFIz17MaUv431VcRx6N4eiZT80jNfzg/7o8tFP4uK7CigDjv+EEhvlb/AISbWdY1zeAJIZ7jyLckY/5YwhFI46NurotH0XS9FgMGj6dZ2EJ5KW0Kxgn1OAMmr9FABXn09v8A8If8SoL2GUR6J4qk+zXEBIVItQVCySqCcfvURkbAyWVCSc8eg15/8X77TrjwLq0EOtWFpqlui3tmXuIw4nhYSx4BPUsgH40AegUVyq/EXwabaOb/AISjRgrqGC/bIy4BGeVzkflVZfid4TkkKW+oz3TAZ/0WwuJxj1ykZ4oA7OiuPu/HtpFIqW2h+KbwkZzFotwgB9MyKtW9L8T3eoXUUQ8K+ILaJyAZ7lbeNEHqR5278ApPtQB0tFcD4h1bX7bxzeQaQsl3arp1qgtQgIimnkuVWdj12qYUDeikntWbpHizUrXT9LSeY3l3PbRR+dPgKZJLwQB3CgdAQeCM9OM5oA9Qorzaw17WhJe6Z9qtnv3uL+T7VLG/lpHB5Q2Im/IJMowNxwAx5xVHTfFmqWaWKK0t5c31lpcUfmZkVJJIZ5HkK7l3E+VjG4ZJXmgD1eiuYm8Q31n4KfVr+wWG/QmMwO+1d3m+WrsRnap4c9SoJHJFZuteItf07UIdKt7a01DUjBJdFoIWCuqlQECmTKkluW3Nt+U7Tu4AO5orgNQ8ZarAurzx6fai2s7u2sI1MhaQyzx27AsBhdqmc9G+bAHy9ajbWPEdzrGlRMINOuRHfbxcofJlVBCUkaNXJX7xGCxxyeehAPQ6K890bxxqmtXts1ho7C0/0MXEbgb08+KOQtvLDaEEo42ncUYAg1maJ4m1CBVaW9klnlsYFgSVGmDzPdzp90MuSVUD7wHyjJAFAHqtFcJonizWNUvdKsksbOK5l+3fajM5XYLaeKIlVUsMsJM43EA/xHHOj4s1/UNNvnt9PWyAi06fUXe63YIiKDZwRjO773OMdD0oA6qiuAtvG2p3V/cTQaPK2l20vkzqVAlT90H3Fi/BywGzbkgg7u1VLPxRq0euW9xeSW0sN9aaa0cEO4JCLi4dCckncwBHzcZwOBQB6VRXFjxNqN9c21pp0dnFNPe3tqJZgzqogYgHaCMk49RjP4UvhPxRf+JhbXNtHZWlqLa0nnim3NI5niWTCEEBQAwAJB3EEcY5AOzory7wf4w1u70rQ4YLJ77ybDTmvZZOXlM0SM8m8uNuASeVbcQw+XrXqNABRRRQAUUUUAFFFFABXOeKZ3g1HS4o5Jo5dQ83T4jGeVdgJC3JABWOKVsn+7gZJwejrN1aPdeaRIdoWK7LElgMZhlUfXlgMe9AEWo2CSQWOk28UEenk/v4dpAMCD7igcYLFAQeCpYYOa16oWplfWb92ZvIVIolU9Nw3MxH1DqPwq5O0iQSNDGJJVUlELbdxxwM9vrQAwxxzSRzZD+Xnb0IDdCR79R+JrmPEEkmr65BpVvOsccZy4DDczAKXcDIOI1ZMHBHmTRnjZz0l9cw6bp1xdTDbb20TSsFHRVGTgfQVjeEre6/fXGoj/SAiIAeSCyiWQ57ZeQjA4AjWgDfjjjghSOJFjiRQqqowFA6ADsKoaLbny5L6dMXd5h3zyUTHyR59FBPA43Fj/Eal1lFl02ZHExVwF2wyBHbJxgMSMZz6097lv7RitYgjYQyzHcMovReOvzHdg9PkagC1Ve+iEsADS+Uiurs2B0Ug45+lPuEaQIAIyodWYSLngHPHvkDFMvIhKiqAC+QR8204yM9j2/w70AYFnA7/EGbzHkkTT9IhjikcgljNLJ5hPv/AKPGTx3rp65vRWLeNfEoYr8sdoq4Pba55/EmukoAKp6xqdjo2m3GoatdQ2llAu6SaZgqqM4HPuSAB3JArN8Z+K9K8IaQb/WJXAZvLgt4V3zXMh+7HGn8TE/h6kDmvJjbeI/GfiC5ufEQWw8SaGYtT0jwq8qPbTRc/vJGORI5JePeNvlMAcfNggFjWfEd98RptPhSe80X4catPJYRanaOi3N9KCVVW3cwRO6uoypZioVgvmAVY0rTbjTo7fTtJtrOPxz4Ri2xwRL9kj1nT3OTgfdxIRknkRzqegOWmkn0doJtWuYf+KD8VsbbVrK8iaJtNvSTGXYD/V7nBjkPBWXY4bkmpxba3PKNDe4eLxl4aU3ekalORImr2h+UpKT83zDZHL6P5cgJ4FAGfrl9oVhod7q1/FNc/DfxNE8t7F5G9tNvT1bC5ZN7jaRzsmUHILGvPLWPV76ffeW7P440N2uYvPG46zauNvlONwLBvmQ4+VWXYRucKJvHGtaZf6lLex6Ze2fg28vVh1y0mbyYxqjRlXkeMKWAjJQSMPlMgRgrlfnktNN1fVb+08L2Yuh4l0y3e80fWFuBbl9PZShd3yzNI3EIKfKBhwxVFyAQahZQ+JHspbG5A8MaterNqVzeWXmRabqbpJGfMBAJ3byp+ZQspEnyq6Ke8+FXhfUpPifrGpeJNUl1ufw5AmkW1/IQyzSOu9mUf8s2SNkRh8xLO5LEmuT8aRRab4Dm8R+BPtOl+GriCSw13Q4tuba72eQoeGTGGLFY5MckbHwx5r0L4JeA9b8IQKusXUnlxwkeT9qkkEk0hVnfAfy8A7lGULHruHQgHomreIdF0aVY9X1fTrCRl3qt1cpESucZAYjj3rO/4T7wcM/8VZ4f4GT/AMTKHp/31XHXvh3XtDW4XTtIGrSy3styL63e3+0TB5d4MyzbAJI1JSORXfGxcptJSoL5/EmpQOsXhDXY3a4z5wfT4jHwC0iq0pzvI2SRnKupLBlOQQDuF8e+EmuFgHibRxI33c3kYDHOMA5wTyOOvI9a6RWDKGUgqRkEcgivLbrw74xvrdoG0zw4tvM4+0Ld6hNOJY8EYZPKwWwduSTlAEbfhXHXeAPDMnhTRJLKfUW1CWW4e4dxAsEUZbHyRRLxGnGcZOWZmJy1AEHw8kSDwxeySELFHq2qsWPYC/uMmsBfHuvarbWdx4f0KwEN6iy263t8/nOjJvQlI42UEqVbZv3ANltq5au/0nTbbSrVrezVliaaa4IZix3yyNI5yfVnY1yA+G1pbNPHpOtatp1jMxP2KIW8kUSnnZH5kTMiBiWCZ2gk4A4wAYEvjTxbaaS+qarceErTTI2zNdwi4uIoUBAbBBUyvlsBYwVyrZZeAbsXjbxJZWY1K803T9X0hka4D6aZIJvI2q6sscuRK+0sWRGO3aRuJwDbb4U6VcW80Wqa34o1Mygq7XerSsCD1GwYTHJ424rl9N8FaFoHieDRfF/2/UbK5k26Pc317LJbydP9FlQnZvG0bQwKuAAACMEA7PxB478Ltp/2aVl1eK9tVl+yxKjCWKRMqGDlVG5TnDEcHPQ15VpTeH9Hu31q0vLgT3JKxtqt9EdR01FO1VQuWxGCDhwWQhtkwZA0ie8an4d0TVbqK51TR9NvbiJdkctxapI6LnOAWBIGecUXHh3RLnTo9PuNH06Wxiz5ds9shjT6KRgfhQB5VdLYJpd7pmvWFwPD99A0d7bRWzFYgORNCg3MAhwSnzNFgbd8KxunTfCPxFdXVlJ4e1uSKXU9OX/R7yJ1MepWgx5dxHgnqrR5GT95Tn5sDA8X/Cuz0wS6h4ROq6XG7rJdw6TdyRvhDlSiDcCBl/lVSw3ZQMR5UnGDS/EQhl1Pw5qtpfG0ni1O3ja1EbW6uxzLG1vnerDzC8artlV5Sn7wsiAH0rRXmXhv4qtqsUxn8L6tut5FiuG05o71Y9w3K+FIkaNlKurqhDKcjOK6bTfH3hbUZ/Ih1u0hut4jFvdk20xY9AI5QrH8qAOnrl9T8CaFql1JcahHqFw8jlyr6pdFASc4CeZtUf7IAA9K6iigDkLX4aeDLZiy+G9NmY55uYvP/wDQ81oweDfDFuSYPDmixE8fJYxL/Ja3qKAON+DkyT/C7wzsRUMVlHbOFH8cQ8tv1Q12VcX8HiD4EgCjCi+v1A9ALyYAV2lABRRRQBEtvCtzJcLFGLiRFjeUKNzKpYqpPUgFmIHbcfU1VbRtMaFoW06yMTRmEoYF2lCdxXGOmecdM1fooAzG8P6M1qlq2kacbZH81YjbJsV8Y3BcYBxxmpJNF0uS2e3k02ye3kjSJ4mgQqyJ9xSMYIXsO3ar9FAFWDTrK30/7BBZ20VjtKfZ0iVY9pzkbQMYOT+dU28NaE9mlo+i6Y1ojF0hNpGUViMEhcYBx3rWooAqHTbEwXMBsrYw3P8Ar4/KXbL8oT5hj5vlVV57KB0FUn8L6A9vFA+h6W0ETM0cZtIyqFsbiBjAJwM+uBWxRQBQuNG0u5vYLy502ylu7fHkzyQKzx4ORtYjIwfSmyaHpMsDQy6XYvC6hGja3QqVDFgCMdAxLAepzWjRQBSstK06xMRsrC0tjErrH5MKpsDkFwMDgMVUn1KjPSqmp+G9L1TWLbUdStYrqW2heGOOeNXRdzK24Ag4YFBgg9zWxRQBRl0fTJdSTUJdOs3v0xtuWgUyrjgYbGR1PeoE8OaGkNxCmjaasVwAJkFqgWQA7gGGOeeee9atFAFK00rTrNYVtLC0gWEsYhFCqiMt94rgcZ7461GNC0hZbSUaVYCSzRY7ZxbpmBF+6qHHygdgOlaNFAGY+gaM7WjPpOns1mix2xNshMCr91U4+UDAwBjFadFFABRRRQAUUUUAFFFFABVLWbM3unvHGEM6Ms0O8kKJUYOmSOcblGcds1dooAwdD1RbifUGlZVJkiYxhw5hZlWMxsQSNwdGBA71pzW+z7TNFPJHLKF+Z3JRceinhe+cDn3wK5nXvD9xbazeaxpUT3UN/AsOpacrqjTbAfLmhY4CyrnGCQGG05BQZk0XxGtx4a0r7fcbdV1FGSCCRBHPIQ207oxnDoMGRRkIQ2cAUAbXiJ4/7NNtIAwvXS02FiCwc7WxjuFLH8KZ4ZO7T7hj943t3nr2uJAOvsB7elcdaeKo9Y1qPUYLe61SK3y9pY6WyyNBGykG4uSXVQzKTsiyXCknaWJCdX4Q1Wz1bTrmSwnEohvLiKQbGQxv5hYoysAwYBhkEcGgC5rCiVbO3LhDLdRkZBOSh83Ax7RnrgfoDjWl0y/FHVbRmVUfR7SVFKnLkT3IYg9MLuTI/wBsetaF8f8Aiq9IVgpT7NcsCez5hAx74L/rWN4jkitvHegCMyPqN98sKrGCqRwhjKXbspWbGP74j96AOk1GXy7vTF+b95cFeMf88pDzkdOO2P6GzJbxSTxzOgMkYIU+mcZ/kPyrM8VKq6ULpjgWU0d2WzjCowL/APjm6tdjtGcE8gcUAc7J5OnePIpCSraxZ+Typ2+ZbsWUA9NzLNIcHtFx0NUvHPjeHw9NBpWmWr6v4ovFJs9KgYB2H9+RjxHGOfmbHQ46HGj48muLPwlqmpWCI9/p1vJe2yupZWkjRmCkAgkMMqeejGvC/hLoN7c6W19qD+R8R9Q2a9peq3zGRLyAoB5JYYOzBKyIOVWRGGcLtANPS9Ohujb+OPHD2+tWet27aVq4uomtzoTM7L5Uak/JGrkxOWw4OJN2C9dM9jqbXSeHZro/8JdoO6+8O6tfR7xfW2ArRyuvJOD5Uo4JykgBOMNfUreNLjxUbWZtE1I/YPFmjOwmFjMFEbTMp/ugKkm0YaMrJghclP7Kmt5YfBd1f/Z9U0/N94R1QlkLoikeQ55DmNSUdf44mDYyCQAJDqOneVP4mitG/wCEf1pjp/inTJJQV0+5A8ppXU424/1cuMZUpJjCknkfH93e6cIPAltdiTxLpMb3mja2ZQk0Nn5Tjy3K8iXb+6JICsuJSQRWv4t8Yx+GdKn8atZQx3V3/wASnxB4dunX95dLHhCrcglR3wQ8Lq3Za8p0jQrqz+y6S0NkfEE0lrqOlazaSrMyKoGETDFpNm1o40+44O8tsiDUAbdha6RpliupWWjRppV4p0nxDpEpxHBcRglRlhuXyyo3yfMQD5mCyhj32g+E30ONfCNzqMCeJ4XGreHdaPmp9qZIwjRNlmyEQCJowxzCyELlSRW8MWsXh9JfGMlpslgDaX4r0x7NWe2iAB80FctIVyru5LCWNywA2qo349HHkQeDxfGGzYjUvB+sxSifySg3LD82d/lqTgEkSQsRn5WNAGVZCHxn8UdH2Q3OnzJGdQ8TaNMdypdWxEdtllH3tzFgcgPHHGSOle415r8E5LjXLHWfGOox2qX2uXewfZJC8QhtgYUCk9fmWVs9930r0qgAooooAKKKKACiiigArO8Q6LZeINIuNN1OLzLeYdjhkYchlPZgcEHsRWjRQBx3hXXbqy1UeFfE8mdXjjL2d4RtTU4B/GvpKo++n/Ah8p47GsPxh4btfE+k/ZLh3guIZBPaXcf+stZ15SRfcHt3GRVHwZ4jlvp59D11Vt/E2noDcRDhbiPOFuIvWNu46o3ynsSAdVXn/jTwzcW0s2raHFJMp3SXFkmSyOSrGeAZHzZUM0YK7yA6lJAGb0CigDwKxu59K1ka1oUkT3TqB5bSBYrwyOztGzEAKHIZlYAbJC7bQv2iOH17TrnQ/G/h+G5e0t72zk4e3vIFZoZBw0ciNna6ngg9CK5b4j+E5fs9/qeiu0HnRSfaliiWRomYDNwiEEP91S8X8WxXTEigPxfh/WNe0PxSl7p9jLqkVxCraqLYoRfKqg+fGgYstwq87RuWaMqQzHY7gHpSfDrRbPe2gTanoLO/mMNMvHjjLevktui/8cqnNa+PNNlkisdd0nUVeXbB/bFoImcBQxAeBl5+/wAeWfuE9MV2ml6haarp9vfabcRXVnOgeKaJtyuPUGrVAHEyeLdf0xWOueC9RaMEATaRPHeqfU7SUk/JTVi0+JHhG4uZbaTW4LK5iGXi1FXs3H4TBc/hXXVyfxUkSHwHqz/YYb65eMW9rDLEsga4lYRRfKePvutADPhFGyfDbQJHBBurf7Zg/wDTZjL/AOz119cHD8K/DtjEBobanolx5aRtcabfSQs4XpuXJRj9VNStovjfTSzaV4ptNUQDCwaxYqD/AN/Ydh/EqaAO3orhm8V+J9MaX+3fBV1LAijbPot0l5vPf92wjcD6A1teHPF+j+Ibu4s9PmnW+t0WSa1uraW3lQHj7sijPPBIyAfqKAN+isew8Q2l34Z03WzHcJbX1vFcRxrC0sgEihgNqAknB7ZqvF4v0eXU4LKOdyZrU3izbCIggYqdzfwkFWyDjGOeeKAOgorC/wCEu0JbR7mXUEhhRkQmdGiOXzswrAEhsHaQMHHGakPiXTfOEKSyGV0LxB4ZESXCb9quV2ltoJwCSADxwaANmisCTxGieF9L1n7MxW+eyURb+U+0yxxjnHO3zM++O1S/8JTooN1uv0RbZHlkd1ZUKIQHZWIw4UkAlScEgHFAG1RWHb+K9GuLmO3ju2855RDteCRNrkZVWyo2lgQVzjdnjNRSeMNHNtdy210JzbwvORtKB0UhWKswCtgkA4JwSAcUAdDRWP8A8JLpHmXim8CrZq7TSsjLEuw7XxIRtJU8EAkg8Glh8R6VLHK/2kxeVFJPIs8TxOkaY3MVYAgDcvbuKANeisy313TrjUjYQTmS4HB2xOUB2htpfG0NtIO3OcHOK06ACiiigAooooAKKKKACiiigAooooAKKKKACiiigArk9asdR03Vbe60jUBa6dfX0X9oQtCrlSeA0RPCl2EaOCGGGLLtbJbrKo61YvqOntBFObeUPHNHJt3BXjdXXIyMrlRkZGRkZHWgDEvPEWgaF4a8Ranp32NrfSGmN3FbbYwbhVDNGT08wkqPXJA61X8Jy3EPibVYbz7TFFfRRX1nBcBdyA/69AQSTskdc56bwBkAY5XWLWa8+DvivS7+9t4PEVkLjULwwQmMRTCZ7mN1Xlih2AK/JIXP3gQOq1vwxL4lm0ye18RXtjo0Efnwpp2EmkmYMBKZznKbXPybeScknpQBuapk61ooXqJJWPyg8eWw69uSOlct8So0utV0PTlVF1C/82HTroll+yTLtkaXepDAiNHwoI3n5GIViRXntJ/EXjXQbmTUtRstK05ZfsfkuYpNQnjdRL5xxgxEKNqgDf8AO33Quey1XRYNS1PS72aWZJNPkaREQrtfcMYbIJwCFPBHTHIJBALGrvDFpF691zbpA5k4H3Qpz+lY3hWK6vfBGmW9/LIt9AiRSylVyZYX2lsdOWTOB2NUviHdTSzaNoVnNLDc6rOwV4wpwIxuYndxhR8+P4tm3+I10xS10vRyjN5dlawYLOxbairySTyeB1NAE9zDHdWssEyh4ZUKOPVSMH9K8H+G8l9rfgnRfDev3seneIbIyv4c1CMbH3WrvC0TrjBZAu1053xSdyHI9S8FpqOmWdhpt1p8/wBme1SZJwUC27bRvhcZDZDZIIBGDg428+TaJFPF4l1vw7qV4bKy13WL3UPDWqIoc2V/DcSJJHg8A5XIXhWVmXJLkAA6ptUaFLjxg1g1rsxYeL9Hmj37Ai4M6hc7tisrZ5EkDeoUCNtLggtovCU160OknGp+E9dDrcJatGpkWIlj83lqCVySHhLLn5TT4r66W5n8WW9ksfiPS2Gn+KdLtWbbcwryJkVh87KhEsZ6sjNHknAHCfFRvs+jQeCbAwX3hjXsXukXjf8ALiSpaOBWxtEe8Bg5I2xGReQBQByY1nUPGvjHUPGtzZ6bBHp1stjeLaCTzUhMTCS+T5d3yhiykjIXaoO7aT3PgzwbBEtto17JeWun6hCL3whqTSRSvayjEhMhRVDTkLG4B3DylZFYBWzk+DdOlmvbnXIbA3mo+GZRb+IdOhfzG1UiQt5wRiCzIQZk3gEsBGoXyxXePp+kwx2/h27vU/4RDXnF54a1CEGJtOvCfMWGOQcKcnzIc46PH8wwCATx6zdrPJ4phtFXxFo6LYeKtJhdl82BcsJ4kJO7aC0kZ6ujOmd2AOe8dwrovhKbw3bRvq2kau8D+ELtWJFpcyuAIVnQ5AQP5kTHrHvQkhcHov7Q1csfECW0x8XeHQtjrul2uHGpWmSwliVsE8bpYjwc+ZHySa5m31DRNN8WTahbaqtz8PvDNl/b8UEIXEF1d7ligCnHG0u6LxtMoGcYAAPWZr7w/wDDjwlp1rd3K2tjaxx2ltHgvLOwAUKiKNzuTyQATySe5rhLn4n+KtbtVuPB/hiztbGYb7e816+SEvEuPOm8hTuMceRuIYnkcE5UYVmdU1G/HiLxcY49du/Mgt7QShG0qB4QUt7YSAbNRd2QqG4ZQeQOK6dCyXELaZbW7D7YYFggZ4IXlSVnaKNldhamIQ75Bt2TsMd8UAY8Nz8RNUS3vG8bW1nAV+0SxaXoYuf9FfzfIniyHaQuYx+7GGUNkjjlsC+PvIgM/wATIzKA8c32fS7R1LKY900JcJ5kEYk/eMOVZCME8C9JLGsckcU08kkjM8srKtvMLhoUj81FkjVoNQlMmI4iQhQ5AGSDU1PxVoWg6iBLeWtqonXzYI3dI1kM28xZhd1tZItoeUYxMx54yAAJaeKPiVpKyzwtpPjG0ihF4sMdu1td3Vo2RHNEY90XzFWYICz7cfKC2B6L4A8e6N43tZzpjywX9qxjvNPuk8u4tnBwQy/UdRkduCCBxKTwXWn2d1peopeR3v8ApBvMIhlkaKKL7RHvjHkX0hkKxRZ8sru4ySBh+K9QsvD2pad8QrVPs9xYXa6dqX2dQq3Ec0shlt5kjZgJ4co7OSEZzwSdoAB79RRRQAUUUUAFc1408NHXIrW80+ZbLX9OYy2F6Vz5bEYZGHeNh8rD0OeoqXXfGegaFdfZtR1FFuhjdBDG88iZGRuSMMy5HTIGe1WtD8S6Lr28aNqlneSRjdJFFKDJH/vp95foQKAKngzxLH4gtJ4riI2etWLCHUbB/v28uM5H96Nh8yOOGHuCB0Nch418OXc93b+IvDJjh8SWKFFDHal7DkFreU+hxlT/AAtz61seFfEFn4k0lL6xLIwYxXFvINsttMv34pF6qyn8xgjIIJANevGfiv4KnGn/AGfQ1jhimmEtjK8jp9hvAzOmx1yUBZj5fBw7tGOJkMfs1V9RsrfUrCeyvYhLbToY5EJIyD7jkfUcigDyL4f+L3tJ5JbqGOzsZGdtTgLL/o03ylrpcADyzvUyEYTDRzAKHkx7LXgutaLdaP4yP2m6kE8gSAXMgVlnGW8iZwBgN88kTYADM7q2EnUDqfhJ4sgltYNIkiu7aEsY7aO8fdJbShd7WjMSd4CfvInz88Rx1jJIB6jXI6i/9v8Ajiy0+JGax0Jhe3cuPla5ZCsMIOeSEdpWGOP3J/iqfxN4ke3u00Tw+kd74in4EX3o7JCP9fcY+6gHIXhnPyr3ZdHwxocGgaUtpCxmmd2nublwA9zO5y8rY7se3QDAGAAAAa1FFFABRRRQBw1v4N1RPDOkaLNrNjNbaYkMaKdPcJOscZj2zL53zqQQ2AQNyg8jgttPh8INO+wHUENrNY3Wn3SR22zdFNI7/u8N+7K7yOQwwOgru6KAOL0/wS1u0Ly3NgJY7m3nMlrYmFpBFvwrkyNnO88jAHPHNNn8DvP4jj1SXUIX8u6muUL2pacLJBJF5Xml/uL5mQAo+6Acnmu2ooA5+Tw5v8K6To32rH2B7F/O8v7/ANmlik+7njd5WOpxnvjnn4vhxHDpt5YRXVmsMtvLbQz/AGIm4jVyD80nmYYDGOFXOBk+voFFAHNXnhf7Re3tx9s2/adRtb/b5WdvkiMbM55z5fXtnocVmXPgLz9Lt7P+0tvladeWG/yM5+0SxSb8bv4fKxjvu6jHPcUUAcRd+BHur7UZv7SS2iud7rDawNGvmGVJFkkUyFHZWQchVJy2TzU2ueFdV1dXebWLOO6lsrjT5XSwbYYpdn3VMuQwKdSSDnpXY0UAcrZ+FJbbxNBqqX0cUcf34reFo2uP3XlgTHzCrgcEHYGG1RnAOeqoooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDK1vw7pGubTq1hDcsqmMMwwxQ/eQkYJQ91PB7g1lDw3qsMX2Cx8QyWmiqoiihjtU8+GMDARJs4AAwAShYDuT81dVRQBga3ZXtra6Y+g2sNy9g/y2s9wYg6+WyD95tY5G4HkHIz3xWAIfEOleKxr+sw3Oowy6fHZ/ZdHOYbZ/MZ3Z45HDSHlFWRBnG/KKMV31FAHBNer4n8faZ9gsLxItGja4kvLqCS22GUFPLWORVZywU/MBtAB53YA0LLxb4Z8U6m+gW8z3k5ieeSF7aVF2xyKp3FlAI3kDHOcEGtTXNGnvZ47zTNSn0zUI0KCREWSOVeoWWNvvKDyMFWGThgGbPOaj4Z8XXms6Zqv/CSaLFeaeJUj8vRplWVJAA0bj7WcqSiN6govPUEAtyT6pafEywh1HVYP7Ku7O6FlaxwNGWlDQsVdixV2VFYrgKcGTsDWVD4YtPGPgHULBpZLXfq17d2F7FgyW0wvJWSeNhgj5skEEEq2MjNbM3hOfW2gfxhfxX7WrGS1TTkmsEicqVMnEzMXALANuGAxwMnNdTbQQ2tvFb20UcMESCOOONQqooGAoA4AA4xQB4RbeLb7TdRW48Rslj4/0WHyb+z4WPX7EEkNB0BkyS6BcHcGXADEL4lrd4+veJX0TwrBbT6Zqd+qWFz5TxW9reSmJpPIYqGCqflAI4DFgoLDH0N8a9a0u2ne8ks7a4u/D0RnW5AUzw3Mq7IUTPIyXD9DhgjAHY2PKdM0ex8J+J7aPxjYXc3h0WBkvjBF/o+hX91JjchXJXb5SoGySDgg/doA9P0CDUNJsYJrSxkXxj4XT7Pq1pGglOs2cjlzMjnl2chplOdwk8xCPmarcVpo5totLhmVvAXiv99pd1BJ5Z029c+YEj3D5N7ZeP8AuSKV2/Mopltd32oNDdafNZ6l468PQ745UYxR69pknQqwJUhwAc/MqTJ2VuX50VrMtIJb74d+LiAUbDJpd67HP+1Erye/7udf4d/AA2fUNRgafV7xUg8ZeE4SupiWJY01fTMljIhBwAwRnTnCSqyMACc8fY6ZJZaV4Xie2s7BvEl/feLbtJpPKtrdYYvNt4ZWAH7lWeEsCOMNWv4i0m78Ta14e8H669wPE1tK0d9qNoZIVv8ARQMu0hU4/eusaFCTtkDEYU/NofHi71TTvFXhCbQ45Ny2WprO8Nstw8MBWAO6xMQH28Haeo7UAXLcw28lxGJbqWKTZJcTyI0lzGkswRXmaGQmYyrGUhlRd0MY57isfxDrWn6Hpty+tNb75LFIxZ3BN68vlRMyWzJ5R8+zjLyO1zuDFgVJyMVzuneI9QSGG9fxFNr0EU8ksdyyxi6TzUOJLNvLaOOaQPIi2cpL4UbdoPGlHpMOuXGjajoV8LI6kn2aBdKt4xaX8KSF1iiWQ5hjiVXeaJgglbcoycYANLS/FdhLrMkRt9fs0nltpFvrnT/NSUXEqmNpZIZWEwkEfkwyhR5QGMk1wfiZ9R8O3Wpabotk+p24t47m+t1uI2exR/MlaGWWRW+1WweVi0rJheAXBzW9q2nWWjadcapq95rGpfZpU1OFwVskWdUjEciKYBtnHyLHaylgsW5ucgVk6pfC+s3urNPDFuknmR2X9lX4smCxlWe2imZhGY4sLK4kj8ty5KckEAHReCLyGxuL7N7JDqmrXJ1t4fsb/wCjxzYdpY445mF6jGMLG0YZoixY45APipaP/wAK618XguILmPTo0EEbmWeKOM2+LdXZP9IgR3LyTht4YhTnkVlnQb3WdN0+9vdctYrG6lj1CE29lJBerI+yZngkZ2WC8mZlUQK3lsCZFHrf+Knk2vw38QzQyWFrHKJbVYbZB5cbNcF/s0JVgYZdsQe4RlId+nfAB7ppmsWUl7/ZJuT/AGnBCjSQyKysRtUkgnh8blzgnG4ZxmtauOsZ57zxSsd1NfTWiOZoPtNkYo1k2kgwSpjICsUZZPvZJBwCD2NAGH411e50Tw9NfWkaF1kjRpZVLRWyM6q88gBBKRqS7YI4XkqMsOLtru4vraCd/iI8k5/euLF7GKER/MPMCmKRtuRsxvfJ74NdP4v8R3mnzjTdBs7e71Zrd7ljdT+Tb20QBAklbBPLDAAHODkqBmvOtf8AD/8AYEB1rXrbwZfs5H/Euk8PRQvcSYybeCTzWLSkAhRh9zcepUAveF5fFFzr/iR9IudB1zTvPglk3N5PnSGEJJE8sfmoJE8mPcuw8SKQyDC1sab4d1zU/Fdhq2qaXpejpZyCY3EUonvpiIzGYWkCgGJuGJOT8oG0HDL6FZ2tvZW0dtZwRW9vGMJFEgRVHoAOBU1ABXD+KtGvNF1h/Fvhe3Mt4VVNUsI+Pt8K/wASjp5yDO09xle4rE8f674h0rX7lZtetfDmk4j/ALPu5rMS28zbcyLPKx+RshgqjaTlSC/zBdTwR4xnvvEl14e1G/0rVp0jeeG90thgIjKjJcRh38p9zZU7iGGeFKkEA7DQtXsdd0q21LSrhLizuF3I6n8wR2YHIIPIIIPNX68716zuPAus3HiXRYmk0G7k83W7CNclGxzdxD+8ON4H3gM4yM139rcQ3dtDc2s0c9vMgkjljYMrqRkMpHBBHIIoA5b4l+HbXXvDs5uoo5PIikDhguXgYDzUBPQ/KrqcgCSKJjwtePLDq1zf6hcSazb3l/BGkNxHbrHFHexpH58Uu8OT5rqHnhnUAI0UgKnfg+rrEfH12s8koPg2E/uoVzjVnHVn/wCncHgL0kIJOUxv47X9J/sPxPGtpHOEgK2/lWqMxNm7PPblVyVDQTRyhFC8gRRjh8UAdR8J7vTrfTRpyIqX82+5+1PzJqQ3YaZmyd0qnCyLk7Wxj5GjJ9BrxSJtYWRdR1zQSdMvVFydW8NzfaVjmwViu4ozmRT5YAOA6tGyK3ClG9M8E65Z65okMlrrdlrM0ShZp7ZBGc9t8eSUbHUHHOeB0ABv0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFY3ijU73T7SOPSbCa91C5YxwhYyYouMmSQ5ACgfw5BY4A65GzRQB43pXgzXm1eLVdZhM8FlMZ7aF9jyzXRLbrqZBhOmVjAzt8zdtQ5A6j4faXDcW3iEajD9pW5nS3uI7qPd5gECFg6n1aR8g+uDXeVHDBFB5nkxpH5jmR9q43MepPqaAPDvEPwy17wVrFh4i+GN5dXFppxcnw7cXLGMxSMDKkJY4AbCttPO5dwJIVaZofizwtq8mrzEeV4a1djB4i0m+Von0u7c7BMcYCxyHIdx919jEqd+PeK8p+M/wn03xnAmq2WnQtr1vKkr7JPIa/iXAaFpMEBiowrkHBAHAzQA/wCCGl3d1BeeK9Zubm+nvALLSrm8UCf+zIyfKZ+Ad0hJdic7vlNN+Kk0cfxB8ICaOB1FhqkgF3gW2UWCQNO+CY41KBt4BIKqOhJruvB2s6XrmgwXGiKYbaH/AEZrVo/KktHT5Whkj/gZehX6YyCDXAfEmH7d8UtDtTbT3Ij0W9fahUxKHkiQvcRl086EDJaJSS2AMGgDGn8O+Hr6W8l1vTdPlkEiw3BvbaL7SRNIsam6WGRQtxM5fyZ1X5UYlsHrjP4tzDexHw8kmnW9+NMu11G4EVvB9nz5dtLsjljSKKSZP3+5S7KuflqXWfFljot5pq2tvcLcJYvqOmrZXKRbLQ7mkuYhNvVvOXCpbMC0axttKkrnh9Ys9OuvEt3axeErnSLi7gBeHQ5Y7xmKpG6QratGiukUkBM0fDGTPzYwCAeiaR4r0q/vBbz3uopcyw/aSt9CsUzxyvCgmleJ1DysAkcE0IzGhy3HV+neHNDhSS4ufDOi7oyLecTWodYJVjZhaXDNG4Mce9C96rZZgoOcYrlbnw7eajdXniHTp9IgjSJNXs9Z077SCgMpeW6ETRkPNIAY/szTDaRtxjBFnVk0PW9S0CxhTRdT/sm5czafpcyXCxZSN1NnH8rTRL5JaWMrIcyOFB4ZQDo18VeHTqFxPJ4p0mSETyFbm4eFpA6TKrzXKJIhkbEaLbyRruRDk8Vl/FOO6TwB4mErXlqUtYYplUtPJb4Eci2UoO4SDMzSNdhgSSFJOMHBuvEPgrWpBbz39lbJEz3Zuon2wwME+a8WN9zSGTfHEtmQSgRh05qCTUbq78HeOYLeTTovD4sZF06GyuczxSNslkt7dyxHlCKNZJ4VZgudq45AAPoPwrmHXtSVzpXmXSi4fyrt5LrjABkVhjGGyMYC5CgEc11lcLoWmi58UPd/2feR2O1LiCQQ2qW6yeXHkpIp+0M5+YFm+RlyuMYJ7qgDK1vw9putSW8t9FKLi3z5Vxb3ElvMgP3lEkbKwU4GVzg4GRwK87lTR9J8RTp4X0q2vNUslbOpa7qVxIluxJDiEv5rsV3EyFNijJDOCCB6zXl+s6j4FutWu5ra+1mW8E6vO+gm+lj8/bsG77ODH5hUheeTwD0FAFa88ZeMtA0JPEPiBfD0ulxqZZ7WKKa1mMWSAySO7RlyDGQhxuLbAc4J9VtpluLeKaMOEkQOA6lSARnkHkH2rySCb4fx6frPirRtPl1XV9FsjfCHUTceagCBkdEuM7AQi4kRcADjpiqt/ffM2qeKPHn2eFraKeJtK1SKKGBhJIsjoq8yISECh0l6FSSeQAezTRRzQvFMiyRSKVdHGQwPBBHcVU0vSNN0lHTStPs7FJCC620CxBiOmdoGapeCrnUbvwtp8+tMG1B0PmP9na334YhWMbcoSoBIOME9B0G3QAHnrXhmvW8Gha5feH4Lq6h+HUlwjaxsU+XYSSgt9mWTPyRSEoZFAwiydV8zNeoeMtZu7CG207RYRPrupM0VopxshAxvuJP+mcYIJH8RKoOXFXtJ0DT9M0EaRHD59oUZZvtH7xrgtne8pP32ckliepJoA04o0hiSOJFSNAFVFGAoHQAdhXOeJ9CbUtd0O7jSQiJ3guHjYKY4jtmVsk84lghGACfmPbNYehyT+AtXtvD2oSyTeGrtxFpF3KS7W0hOBaSN3HP7snsNvOBXoNAENnaW9jbpb2cMcFugwkUahUQeiqOAPYVha/4L0PW7o3txaG21TGF1Gydre6X5do/eoQxAHY5HtXR0UAcLLb+OPDqE6bPaeK7FFO2C9YWl6OAAPOUeW/Q/eRSc9a0vDPjSx13U5dLay1TTNWiRpXs7+1aNvLUhd4cZQjLDGGz7V1FFAHHw+N4H/tyV4I/s2kfaPtAjuVefERIJ8rGQDtOMmpx440oagkMxlit5LWO6Wd43wA8jphht+QApyzYHI5pNV8Kz6xeTyanfwmD7NdW0C29r5bos4AO9y7b8AcYCgnk5qG88H3F9Z38d5qURnu9MTTWkitSirtd2DhS57OBjPbOecAA1fFniO38NWlpc3cM0sM9wIGMQB8sbWdnOT91VRicc+gNW9K1SLUpdQSFHX7Hcm2ctjDHYj5HthxUet6Suqy6YzyBFsroXJUpuEg8t029ePv5zz0rK8K+F7jw4jQ2uqeZaPevcPHJBljCYhHHEG3dV2od+MnbjHOaAOpooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACivMdVg1y58TeKl026l+xTNHaXIM5X7NH9njfzIhnhiDKvy87pEbopqnoviG8ht9Nhn1A2VtPFYR3GoSMGMQazZ85kygLOqrkjHPckUAetUV43Y+JrzTfDdnDDrMVvImlTXlurojPeTrM4WMA8sG4G1MMcjBFdCvifUv7bMTXUa3X2uaCXSdqFoIEhdlnz97kqnzE7TvCgZ5oA9DoryW813W5fDrtPq0iPLp+mamZ441jNv5k+JQMD7m1cndnjdk4OBqWur39zrsun2WpgQ3OrC3+2RKsheMaZDMGTOUGWOeBjB6d6APRqK8l/4TTXZotKc3VhZNJp1vdK1zIkMd3KzMJF+ZSSAFX5UIYFwTkECvWqACiiigAooooAKKKKACiiigDkPEnh27t9WPiXwkIYtcwq3ltIdkOqRKMBJCPuyKPuS4JXocqSK8s1PxFYeJfjd5NrFK9/FoaWzaTeCa1Y3CXH2hkaZQQmwRo+4bkfG0Eg19BVwPxS+G1h43hgu4nSy1+yGLW9MQkVlznypkIxJETnKkHGT2LBgDjNU0S01tLa5u4pLm6gkFw080a2NyZSbdPMxiJ7e9ldUWJS3lsqKTziom8NabeeXAbK41COO92PaahfXMkdzcsJZDbTDzJVjkjAjkeYBkc5A6kUuleI7vTtU/sfxDIdJ8VIxa4kffP58ZYyNOihx9rjcARRoFLwfMOcGtG9shaWiefZJa6hHbrp6wSFZ9kAEKi2ZnjBuLFTIXnlB3ryM8HAB594ln0VrizWzvYZ9M0+WXzI7myeytbuR08sXHmJEsCXG1ZEhYgp+7DlwcqbMmowarb2sK2Gn30KSvaxxNq1vbLOTulSH91M6R3JkG83Com4kr8uc1sHSLjTbi31Pw3q6WC2Uc1+9g6G4s1jm3s95CkMpZraVo0ijjwSqkvt3Emql34Z1G0lu7d9Kgk2SQ2McF3qxlC2vmFniike03yWytMrSsG3Kqbdw2mgDlLbxZIl7FpniDxRfMI7qCYzLpEbOmwNCXut0cki3WI4xG4MgPyZPzFh1Os6nqsHwi1qDxOiafcwWUljdyW8bGMzlHeOBoo3Ijnk82OV5lGw7tjYI4ueBNIfwlpuqG31uGG4kX+0RPDDuitbZIXBu1hSY/arZgqJGG+YMd23ir3j+1ey8EeKFe21G3vLbSZbWKKIvPJbwP5Y8mOR48XEbbPMmfcWiBx9ADoPCk1ufFNhdfYJJ72W3hQN5FpHIE8pFMmXlE+0YOcKFIyQpzuPq9eDeBvEOh6d4ZtY5vEGfsljbyywx+Xc+c/kKXR4li2g4wAVkZ24BbOQfYvDWu22vWIuLdotw+8IpllRhkgOjrwyNglW47ghWDKAA8WaOdf8P3Wmi4+z+ds+YoXRgrqxR1yN8bbdrLkblZhkZriZIvEukWKCXQLBUsohEl5YakkaR26tu27ZUUIAAMDnG0ZZhnPptI6q6MjqGRhggjIIoA8V8Oaj4nutasvEEPhSdLRLKSCyW61QbrlZTG7EAqZAMQGTDqXYt1wNtXdIv47TXbkab8PtAsNcNlLqFncWUsEpvI1dA+GRFZd6yfKx4JOD0IrpNQ+F+h3EBhsbvW9Lh3KwisdSlWNCsnmJsjYsiBXGQFAx2xXQ+HfDOl+HvtDadBJ9ouWDT3M8zzTSkf3nck4ySQowoLHAGTQBJ4W1y18S+H7HV7DeLe6j3BXGGRgSGRvdWBU+4qfXdWsdB0e71TVrhLaxtIzLLK3YD0HUk9ABySQBzXEefbfD7xndtf3UNn4W10tcJLO6xxWl6Bl13HAAlUFhk/eUgDmrulLd+M9ZttYvrc2/hmzbzdNtZ4yst3MD8t1KrY2KvWNCM5O84IUKAW/A+kXfn3niTX4UTXdUC/uuSbK1HMVtknGRks5AGXZuoC11tFFAFHW9Kstc0q503VLdLizuUKSRuOCPX2I6g9iAa5Hwpqmo6BrUfhLxPcS3burNpOqS9byJeTFIe8yDqf4lG7rnPeVkeKdAs/EujyaffeYg3CSGeFiktvKvKSxsOVdTyD/SgDXorL8Mwara6HbW/iC6t7zUogUkuYEKLMASFcr2YrgsBxuzjjArUoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDJufEWl299PaS3JE0ClpdsTskeE8whnA2htnzbSc4wcc0t34i0m0BM99EuI4pOMt8srFYyMddxUgeuKzpvDEkni5NZS7igiDbpIoIWR5/3RTbK2/a6855TIwoB4rJ8N+C5LfQ1iuZXgn/ALRiu0STEhit4JB5EGQcYEaqOCcFm69wC9q3iXQLC1l8Qxl7i7FpOiIkcvmMkTEurJjKYcYLMo2k4NaL+LNFikkhuNQhiuYo1lmhJJaMMoIzgd9wx69BWHeeBZ3XUfseqxwvfx3kMxktTIBHcSF/lAcYZSTzkg+nStCXwlvttUjF7tku7i1uon8r/VSW4i2EjPzDdCpI44OPegC8/irR0t45mum+d3jWIQSGXeoyy+WF3hgDkjGcc9KSDxXok8M8sWoI0UUaSl9rYdHO1GjOP3gLfKNmcnjrxVPT/C0kGtRardXyTXhuJbmfy4CiOzwxwgKCxKgLEvc5OelZUnw7jk0bTLGTUNxsNNtbFHMHyu8Do6uy7vukpgpnoThgeaAOqg17TJ4rV0ulH2m4NrGrqyOZgrMYyrAFWAVjggHitOsDRdDudKtYYba4sIAboz3AtrIxrMhQrtwZGIbIU7sn7uMc8b9ABRRRQAUUUUAFFFFABRRRQAUUUUAYnizwtpXiqxjt9WtyzwuJba5iYxz2sgIIkikHKMCAcj05yOK8gm0bxH8MZIpLu0fxR4TtydlzZoY9QsItyuVwhX5Sy7pGGfMwd+BXvVFAHiOlalZazYx3ekazFrQRTcNLa4j2z7Y4ftKo6MYLpg7xxW7Hy3wW9caFlbxyPDd28JluJZfKjtElWEpLummNvG0bj7NcFVD3OQVkI2jrx1Xir4YeEfE959u1HSI49SB3rfWjNbzh+zlkI3MMAgtnGK5q7+DLXCTQv488YyW09ubSWOe8WXfCSSUJK98kdOhx04oAQwSLDb3F5IRCssly1/co1pFHIixQteBZo2+zyrl0jhY+W4BfpXEXd/d/EfR5tE+HkP2ma6iaK61ae38i0sYHeR3UMBn7VMHTztgKt2GASPQNP+B3hNNSbUddk1bxJfEqRNrN405G0YAIAUMPZs16VZWltYWkVrY28NtawqEjhhQIiKOwUcAfSgDzvSfhtqtpoGmWlz4xvLi705IxbB9PtWtYWjGEKxmPeMLxuWRW6ncM1BAus+EdUn1jVfB66tcfZzCb/QGWSZ1LqSrRylZTnaGxvmIOcEAmvUqKAOQi+JXhEztb3mtQaXdIAzW+qq1jIoP+zMFP5VsweJdCuIllt9a0yWNjgOl1GwJ+oNakiLIjJIoZGBDKwyCD2Nc/L4G8JTS+bN4X0KST++2nwk/ntoAi1P4geENMWQ3vibSEeMZMS3aPKfpGpLE+wBNZi+NNX1p5IvCXhXUZVVtov9YB0+1IK5DqGBlcZxwIx9RXWaVo+maRF5Wk6dZ2MR/gtoFiH5KBV6gDz27+Hlxr1ncTeLdbnvtYdQbR7cGC202QEsrwRA8uCR87lmIGMqCRW/4E12fW9FI1JEh1qxkaz1GBc4SZOpGR91hh1Pow5ro64fxWv/CL+JbbxZCAmn3ASy1oAdI84huDyP8AVs21jz8jk/wigDuKKKKACvIfDOv+KbnSfBxv5p/Lle0luL0xqBercRhlQcY+XMgbGD8qH+KvXqrJYWaW1tbpaW629rt8iIRgLDtGF2DGFwOBjpQBwGn+O9XudKj1J9JRLK9jia1kcbFheWeKJEkO4l8ebuYgLjYwxyDUcHia+0q/1H+2L9HSG9u98iowiVY7WJwAmWbGSTtBzknrXcroGjLNdSrpOniW7VkuHFsmZlY5Ic4+YE9c06HQtJgi8qHS7COP5vkS3QD5lCtwB3UAH1AxQBxdv4l1a71Wxsb+NrWeDVoYpCiiLzontpXAZBI+OQOC3YcDpVvxx4ju9A8Q2rW6vMslkUWAn5PNe5giVyMjOPMPcZ6ZGc11NloWkWIUWWl2FuEcSKIbdEw4BAYYHXDMM+59asXVhZ3ZY3dpbzlo2hYyxq2Y2ILIcj7pwMjocCgDjT4l8QFrazeytbS9kW6cyXCHaywiMqwjVyV3eZjBY4xnnoYE8a6oLRJGtbIyXcOm3FsoLgRrd3Ih2uc/MVyDuAGemB37Oz0XS7JUWz02yt1QOFEUCoF343YwOM4GfXAp39ladiMfYLTEaxog8lflWNt0YHHAVhlR2PIxQBxk3inVlaOKO3iutRhmvrfyon8mO4eJAU4YnbnIGN3BzzUml+KtT1S+i0q0ksk1FRO9w9zaSwiPyxCfL8ovncROh3BiAuDznA66bSNNmDibT7OQOXLB4VO4uMOTxzuHB9e9QP4c0N7OO0fRtNa0jcyJCbVCiserBcYBPrQBgjxddstusdnBJPLe3tosfnbQ3kJIynceBuKAZPA3ZrR8G61c6tBdpqOxL62dVlhFs8DRblDAFWLZ6nDKSD7VoHQdHN5JdnSrD7XJkPN9nTe2V2nLYyflJH04qfTdNsdLgaHTLK2s4WbcY7eJY1JxjOABzgD8qALdFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXmPj/4m6h4d8fab4S0TwyutajfWguo92opaA/M42jepBOIyeor06vIfHF3bW3xM1dNc0eS/8My+HrUalcRnJs1FzcFJCg+cgEE705TaG4xkADIPid44m1640VPhjjVIIVuHt31+BC0TEgOhKAOuRglcgHAOCRUVj8VfG1//AGqtp8L5ZJtLcx3cH9tRCaNgu4fuzHvYMOVKghv4c1euoyg0/TvFOpPNb71l8O+L7cr5iMwwsczj5Q5BA3EeXMpwQG4ZdQi1O91+3guriz0b4h2aOdMv0VhZ61bD5midM5K8ndHkvEfnQkHLAGXH8XvF0vhmDxDF8OEk0WYKy3aeIIGRQTty+EygU5DFsbMHdjBxcl+KfirTtY8P2viD4ePp9lrN7DZxXqavHcxoZHVQSY0I6NkAkbsHHQ4u6XcTvPfavoOmzWWtsytr3hW4ZP3x+6ZYicKWIB2yqdkoXDYYZTC1Isum6NL4QlSbwlceIbBLmwnzFPpE63kW6JUPITfgGI4KE5XKnCgHt9FFeZar4qh8PXHj77Dd2Euurdxy29hNKN7f6Fb/AD+WDvcAK7YXkhGAoA9NJwMnpRXi+sazLK2paXpnjr/hI4Z/Dt/cXCqLR2gdVj2SAwxjAbeRtbOc5GeozvFPi/xPo3iC6sbXUcDT4reKwjnu7WH+0MxI3mPC0Zlm3yFk/clPulVAYE0Ae80E/rXlOp6/ram7nu9ebTNIuddk0+S88mELpdvErBdrMpG6WRQpkk3Ku8AAEgmnp2tDU9fgtIfEv/CSadba7apb3eyJvLJtZXZN8Kqr4IB3Y43bScg0AexUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRUFteW10ZBa3EMxjO1xG4bafQ46GgCeory2hvLSe1u4kmt50aOSNxlXVhggjuCDipaQsoYKSAx6DPJoA47wDdTabNd+EdSlZ7vSUVrSV2G65smJET9ssuDG3HVQf4hXZVznizQ7q/utK1XR5I4tY02bMZlcpHNC5AmhcgHhlAI4OGRD2ro6ACikZguNxAycDJ70tABRTHmjjkjjkkRXkJCKzAFyBkgDvwCfwp9ABRRTFmjaZ4lkQyoAXQMNyg5wSO2cH8qAH0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFcxq/hNr3xI2t2WvavpV49pHZyLZ+Q0boju6krLE/OZG5Hb8c9PXm/i/xR4ls/Hw0nSW0e10WHT4Lm6vby1luJElmmkijRY45FJDMijOMLySegoAnsPhktho15pNr4r8Qrpd15vmWjLZPEFkzvRVNuQiHJ+RcKMnAGabe/DAX2kW2mXnjHxTPa2zxyQl5LUyxPG2UdZfI3hgf4g2ccZwcVQfXPH0UC/aLzwyt0sfkzQrps7CO+ZY2jtd32kZ3CT/AFn3RjnrxIdd8Z+YsMeqeG5LiUiCCNdKlHnXK+YZ4FJuxgxrGW3HAbPHQ0AaV78O5b3VLHUrjxn4oN7ZeYIJUa0QqH271IW3AZTsX5TkcZxUC/C22bXV1W68TeI7mY3FtczRvJbpFcvbuGi81UhXdgqoz1wAM8DFEeKPErwm4i17w29oytcxTDSJcSWiCPzbkD7ZwqNJtKn5jtJAIIqK/wDF3ivTn0SVrzQr6C81SztZ4YtOkidLW4maOO4DfaXGH2ZUYJ+YZAwRQB6tUD2ds90ly9vC1ygwspQFwPY9e5qesXS/Eunal4k1rQrd5BqOk+UbiN1wCsiB1ZT/ABDnB9CPoSAalraW9oJBawRQCVzK4jQLvc9WOOpPrTnhikljleJGljzscqCUyMHB7ZFc7pnjjw/f6dqeoHUIbSw0++k0+a5u5FhiMqYB2sTgglgAe9aN14j0O00mDVLrWdNg0ycgRXcl0iwyEgkBXJ2nOD0PY0AaciLIjJIoZGBDKwyCD2NKiqiKiKFRRgADAArG0nxLp2rTBdPkE0JMwE6uhjbyigYghssP3g5AI4OcHGaTePfC76fqN3Ya5p2o/YLaW7mhsrqOaTy413MQobnjv05HNAHT0UUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAGJ42tby98JarbaaHa6kgYIiPtZ/VAexYZAPHXtXP6nPayWCHQNJ1Cy8toY7qSDTZbeZLbzBvSP5Ax+iZIGSOcV2OqX9vpenXF9euUt4ELuQpY4HoByT6Adaxp/FUduqLPpWqJdMskptvLRpFiTbukOHKlRvXgEsTkAEggAGDpMGtX2r6VDNdazb6SEv5QzApJIqz2/kLMWXcCVMuAcMVHOfmrB0y11vTvDGjwaTb6oL610+7jm86Bi0UwEICxlxjoGK4O1iO+DXX6x49srO0vpdPs7zUTaJE7GKMrERIEZcSEYyVcHHX6cVbfxZDFeS2r2lw91viihtI1HnO7xtIVOSFGFViSWxx16CgDndReRfIFlJ4pOleVcEMIroz/asReWDuXzNmDIRu+TO4NxgVVe68Q2mpTy3pv55ms3aV0WaGGzZbXJwCvkyr5gOGBDguByFOOwHiyz+1rC9texqJYreaV4gEt5pQpSJ+c7jvToCBuXJ5FVD410ie3c3UF0lrLDI8RmhBW6VXEbqgBJJ3Oq7SBndxkZNAHMaZLqt5DaTWn9q3NjI+lyyNeQyE+cZSZ2QSLkJs2EkDYP4cfNTo5PENlZwXLRazeS3OnXjXUTNKNki3EKxbQBlCI3lOEAZwpxkjNdVH4rsoY4bWLT75LwTmzXT0iQSI6xeYF+9sA2YIIbHbOeKoXfj6BYrua1sppLSLRv7YW6bhAu2Q7XH3h/q+2Tk4xxQBkeG4tXm1nTvti309raaxN5E09tPHiBrAHJ80s+3zHdcsTzxxwBa8bXOsjxJF/ZkWoxGB7Ty2hiuJY7hWm/eghCIlwucl9xx0A4NdJ/wldiNYOnmK6XFybM3LIBEJhF5uzOc/c5zjHbOaZ4b8YaX4humgsGfeYRcRF9v72LON4AJI5I4YK3I4oA5Zx4nhimu7A6jJqMz6xGkc+4xKElk+yfKflUEKm1v4g3UjFavga32eIdbuIk1b7NNbWYWXUUmV3cebuH7wA8ZGQOBnjjFWo/GsCLfteadfRLbagdOjMcfm+e+cDaF55+nHHPpNN400y21eLT79ZbOWWNpEM7Rj7sZlbKBi64VWOSoHGM9MgHTUVydx4xMcmjhNE1MpqVz5EZkVUbaYJZQ4GTniL7p2kA5IGMHT8P+IrbXZLj7FDceREzKJ3C7JCrFTjDFgcg8MFPfFAGzRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABXknim7sdP8AjXJd313YWbLolnHFOzxi7QtdzBjCJAU8vbnzTjcFIKkc163WNrPhbw/rl0tzrWhaVqNyiCNZbuzjmcKCSFBYE4ySce5oA82lu9NNjFC15oSIlgbEKlzCItpjhzbxt5ZP2FirBpD+8BBxjGBb/tDRnZI5tR0ieOdI4TBJeQKkiRtOVikYRkrbpkNE4+ZicN157D/hXvgv/oUPDv8A4LIf/iaP+Fe+C/8AoUPDv/gsh/8AiaAODvdb0RLJp5tct5GJN/JPLNCkxeOOFRcOghwLtMbUhxsYLkgngY3iPW9A1CTw5YabrWk391F4l067+zRXaMUZ7uTdOm1VLzOHzInKx54A4J9V/wCFe+C/+hQ8O/8Agsh/+JqS18C+ErS6hubTwtoMFxC4kili0+FXRgchlIXIIPIIoA6OvO9b8I6/LeapqOh39tZarLfP9nmkLOq2k0FvHLwMYcNCJF6jKDPDGvRKKAPJNW8BavZXSXOgNLHZ2Gpie2sbW4RJGg/s+C1Uq0qsm9PLcANjIZvmB62NI8M674fOl60ulRatqCNfPNZvep5sDXMkb745Cqx7sJ84AQEuxXPO/wBTooA8rj8A6vNo91E8WkWU9xb6mot4ZJHhQ3M8EqRMdoJjIiZZMAfeO0YPEmu6B4m8VyyT3Gj6ZozQ6Tf6dFm/MzySTxoqn5YwBECp6/N0O0YwfUKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAp6xp1vq+l3NheBjBcIUYo21h6EHsQeQfUVj3PhX7SUlm1rVTdqkkJuR5Cu0UmzdGQI9uMopBChgc4Iya6SigDnT4R03+ztTsYzPFb34jDKjAeV5caImzjjARTznn24pk/hG3lvPtp1DUF1ESRyrdqYg6skbR5xs2fMrsCCpHOQBgV0tFAHOf8IlbNeefLfX0qvPDdXELGPZcTxBdkr4TIYeXHwpUfIvFZej+A410qKDW724up44pYogjKEtt8okzHhAd2UjOW3Y28cE57eigDn7Pwta299BfS3d3c3sdy1008xQNK5h8nDBVAwEwAFA5GecnNGTwHp7aY1gl5qEVvJpjaTKFaPMsJVwM5Q4Zd7EFcc9QRxXXUUAYT+F7F7lpnedi2of2iVJXBk8nytvT7u3t1z37Uvhzw3DoAWO0vLqS2ji8mGCUR7YkGMAMqB2wABlmY/jzW5RQBz//AAitr9rkm+1XnltfLqIgymxJgOSDt3YPUgk+2KqTeB9Onv2nmubx7drqa7azJj8ppJYZInydm8grK/BbjjGAMV1dFAHN/wDCKgwWKSazqskljMs1rM5hLxERvHj/AFeGBSRgdwJ75yM1NpPhm207XLnVvtFxcXs8flFpVjXCbt2PkRS3blixGOvJzvUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABWL4zZ08KaqYr99Ok8hgt2iFjCTxuwOfxHI61tVT1i/TS9IvtQmVnjtIHndV6kIpYge/FOMuVqXYmesWeC6bq8ltpN/ElvbXZhksle+trya5tJ2adRyJDxJ1PH411c3jjV18XrZyX9vCza+umf2YYBvFrgkTbjz82BjtzxXSWXxI0i9utAt7eO4abVwdq4H7jDFfn545VhxnoaIX8FXXiOa+F3FNqNqXuS0tzK0UZUYd0Vm8vjuVHHNdv12jUbco/r27nBGnZLkn+nn+pyuh+MvEsn/CPX13f2Uttqyaipga1KiE24kKsWUlmyUGQB06Anmtr4TeKdT8Qz6jFqtz9peBI2LwxxmAM2chJEP/jrDIrTj+IFhc3N8liiS29sLcieSQxLJ5rFRjK54x+Oa3B4l0g6wNL+2oL4sUEbKwDMBkqGIwT7A1lPFU5xaUEr/wCb8vl8jWnGzT9pf9enfurnmNv8QdXk8avZw3aSWUj38f2eeFElgMMbumVHI+6B8xO4ZOBTF8ceK7LTYrx5rbUXvdBbU4oEtdnkyKyDsSWADEn6cYr0vw/4lttU8IweILhRZWrxtK4dt3lqpIJJx7U6LxboMttd3CanbmG0CmZiSNob7p5HIPYjOe1X9bpafu1/Xy/qwlTdr+031X9XOO+FV8b/AMYeLpf7XXV1MVhi7RAiudkmcKOB6fhWfY+L/EWoeMtT0i3vYXl/0oWq28KSRRlFOzzckSRnOASwwTwOuR6A3i7QU0+O+fU4FtXlMCu2QfMAyUIxkN7EZqk3jzw+97pVrDeGYaoH8mWIfKu04w3Qgk8DjtzioeKg5OTitUl00srdh8qUVHn639bv1OHtfH3iHUfCF/rsAhtES5s7GBJYN2JSUE7EZGRufA6dPyn0jxT4lTXrSC+1K2urZdem0WRBaCNpQI94kLA8EZAwB25zXS+H9f8ADPh7wvp8YmtdMtH84wwrM02QsjByGxljnk9+T6VsXXi/QLVbZ59VtlS5jWWNskjYTgMSPugnjJxVSxVHVRgrf1YUYOycqmuh5ZovjbxD4g0qNLXU4rm5utKu5rqO1ttrWDoD5Tbgc7n6AfiBT4fGur2vhjQyNfhEbaS9x9ukt/NM92gUC0JJOX5OT94n3r1KM6J4L0K1tVdLHTom8qCMszkkknaucsx6nvQvivQ2tprj+0oRDDGssjNkbVZtoJBGeW4+tXLF0uZ2grfLz8v6/ESoyStKprb+up514t8a+J7JLq4t5Leway0i01Ga0ktt5Mkj7XjJJyoHT147Ums+MfEel22s2smp2DXFlqkdv9qkiWAtE0W8qm4lAwPTcemepr0X/hLtBGqrph1S3F80xgEOTnzP7p4wD/OqU/jnSl8RWWk2sq3LTPOk0qE7YDFGXOTjDdCODxULF0kknBf1by9fvHKHX2n9ff6fcXPAupzaz4T03ULozmadCxM8Iic/MQCVBI6AYI6jB4zW9XPjxn4dazN0mrW0kO8R5jJcliMhQACScc4pb7xj4esLe3nutWtkhuI/OhYEtvTOMjHWuWc4yk2tDpjOKik5G/RWHb+LNBube+ng1W1eCxx9okD/ACpnoc9wexGc1d0fV7DWbd59MuVnjjcxvgEFGHYggEHkdam6KU4vZl+iudsfFdlNZXWoXZSz0yO6NpBcyvxOwO0sBjgbgQOecHpUn/CXaH/Z4vhfq1sZTBuWN2IkAyVKgZBA55FHMhe0j3N6isNfFmgtNZRDVbUyXqo9uu/mUOxVdvrlgRj2NJa+LdCunulh1GMtbQtcShlZcRr95xkDKj1GaLoPaR7m7RXMx+PPC8jqia1aFjIsYGT1bp26f7XT3q9/wkuj/wBsDShqEP2/ds8vn7+M7d2Mbsfw5zRzIFUg9mbFFcbc+P8ATP7SNrpzR3irbXFw84kKRr5IyRuIwQefmGQMVpjxbo8b2cN3eRwXFykbKp3MgLgFRvxt5zxnGaXMhKrB9TforCTxboMmrrpiapbm/MrQeVk58xeCpPQHjp3qDXfF1joeu2+n6j+5iltXuTcEkhdrAY2gEnrnPYCnzIbqRSvc6SisY+KNEF5DanVLX7RMiSRR7+XVhlSPUEDNQQeMdAmgupk1KIR2yLJMXVkKoTgNggEjPGRxRzIPaR7nQUVgQ+MfD81ndXcWq2zW9s6xysCflZvujGMnPbGc9qzLn4h6HbarFbz3CR2clo1yLttwG5ZNhj2YznqfwNLmXcTqwW7Oyoqld6rYWml/2lcXUSWOxXE5b5SrY2keucjGOua5zxB4/wBK0zSLW9tHW++03P2WNFby9rj728kZXHGQRnkcU3JLccqkY6tnYUVl6trun6LbQS6zdRWXm8KHOcsBkqMDk/zrN/4TbQ57W7k03UbW7lt7Y3ZjEm0FPUtjjqAe47ijmQOpFaNlzxmzp4U1UxX76dJ5DBbtELGEnjdgc/iOR1rw1dU1GDwnr40u4aKazitXl1XS76eeCYecob75yj4JYkfwhgeK9f8AEvjrTNDsN7utxfeXFJ9kjYk7ZGVQSwBA655xnFS6T400y91W7064kW1u4b6SxiR2J84qAcg4wM5OAeTg9a6qGLjRXK1fVM5q0Y1JfFZ2t95gWWu67qHiDULXTtWs7izsdPgu1kS03G7Z1f7pDYUEqD/F7Vz0fxN1a60+2bSRFfXyaJJdXMCwMNtyropGP9kFiVHpXplv4s0Oe4nhTUYVkgjaWTzAUARfvMCwAIHqM1BH4v0y7ms006eK48+4WA7y0RXcrMCAy/Nnaen501iaS3gn/XoDi+lT+vvPOtf8RXpi0K6s/G8c9muorHdXcVr5cce6NiFkwQrAEH5T6jPIFaQ+IF8NYTSnmiXUP+EnNg8JhIIsju2Nnpk4GD3rq9O8c6VN4fstU1FzYJdGbZGwaTAjkKMSVHA4ByfWtQeJdFN/BZDU7Y3c6o0UQf5pA4ypX1BHNH1qm0k4fl/kKMOqnvb+tzzNPGPipfh3pXiCa7tWGozpE8kdptFlGDIGdiWIOSqjJAVfQ5zVPVPiB4gtdE0uZtS05i3nebJaeW0k+1gEKB/kbg8qpznpXq+r+JdI0e7S21K9S3ldVf5lbaASQCWAwMkEckdKp61420HSY7/7RfxvcWSsZbaIgy8Y4AOPUe3NUsXSTu6a3/pbBKm0v4nT+upmeMtQljtfBcjRhnutXtUfz4trLujck7c/K3HTnHNc1o/inxPeXmiyvqNqYNUvL2xEH2QDyjGH2PuzknKjjAGPzruW8a+H0s7S5m1KKKO6j81A4OQudpLYztAbIyeMjrU1z4v0C2nuIZ9WtUmt8mVN2WQDGSR6cjms44mEY8rin/T/AK+Rcopvm57f0vM85sfHnia+8OazqMdukTaXFBZzgwFtt15mJ5cDkhFwdvv6Ckuddv8AVhoYmu1vbWDxVbwW2oRR+Wt1H5Tk8Dg4JIyODj2r0bWvEtvYWOo3FqovjpuxryKJ8NFGRuLDjBIX5sccd624ZUmhSWJg8bqGVh0IPQ1osVTu+WCX9ehKouWnPf8A4f8Ar7jyaw8aeKpm122S1juL3QLWf7UFgOLifzGEO0DnHlruwOv41Qs/H2vnQr2Y6lYTx+faIb1Y1ZrFJGIkeRF4+XAwDyM85r2uij6zT/59r+vl/XmV7Cf87PPvg3cG6sfE0pvPtynXJ9txgASDy4vmAHAB68cV6DRRXPVn7SblaxvThyRUQooorMsKKKKACiiigAooooAKKKKACiiigAqjr2n/ANraHqOneb5X2u2kt/M27tm9SucZGcZ6Zq9XOfEeXV4PAevy+GldtZSzkNqEGX37T90d29B64oE1dWZlW/w7sLS90e7spRDcWc0c1w4jJ+0skewfxfJ3Pfkms63+FlvFbzWZv0eyMU0UObb9/EJAf+Wm/BxnsozjmvMdD1tNO1LSbz4f6lqF6IvD95c+I/tM806RzpBuhaUSEhZTLuBAwcZ4xXcfC7xZ4n1DxdpFj4g1K1vrXV/C8WvIsVoIDbyM8alAQx3DDnJPccAdKjkj2Mvq9Psb8nw/u7r7Y9/rcc09wLRd0dlsCiB9w43nr09v0qZvAUr+K49Zl1cyrHfG8SOS3LSKCCPKEm/hBngBePeuE1j4ha9F8W7nQGvYZNOM5gitbKGOVlQRbmM6sRKoz/y0XKAevfjtV8cao3w00zTJNQtdB0288I3V4rpb5+23GXT7NGWPyYXDcfN83tT5EHsIdj3KXwtcad8LLrw5ZSfbbpbOWGNtoj8xm3EcE4HXHJqlF4AmvLSSfVdTJ1R4rZYXjgCpbeSdyqV3HfznJJ57YryyT4jeKtIvdG0y2urDT7O203THto74BV1JXiQykOfmJBJUBOQRznNem/F3xRqPh698O29vqUWh6VfSTi81iW3Ey2xSPdHHg/KC5yOf7uByaORDdCDtfpoadt4IaO4tLqfUvNvE1Q6pO4g2rKxTZsVd3ygDHOWNMs/A0tlf6deWuqqs1neXVz81tlXS4I3JjdwQBw36V5p4RuNc8afFXwXfeJ2+zOnhs6qbBoWCJKLhU3AbvlLZV8nOB8vvVv4jeIdZ8N/ELxlqOgQm4vLfQLEohQyLEGumV5Ng67VJP4c8A0ciD2MOx6FongX+zDpP/Ex837BDdw/6jb5nnuXz94425x3z7Vkj4WpHb2qQ6nEzJaLaT/aLQyJKFJIYKHG089yR7V5zc/FLxTD4Ra5j17Qp8al5YvUkhEjweVu2BiPIEgb1IyCOAae3xA16NdU1ixti+of8I7Y3DXFzYFJo1kuWR5XiVjlVTLgDjjPTijkiL6vTtax7Z4u8Nf8ACQaXbWYngi8iQOGlgMg4BHG1lZTz1DCuVuvANwdd8JoZrm8tbCJhfXk0gzMFcSRRlc5I359QABya5JfiB4on060g0zVrS6iufFMGjWuuGyBS6t5IXdmCAhSVcY3KQDj61teAPGms32r6dpWu63ZNdxa3qmlOBZMr6itsmVZduViI+8ckAgYGTQ4JjlRhJ3Z1reCNxk/4mH3teXW/9T0xt/dfe/2fve/SqVr8PZre5sVGsBrCxa7NvAbX51Fwrghn3/NgvnOB0xXf0UciD2EN7HIf8IdJDpXhyGy1IQ3+iKVhuGt96PlNjbo9w6j/AGuKox/DqKGxitYNRcIml3OnFnhDEtOxZpOCOhJ+X9a72ijkQexh2ODufh5FdWt9BPqL4uLO0tlZIsFGt+Q/JOcn+H9e9bnhHw82gRXQknt5pbhw7NDbmEHAxzlmJPvmugooUUtRxpQi7panml34b1seEotDt7YeZY6sktvcF0KyQeaZA5XcDlQcFTjOOM5q7N4Anlgy+tFrqW+e9ui1t+4nLKFCmIOOFAGMsec5zXfUUuRE+wh1OL8IeB/+EdurWb+0TcGDTf7P4h2E/vmk353HH3sY9s57VmWXw0lgkvHuNaFxJcafcWBla1PmHzf+WjsXO5h+GfavR6KfIg9hTslbY4K8+Hv2myvrf+09v2q0srXd9nzt+zsG3fe53Y6dvenr8P44/EM2oR3kbW014b5oZbcu6yHltj7wACc/wkjPWu6oo5EP2FPex51B8OJ47WO1k1tXtoLC60+3X7GAyJMMZY7/AJiPoM+3WjUvhvNezwM2tEwxR2qKktsXMZhCg+Wd4CBtuSME5PXtXotFLkiL6vTta35nGr4Jx5f/ABMM7NebW/8AU9d279197/a+97dKn8UeFrvV9Xj1Cw1SOxkWzksmD2vnZVyCSPmGDx6Gurop8q2K9jC1rHJ6H4Ni0ae8a0vpljmsIbBMLiSLy1Yb92eSc56DBFc6vwskNnqEM2tI8l3YpZGUWZB+WUP5jZkJZjjB5H9K9Ooo5ES6FNqzRxmr+Bxf61qGqR6iYLma4tLq3/chhDJArqCwJ+cEOeOMetPfwjd3V/cXuo6sk9zPpc2msUtRGo8x9wYDceAOMHOeua7CijlQ/Yw7HM3nhVbnwdp2hm8ZJLGO3EVyI/44du1ihPIJXpnv171Ri8DtttpJ9S8y8XWF1eeQQbVkYKV2Ku75RgjnJPHft2lFHKhulB7oxta0T+09X0W++0eV/ZszzbNm7zNyFcZyMdc965SH4a+XpFtY/wBq58nTJ9O3/Zuvmvu3439umO/qK9EoocUwlShJ3a/r+kef6t8PZrwX8dtrAt7e/jtVuUa18ws1vt2lTvG0EKMjn61Yj8Czf2u88+qh9PbVjrH2Vbba/nADaDJuPyjA/hGa7iijkRPsIXvY85svhtLBevcXGsrdOYLiDfNZ73kEveQlzvx06AEelTaN8O30+4spW1h5Ftr1LtYFiYRKFRk2orSMVzuyTk9BgCvQKKXJEFh6a6HnU/w3lk0PT9NTWv3VslwjrJbFo5PNdn3BN4wy7sAkn6Ct7wr4U/sC9Nx9s+0ZsLWx2+Vs/wBSpXdnJ656dvU109FNQS1HGjCLukcJ458BS+Kby4kOrmCGWBYfKltzKIirZ3J86hSe/BPvWk3hFHsPE9q94SutyPIWEeDDuQLjr82MZ7V1NFHKtw9jC7dtzz7UPh5LfPazzapBJdpaCynMlmWilRWJUhBICpAOPvEH0rVsfCcdhpPiG2kf7bHqZZzEqCMgGIJsBJxnjg8YzXWUUciBUYJ3SPOdC8N6to/wwn01Lc3Gu6irLcFpVxG0g2bmYnkIgHTOSOOtd7plothp1rZoxZLeJIgT3CgD+lWaKFFIcKaht6BRRRVGgUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFIzBVLMQFAySegFLWb4l019Z0DUNMjuTam8haAzKu4orDDEcjnBOD2PPPSgDnLH4kaPdeG4taeG+it5L6Ox8sxbpFaTaY3Kg/dZJEf1ww4zxW43ibS0vvskk0yTFSU320qrJhC5VGK7XYKCdqktgHjg1z03w8ige5OjahLaxySWVwkdyZLsJNbSbgxLybirIEQqCMBAQRzln/CB3f/AAlFtrb6rZy3NteS3kcktgzTZe3li8oyeb/qlMu4IAOFAJJ+agDoH8VaSywGzu4bvzWtgDDICAs7Yjbd056gdSOgqzpuvafqN9NZ2ssouYl3mOWCSIsucbl3qN6543LkdOea5XSfh5/ZlmbSHVN1u+o2+qybrVQzXCOrynKkAK5UYXHyc4yMKJvB3gWTw/rkepT6hBeTJZPZtKLQxz3GXRvMmkLsZH+Tk4A5OAOlAHQSeJdJj1ZtNe8AvFYoVCMV37PM8vdjbv2fNszuxzjFYen+OkvPhvqPjAWJW0t7OW/hg8w75Ili8wBiUAViOONwHZjVj/hEZf7bM/8AaCf2X/aH9qfZfIPmefs2483fjZn5tu3OeM44p3/CI/8AFrP+EN+3f8wX+yPtnlf9MPK8zZu/Hbu9s96ALdx4t0q0luI7yZo5IrhrZY0RpnkZUV22ogLHCuDjGcc9Ko6j4+0WDSri9srgXqwfZ3IQMoeKaVYxIjEYdQSeVyMjHWn2nhH7P4m/tf7bu/02e88rysf6yCOLbnd28vOcc5xgYzWOfhzImhaXYQauiy2GlWempK9qWVjbyxyCQqHHDeXjbnjPWgDoX8Z6EkMchvJMu8ieULaUyoY8b98YXegXcuSwAG5c9RnW1TUbfTLYT3QnKFggWC3knck+iopY9D2riNW+HtzqMVzK+rWseqXdxJcTX0dnIkkTNFFEDblZg0WEhTqzhiASDjFdD4s8PTa7aWMMd5GgtpvNkjuoDPBcjYy7ZY1ZNwywbGcZUcGgBZvGfh+Fbd31KMpPEk6MiO4EbMVDsQDsXIILNgA8HFMn8XWC+JdP0W2ElxPczyQPIqMI4mSJpCN+3azfLgqDkZ5rn7X4bC30G80xdTXFxpQ0wOtrtCYllk3hd3T97jb/ALPXnjTsfB1xaa3ZXK6nG2n2moXeoRW5tj5m+4EpdTJvwQGmYj5emBz1oA2dX8SaVo90tvqF15UpVXIEbuI1Ztqs5UEICwIBbAJBApl14m023u7i1eWVbmGORwskLxpJsXcwSRgEYgckAnH4GuU8e+HtYv8AWLoaJC7RarBawXckiRmKMRTMwIYyq6nDtkCNwflxg5NOuvhzJc63LfzapA5Mt3Ikj2Ra5CzxyJ5bSmTlE8z5VCqMKB1+agDpPD/ivT9c1K9sLQTrc2ixvJvj+Qh40kBVxkHiRR+eMjmnTeJbW2vNV+17LfTtNMUU95I+B5z7SIwuOweM5z1cDscQeF/Dc2gX91Il9HPaXMMCvEYCriWOJIgwfdjaVQfLtJyfvdqp33h66vpNc02TMNld3ltqUN2ArAMjRF4iu4NnMOd3TEg7rggGjZeL9DvbuG1gvW8+V2iCSQSR7ZFBYxtuUbX2qW2thioyBjmmJ418OtYz3p1WGO0g8ovLMGjXbK2yNwWAyjNwHGVPODxVG88ER3k05nvSYptWbU3QR4O023kGPO733bvwx3qmngO5lht11DWI55bX7BHA8doYwIrW5SfDjedzv5YUsMAdQvUEA6C38V6LcXkFtDehpZ9oQ+W+wMy7lRnxtVyvIQkMQQcc1uVxb+Box4suNYiksXjuLuO8kjurIyypIiqv7uQSAKPkUjKsQc4PQDtKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAzvEmrRaD4d1TWLmN5INPtZbuRI8bmWNCxAzxnArIi8aWMU91a6tBc6ffW7xobcr57yb1ZlMYi3FuEckYyNhJGME6fizSP+Eg8K6zo3n/AGf+0bKaz87Zv8vzEKbtuRnGc4yM+tZl54Qt4JLG48NCz0m8tJnmDG182OXehRvMUMhY424O7I2gdOKALM3jHQIpLdDqUTfaIoZ0aNWdfLlYrHIzKCFRmUgMSBnvzUFl4z029v5LO3WcTRai2muJU2DzFViSpPDD5D0574xWTH8PEi0++tY9SbF1p9nYl2hyQ0E00rSfe/jM5+Xjbjqc4F1PB8y6sLj+0ozaJqx1ZIfsx3h2idGQvvwRl8g7RjGOetAF6y8Z+H721murbUo2t4oEuTIyOitE/CuhIG8EjGVzzx14rU0nVLTVrd5rGVnVHMcivG0bxuMEq6MAynBBwQDgg9CK4lvhpFJoGnaXPqRcWWkWmmq4gwGe3kjkSUruPBaNcp6ZG7vXT+EtDOg2NxC32DzJ5zM5srU26E7VXlS7knCAZLdAB2oAj0/xloGoRiS11JGjYQFHZHRZBM4jiKEgBwzkLlcjPBwanvfE+kWY/e3e5/Oe3EcMTyyF0GXARAWO0ck4wO9cuvw5aPR9Hs4tVUTaZptjZRStbZVpLWaKZJGXePlLRAFM9CfmqzZeDNRsb+PU7bWbX+1hNdu8j2LGFkuDEzp5YlBGGhQg7+mQc5oA0IPGumH7cblniW3u2tYxGjzPMBFHKXVEUttAkGTjAxknmtfS9YtdTurmKzkSVIUikEqSKyusi7lIwemPz7Vx+ofDo3WovqX2+2kvjcTTAXVmZIdsscCOpQSKc5t0YMGGMkYNdD4X8NroM91JHLCUmgtoVhhg8pIhDHs+UbjgHsOw4560AdBRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQBzfxD1ebQ/DP223uYbRvttlA9xMAUijluoonY544R2OT0rltH8Qa5qesabp1lq8EljLPe7NRNskjXkEJh2su0qgOZHQsBg7Mgc5Hoep6fa6nbpBfRebEk0Vwq7iuJIpFkjPBHR0U46HGDkcVaoA8ei8ca0dGNzBqMFzeSab9qvIDChGlXXnQoICFweRJKMOScwk5wcDXh1nXLTXZoJtVe6t7PXodJKSQRqZo5bWKYs5VR8ytNgbdowvIYnNelUUAeNad4q1z+wkuYL0QxWGjaXfmHyw/nvPcTo6uzZbbtiHQg55z1Bmv/ABtr8Opa6ftmnW8lmdQUadPKglWKGKVoZUi2+YxbZG5JYoVc4AIFev0UAeR6/rOtQw3Fvca7LAltdaRdPehEi8qOeUrIrYAXyxtB+bPBIYkV23iW9kgm8KeTKJUudSSJpA3DqYJmz8pwclQe4/SumooA88+Guv6vqjaO2rXouv7T0C21Vl8lYxDI+NyptGdp3D7xJyOCAcDN0rWZ7Xx3qdnZ6qk08/iAxS6V8jMIDaRlpv767SoOc7e2MkGvVaKAPDNA8T3FtpNneS3klpPqGkaIv2kyokcTvBcOWkkmDhFO3G4hiSVHJIq3pvi3XZnt9Ua/Et3/AGJeNb6dGQYtRuYJpFAQYBZ2CoTtAOOwBxXtFFAHkOl+KtfvjZ21nr2lXAu723gFzGY7mSLfFcPIrIgQL/qk2hvmGW3ZxzFqvjC/l1q+01NQWa2kW/spraZ4lmiaGCQiQRIm5FYxkhnc7lYEKAQa9jooA4jUryW0+Hfh2aInzHuNHiJJIyJLq3RuhB6Mfb1yOKw7TX/FF15Rsr2Ka6v4NUNvbvAixpJbTqkQBA3fMCQxJPUEAY59TooA8sTxtd6qlpqR1NdC8NahNKtvezRIrRiONcKxkG1S8nm9R0i45bIq23iPVoL+58QXUYhaLQtFvNSgMZAELS3vnsFOSpVTvx1wm0167RQB45qvjTxNEbZ5Lqw0tbmy/tGz+3yJbxzF5ZNlu5dSSUjEW4JtfMme2K2X1nXbrXreGPVjb293rtxo4jjt4z5USW0swkUsCTJmLbk5XDfdJGa9KooA8XHjrxFKNOD32nWTCzjlSS8ljgjvpfOkSQHcpLcInyxlWBkzyCorTv8AXtfm+0eVqD4u7vVdNigihUGLyY5jE6kDcZMxgdcHPTPNeq0UAed+HbhZYvAupQ6oNRu7xWs7i5DKxli+zySlW29SkkaDJ5GWHVjXolVG062fVY9RaMteRwtAjl2IVGILALnAJKrk4ycDnirdABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFc58R5dXg8B6/L4aV21lLOQ2oQZfftP3R3b0HrigDo6K+aND1tNO1LSbz4f6lqF6IvD95c+I/tM806RzpBuhaUSEhZTLuBAwcZ4xXcfC7xZ4n1DxdpFj4g1K1vrXV/C8WvIsVoIDbyM8alAQx3DDnJPccAdKAPX6K8K1j4ha9F8W7nQGvYZNOM5gitbKGOVlQRbmM6sRKoz/y0XKAevfjtV8cao3w00zTJNQtdB0288I3V4rpb5+23GXT7NGWPyYXDcfN83tQB9TUV81yfEbxVpF7o2mW11YafZ22m6Y9tHfAKupK8SGUhz8xIJKgJyCOc5r034u+KNR8PXvh23t9Si0PSr6ScXmsS24mW2KR7o48H5QXORz/dwOTQB6PRXzbq3xZ8UxWdn9v1C00C/l8LpqsVtJZ+Y91eGeREiVScgSBF4wSM1d1v4o+KYPEmqWMd5aW2q2k+lLa6B9l3y3hnhieePdncAm9jkdMdaAPoWivD9M+IfiSb4hDTpbiF3OrXdnPon2Qh7S0jQmO6Mg+YhsKc8q27C81xC/EzxBrOlahDrFxa6i8M1nIfs8Eclkha8jQBZEYOrYJxHIN3Ge3IB9T0V853fjPxT4duviT5OsPf31nqaCGyngLtaWrmIG4Vdx/dqrEbQNufmPcV6D8LfEup+JPBuuTatqFhqL280scF1ZspDx+WGAfZ8u8EnO3jpwDQB6XRXyzY+PfE/h/wL4IsdMvbTTLSbQzdJf3yr5dxciRh5LO/AAUAkD5ju46Yro7/AOJviJvH9npk13bGyuhbqLPT4Umdd8IeQyo5WUJkn94vyhcE5PFAH0HRXzRD8Rde0vwT4b+y3dnotu3h19Qtj9j81NQvVkKrZrk8ZABwPm+fPQVreMviF41tF8YX9nd2mnR+HLTS7t9PlsxI0jXC5kiZywKgHPQE+47gH0DRXNeEdXk1PU/EkD6lb3osdQNuscUDxm2GxT5bFhhzzncMjn2rpaACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKzvEmrRaD4d1TWLmN5INPtZbuRI8bmWNCxAzxnArRrK8WaR/wkHhXWdG8/7P8A2jZTWfnbN/l+YhTdtyM4znGRn1oAzoPF9sst7b6lZX9neWjxrJAkJuWYSKzKy+TvJGEfPAI2nPBBNn/hLtANzb26apbyT3Nst5DHGS7SQsGIkAA5U7G59sdxWbrXge0uLe0h0dLGxhjnaee3ltPOguyUK/vUDpvI4wWJAx0PGKej+AH0vR7yxg1iWOSfRLbR0ngi8p4jCbgiVcMcZ8/oMY2deeADTufGmmoLNoPNcS3gs5llieCS3JheXc0bqGxtTjjnORV668U6LaxRPJfxsJYY54liVpGkSQ7YyiqCW3HoACTg+hrm9G+Hv9n6kl4byyRhfw3rRWdgYIyY4ZIsYMjHJ8zcWJJyPfiroXgGRPD+pW1wII5rm9Jt472L7QttaRSN9nhXY6kbVJZSrZUuRk4oA6eXxfpMMn72ZljMMUyHYxkcyOyKgiA8wtuQjG3P5GtI6vYro51SS4EVgqGRpZVKbQOuQwBB7YIzniuO/wCFeym1VJ9VivphaQ2pe/tnmGY5ZJAwPmhxjzMKd+5doyzc1tDws7+CI9AudTnnmRVK3smWYSLIJEOGYkqrBRgsSQMEnrQBharr/h+28RafrmmWjXfiDUM6KHlM0PlRoDOUlTaShGQRlNx3ryF5Fu+vtJ8NePZI7LTz/auuxC81C5aSXb5UAWJSAFYbgDwoCg4OTnGbVj4QnTW7bV77UY575b572byrYxRvm2+zqiqXYqAuGySxJz0GMWvEfhmTV76a6h1KaxlfTLjTleFcPGZWRhIGyMEbOnv1FAEw8XaKbR5zcypsmW3MD20qzmRl3KohK+YSV+YALyAT0Bp6eKtGe7t7Zb397Ps2/unCqX+4rtjCM3ZWIJ7CuW034dT6dfHUbPUNOttQW6S5jFvppS3BELwsGj80sxZZCd28HcAckZFWj4DZvEjavNc6dcS3Fxb3d0J9PLnzoljUNCfNHljESEBg+CM5oA7iV1ijeRzhEBYnGeBWC3jLQI7OW5udQFrHFIkTi6ieB1ZxlBsdQ3zYODjB7ZqSKy1PUfCl1aapdvZ6jeRTp51rhXtg5bZtI/iRSoz3K5rmtJ+HRsr83b3tijtc2lwyWdgYEYweZ1zIxLN5nLEk8d+wBvP428PpOIft5aQsEASCRsuU3iMELzIVOQn3iOgrZ0y/tdUsIb2wlE1tKMo4BGecEEHkEEEEHkEYNc//AMIj/wATH7V9t/5jP9r7fK/6d/J8vO7/AIFu/DHepfDWkajotxFYrcRyaVGlzMz7ArSTTXBkUAZOAilgf724HtigDRvte0+x1GGyu5ZYppWRFYwSeVuc4RTJt2BmPABIJJAHUVUh8YaDLLcoupRj7PHLLI7qyptibbIQ5AVthIDYJxkZ61jeJPAsmteIk1F9Qg8pbqyukSe0M0kBt5UkKQvvAjV9mD8pOWJyRxUV58OkutNtrSTU2UQx36h1h53XMyyg8t/AVAx/F7UAdB4a8SW+v3erRWsM8aWEyQ7po3iZ90SSZ2OoZfv45HOM96p2XjjSZLCK4vpfsjSSTKUIaTy0jmaIyOyjCISv3mwOcZ4q54b0W70y91e81C9gu7nUZo5n8i3MKJtiSPABdz/Bnr3rk5/hfGzmRbuxuHlilt51v7AzxvG1xNMoVRIu0jz3UklgwxwMUAdlF4k0mXWBpcd1uvC7RAeW+xnVSzIHxtLAAkqDkd6168603w9rEHjSzVIXTQrHUL3UVlnSMFmuBIWVWWVmYb5nI3RpgDGTgZ9FoAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigCjrmqW2i6Rd6lfFhbW0ZkfYu5jjsB3JPAHcms1PEE9rBLceINMk0u2UKUkMyTbmZgqx7UyfMJIAVQwJOASav+ItJh13Q73TLmSSKO5jMfmRkB4z2Zc8ZBwRnjisW+8P63qVtGuoa3ZNPbTRXFq8OnMirIjZzIplO8EZUgFepI5xgAu/8JfoI+wBtThV79nS2jYMHkZHVHXaRkMrMAwIyOc4waZY+L9Ju109RMwnvY45UiRGl2K5whdkBVAxBALEAkHGcVV0Pwi2na5a6tPfie6SK+WcLDsWR7mWCQso3HYqiAKF5znJORzT8N+Cbvw8sMVjq0L2z21vbXiTWZJlEW4ZjYSDyyytg53YwCMc5ALeoePNGg0i5v7Of7WsDQblAZN8csqxiVCR86ZYncuQcYBrVsfEmk3xUW94PMbzR5UiNHIpi2+YGRgGUjcpwQOGB6GuUb4e3cmlQ2k2tRPJZWsFlYy/YiBHFFNHJmVfM/eM3koCQUHXAGasP4Hvvt0mpx6xbrq9xLPJcymyJidZYYYsJH5uVIW3iwSzchsg54ALGqePbKxvCkcLXFr5WnTJcRsSHS8mljUhQCTjyt2BydwFacvi/RYtPivnupfsj+ZmRbaVhF5Z2yebhf3W08Nv245z0rn2+H0yQWwtdWjS4t7TSrZHktC65sZZZAxUSAkP5uMZGNvU54qaz8M5tUsriGfV7aV7tLr7ULixMsPmTMD5sUfmgIygBQWLnAHfJIB21tr+lXWtXGkW99DLqVuAZoEOWjBVWGfTKupHrnjoabJ4h02PVP7PlnkiufmC+ZBIkblVLlVkK7GYKCcAk4BPY1H4b0L+xZ9Xk+0ef/aF1Hc42bfL220EG3qc58jdnj72O2Tzlx8P5LjxRFq82pQSeVeTXSNJZlrgLJbyw+T5xk/1a+bkKFH3QDk/NQBuW3jPQLm1nuYdQDQwrE5PlOC6ykrGUBXMgYghSuckYHNT+GPEEGvaXcX8cb28ENzPbnzgUOInZCxDAFc7c4IyK50/D91TTXg1UJdafZWNrA7W25C9s7MHZd4yrByNoII6hq2NL8MeR4a1TSdRuxcjUpbqSeSGPyceezMwUFmxjcQDk9KAHp4z0J7VbhLuVo3dUiAtZS0xZSwMa7cyKVVm3KCMAnOBUGrePPDumWjzSajHO4sf7RSG3+eSWDa7B0HQg+W2DkDI5IyKr/wDCM60V0yV9bsWvtMO22l/s5hGUMZRhIgm+YnKnKlcFemCRUWn+AobSy1S0N/I8WoaPDpLnywGBRrlmlznGWNyflxgbe+eADSj8Y6Q0ZmkmaK3+zR3AeRSGPmSNGqiP75YsuAAOSQBmpG8X6GrW6yXpjacAgSQSKYwXKAyZX90C6so37ckEDkVi3Xgi8u7i3vZ9Xg/tK3gtY4pI7MiLfBM7qzIZCSCr7SNwPUgjjEmpeDr/AFKS7a61i326lbx2uorHZMvmJG8jL5X70+WSshUk7+gIwc5ANj/hLdEC3rtfBYbPd50zxOsQ2vsbbIRtbDfKdpODwcU1fFulSeSYpzsaaWCTzFMTQtHEZWDo4DA7ADjHRgehzXJeIPAepC012fS7uBpb2NljsbeFoIXdp0k82RWlKM4Ct8yhM7nzkkY07jwJNeXEt5fapG9/PcTTzPFalIzvtDbKqoXJAUYbliSc9ARgA27Xxbo13bXE9rcyzrAIyyxWsrOyyZ2MqBdzq2DhlBBwcHg0WHiaz1HWbOysf30NzaTXSzgldpjlSNkKkZDBmIIOCCpBGawtQ8Ay3DB4dVVCLOws2jkti8UotmnJEih1LK/n/dyMFASWGRVnwd4JHhy5s5lvIpBbx30YihtfJT/Sbv7R8q7jtC/dA79eOlAF0+N9DiudbhvLlrNdIuY7a5muUKRbnWIqQ/TBMyLzg5zxjBNuHxRpM13a26XEoe62+S7W8ixuWUsFEhXbuIBO3Ofasq/8HzXN7qrpqUaWmoanY6q0RtizpLbtbHaH3gbWW1UY25BYnJ6VT1bwC2p+JxqlxqEEkQvI7tFltC88QVAhhjl8zCRnBbATOSSSaANC98f6BbQ28yz3M8M9ylskkNtIVYvuw6kgB0+Q/Mm4V1SkMoI6EZFcVF4P1SPQdM0z+27Vl0l7drCQ2ByBDwBKBL85K8ZXZzzjtXarnaNxBbHJAwKAFooooAKKKKACszxPYT6n4e1Gzsrh7a7mgZYJ0YgxyY+Rsj0bBrTooA8jt/GNxqOj3vijzrrTre7ltdLtgzpHHbuoLTO7SqyJ+9d4ixU8xKADkVd8GeJdf8QXuhwNqFpHGUv3unihE32gW18IF2v8oG5RksFGc5CrwB30muaZFefZJb2BLn7StoI2bBMzR+YEHuU5rEt/HmjTax9j87EEkNrPb3SqzxzC4LCPkLhASqgFiAxYAUAee6R471FNN8HCC9SOWS30WO5tLmVF88XRiR3iUq0smBIfm3qAVOdxBBz7vXLkeAvEtjZ6st6raZr73VqpQtYlHl8t9y/MpO7GGJzkFcbTXsL+LtDje9WTUERbOKWaaR0ZY9kX+tKuRtfZ0baTtPBxV3R9ZsNYFx/Z8xkNu4jlVo2jZSQGBwwBwQQQ3Qg8E0AcNp3ijWbn4gSWE93YW0Md/JbHTp50SV4AhKSxx7fMZmO1t24ptyMZGam8aa5qGneJLqHTpUhdotJiV2UuF8/UDA52k4ztY1tWXjjSZLCK4vpfsjSSTKUIaTy0jmaIyOyjCISv3mwOcZ4qxd+L9Jhi1JopmmawSR5cIyxny22uBKwCEqxwQG4PBxQByNvr+uWl/aifUzdRHV7zSSkkEa7kjtZ50kYqo/eZiVTjCkfw55rK0/x7eyaGtydaW9iubGxllu7cQImn3Mz4aNnIKKuP74Zl99yivSJvEmiS3V1p8t6m9FkWQFWCHYuZFD42llHJUEkdwKPCep6Ld2KWGgTbrexhiRIyrrtiK4jYFxllIU4cZB2nk4NAHmP/AAm+s/2St8Li1lvbfS9aZJ4282ORoLq1SN+Aiv8AK3JCrnsFBIrW1rxF4j0rxMumXGradG0CQSRvdNHapf75G3gKwZm2rhQqMGBwW3bgK7i48WaJb3VxbzXwV4A/mMY32ZRdzqHxtZlXJKgkgAkgYNVtW8baJpstuj3LXHm3KWpNqhlEbvE0q7tvqi54ycMpxg5oA5Dw5rM+r/EDRpbvUxJdiHU0n01Qg+xbZYlVSAN+SoByxOeq4BqfxJrepaR4u8TtBqrLssLOW2spQGUKXkWWZFPJ2Abm29cAHtXZP4r0VLm6ge+RWtllaR2RhH+6/wBYFfG1inO4KSVwcgVHH4v0OS2mnS8ZlikSMoIJPMdnGU2Jt3PuAJBUEHBxnBoA5LTPGktvq9vHeaxa3egG+ltY9WkMapcYtkkVd64QsHMi5UAHbjGVNReEPF17rJ0BtZ1uDSpbnTNOu47fy41/tGSdMyY3DJGflAQgqTk5BArp9F8c6VqNnZyyNLBNdPIqQiKSRlVZmiDvhf3all6vgZ47GtjWdc0/RvJGoTMjzbvKjjieV5Noy21EBY4HJwOnNAHB/Ce+1CKDw7p9zetdWl3ohvFR0UeSySRqApAyQRJzuJ5HGBxTrrxheL8SLbTrW9T7K2o/YJ7G4kiEgH2dpPMSMJ5m3cB87Pg5wF5BrsP+Er0M3NpCmoxSNdLE8TxhnjIl/wBVlwNq7/4QSN3bNUb7x5oVpp73omuZ7dbiC33w2zkMZZhEroSAHQMeWQngHGTgEA4iDxl4gg0fT7ye+SY6lpkd5IzW6BLIG5giklUAZKrHMzncT/q+wyK6v4YTLOviZ49RbU4/7XcJdFkPmDyIOcoAv5ACtweKdG+3rZm8AmbHWNwgYpv2FyNofZ82wndjnFU4fHGgXEcNxbajby2MkcshulcBAIxGT15biRemfTrQB57ZePNan8Pre2Wr2l/cy6V9puAIkZNPuPOhREIQg/OskhKsc5iJBAOK3dQ8QaxpmvGwudXikvoLmzht7IwIh1KKV1EsgHLfIGcfKQF8slsg10Gn+IvC2h+HrRIL2Oy02GX7BFHOJEdJAhcRFXG8PsG4AjJGMZyM2NI8X6bfR3zTypataPcl1kf/AJZQSFGl6dOAT6ZFAHnlx491ePR9ZvrLVba9u7aw1eea0WOMixa2ZhA7bfmG7aAVcndnIxg519e1jWNE12e3utTiP+i2RuNQEPlpbRy3UqvIELFQAoADNnGctkA16DotpZWWmxR6Ymy0ctOgyxyZGLsfm55LE/jV6gDyq38XXk81tBqHiGDTNNIu2t9XaOILqHlyhUALDZ90kkLgvjKbRmqsnjbX1udela806GW0j1H/AIls0qedEIVcwusW0OchFYlmKsHyuBivX6r6jZwajYXNleR+Za3MTQypkjcjAhhkcjgnpQB5HqHibULpImt/E4fS4LzTpZdWg8sRxtL5omgZl+TYpWFvmyf3gBJq1c+Kby2vL6GXWItJsxcX7R3rqriaWIw+XCN+R8wdztXDNj5SMGvV4o0hiSOMYRFCqPQCn0AeYQ+J9flvvtNxMLVIdQ02zk0/yVI/0mKEyBmI3ZVpTjBHTnPb0+iigAooooAKKKKACiiigAooooA5n4oTy23w08Wz20rwzxaRdvHJGxVkYQuQQRyCD3rhNSbxToOtWc83nXkmn2V/Bp1qs7P9vEUJeOSQA8u37tCDyCjEfer2GigDyHTvGOqSQRrP4g01tPmureKbU4ZoZZLIPFOzbwECRgvHEi7wSDId2cCs7QvEs2k6MrfbZmjNvPtu0ZBhn1N4xIxfMarg5LFSAOx6V7fRQB5T4M1y+1rxPoT39zBcvB/aluJ7eQSJMqtb7W3KqK3DfeCqD1ApnjHXdQ0bxvqYspltoLgWENxdySKi2ybLtgdzqyIWZUXcykc46kV6zRQB5FeeLPEQ0q7uk1SxL6do6ajutESaG6fz5kwWx9xljGdmOScEDrpyazrieII9A/tVyX1xbE3hgj80QtpslyQBt2ZDpgEqeOoPOfSqKAPHm8WaxJY2t19vsra6bS0aW5uJBChIu/LcgtmNXZQdu5du4gHjitDw74wm1W9so7zXX0qD7PG9v9rigEmpSGeWNxkZV1AjTHkkZ8wN0ZRXqNFAHkcPj7Ur3S7eO11PSotRXR5Li8MzKi21ys8MZVzyI2AdxhhgHBPFdx8P9XbW/DiXTzXE5WaWLzZxES+1yMhov3bj0ZcA+gOa6SigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigDiPFXgGPXdW1DUYtQe0ubizSGEiLeIbhH3pcYyNxGFXHHAIzzUt14FhdLyK1u/It5otOhjj8rd5S2kpcDORncOO2OvPSuyooA82k+F8f9maxp8N3YpBe2t5bRTtYFrmEXCsDmTzMMF3ngKpIABPUntNO0j7Hrur6l5+/+0PJ/d7MeX5aleuec59BWrRQB5tP8L42cyLd2Nw8sUtvOt/YGeN42uJplCqJF2kee6kksGGOBirOo/D2W9uddZdVitLfU4LiEwWts6IWldW8yVTKUdxg/MqoTuYknNegUUAcRP4GlnZ4H1RP7NS5vL22hFsfMjnuVmVyz78Oo+0SkLtHUc8Vr6B4c/snVZL37V52/TLPTtnl7cfZ2nO/OT97z+nbb1OeOgooA4O28BSWGsXV9pt3pqM9xc3kElzpxmngmnEhYiTzVBUNK/G0Hadue9N0z4evo+k2mn6PqqRwWF8t/Z/aLQSbH8tkkEm1k3hi7MMbdpOBlQAO+ooA87Pw0jUapFDc2Igu1vPLlksC1zC1wH3fvfMAIBkb+AErgE9SdG98FSya1Fq1pqaQ3tubZoPMtvMRWiinibcocFgyXD8AjBAOT0rs6KAPPR8PLgRacqavBFPayvK93DaPHcHdctMVR1lACndt2uHHfHJFbHizS9XvfEPh660WS3g+yG482e4i85EDxgD5A6E5PoeO9dVRQBwNj8PPsFtDYWeqY0omze6ikg3SzPbbNrLIGAQN5abhtPfG3NRx/Dy4SG9RNWhgEstrcQQ21o6W8csFws6uYjKwyzKoOzywRn2x6FRQBwY+H+Naub43GnS/ap/tUhlsC0scpQKxifzcKuRkAqxGSN3TEmoeAVvdK0CzbUmRtIsPsiSLD99x5JSTG7gBoAdvOc4zXcUUAcja+EJ/7Vs9UvtRjmvo9UOpzGK2Mccn+hvarGql2KgBw2SWJIPQEYyNd8BSXbabbRyPJFJq11dXsy7UH2SYtJJbsCSWV2ESnHpnjGD6LRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFU9Yv00vSL7UJlZ47SB53VepCKWIHvxVyqOvaf/AGtoeo6d5vlfa7aS38zbu2b1K5xkZxnpmkxSvZ2Ki+IrBfD9hrF0729reRRyRhkLN867guFyc49PSqMnjnQlv9Ito7ozf2oHMEsYyg2nGG7gk5AGOoOcVlf8ITq0nh+00m58RpJBZmEQqtjsRkjUrskUSZcH5e45XvS6T4Cl0saA1rqy+fpU1y+42vyypMQWXbu+UgDAOT9Ki8uxhzVnsv6+83ovFugzT3UUepwM9tG8snJwET75BxhgO+M4qN/Gfh5bMXQ1SGS3LtH5kQaQAqoZs7QcYDLn0zXNWfwyS0t7m1h1GI2zW9xbwM9rumiEqMvL78EDd2UE461pa94Jl1TTNHso9V8mKwt/s7o8Bkjm+QKHKbhhhjIySBmi8+wlKtbbX+vM19O8R2+oeIJNNtVEkS2Ud6lyr5WRXJAwPwzn3pt/4w8P6ffvZXurW0F0jbXjckbTt3YJ6DI6Z61T8KeEf7Avorn7d9o8vTodP2+Vsz5ZJ353Hrnp+tQXngn7Tqlxef2ht83VbbU9nk5x5KgbM7u+Ovb0NP3rFXq8u2pp2/inT7y40sWFxbz218Jisvm7SPKAz8pGT156YrPt/H+jXGsy2sM6NZQ2TXkl7khAFkVCORz97ORxVW3+H6JdW8k2oM8Ucl+7IsO0sLoAEA7jjbjrg59qx9W+H2pxaJeLDqKalcJo50q1t1t1gyodGUli5BOFx2zSbn2IlKsle39WO1TxZoUlrd3K6nAYbRlSY8gqW+7xjJ3dsZz2zTJfGHh+Gxgu5dUt1gmZ1jY5yWT7y4xkEehGawf+ECmuhPeX+q7tXeW1mimS3CxwGDlBs3Hd1Octz2xVrS/BBstW07UZNRM1zBeXV9cHyNqzSTx7DtG75AABx82ad5diuat2/q/r2Ln/AAnGhNqmlWMN0Zm1OMyW8sYzGRu2gE9QS2RjHUHOKbF440WPSbO91O+trQ3MbSoiyGQFQxBKkDnp6VR0fwNLpL+H5LXVV8zSzcK+62yJo5pN7KBu+Ujpnn1xTdF8A/2ZDp8f9peb9k06fT8+Rt3+Y+7f944x0x39RSvMSdbt/Wnn6m7c+LdBtpLZJtUt1NwiSRkEkFX+6xI4UHsTjNW9Y1rT9GjifUrlYfNbbGuCzOcZOFAJOPYVwzfC5FjhWLUom/0SG1uBcWnmLJ5YwHUbxtOOx3Cuk8b+Fz4mgtY1uYbdoGZg7wGQgkYypV0ZT9Dg9weKd5W2KUqvK7rXoXB4o0QwTTf2jD5cSxO5ORgScIcY70xPFugyauumJqlub8ytB5WTnzF4Kk9AeOneuWuvA88ni7wzKXuLiy0+2AvLqaRSbh4zmIMuckhiTnBGOM1qL4Jx5f8AxMM7NebW/wDU9d279197/a+97dKLy7CU6r6E0vjvSDr1rptrMtwki3DTXCkhIfJUMecYbv0PGKuHxn4d+xi6XVraSBn8sGMlyW27sAAE8A5Pp3rnLX4czQJZW/8AbIaysYLy3tozaYZVuFIO5t/zEZ9BnHbrWrP4QlFj4cFhqQt9Q0S3+zxXDW4kSRTGEYmPcOTtBHPHvSTkKMq2t1/Wnn6l/UPGPh/T44JLvVraNJ4hPEdxbehOAwx2zTofF2gTWl5cxarbPBaOqTOGyFZvugeue2M57Zrnh8OYYrP7Lbai6RDRpNJG+LccvJvMn3h3z8vv1pdQ+Hcd7/aDPqLq9x9iaJlh/wBU9upUEjd8wbceOMetO8+wc1bsjsNI1Sy1i0+1abcJcQbihZcjaw6gg8gj0NY9l4vsJdLk1O8K2entctb2sjtua52kjcqAZ5KtgcnAzxVnwloR0CwngaWCV5p2nZoIDCuSFHQsxJ+XqTXMW3g68vPCNtoF75Nv/ZtywgnljEyzxAtscbXV0bDAHkHIPUGi8inKpZWWv6mldfELRLTV0trq4SKzksxdpdsThsyMmzbjOQVJJrYufE+i219DZzalbrcTBCi5yMP9zLDgbu2SM9q56DwC0UFxHJrE9w82ivpBknj3t8zu3mZ3cgb8BfQDmmT/AA88wPCuqstldR2i3sXkAtKbcKFKNu+TO0ZGGpXmSpVu39feaetePfD2k2188l8txNZEia2tyGlBDhCMEjoxHUitt9X09NIOqSXcSaeE3mdztXb0zzXPT+CUn8M+IdIe+IGrXk155qxY8ou4YLjPzYwOcjPtWnrmgvrnhltM1G8/0htjm5hiCjerBgwQkjGQOCTT94tOprddPxIYPF+l3N3EltcRPbtHK8kjMUaPywrH5CMnhgc8cEetP/4TLw8bMXSatbSQs4iUxkuWfaG2gAEk4IOAOO9Zl14Qv9QvFutU1qOecW1zbAx2XlqFlRVGBvPTaTyTnPbAqabwjKtl4b+w6iINQ0ODyIp3t/MSQGNUbdHuHXaDw3HvReRN6uun9feaieJ9Fe0uLpdRgMFuIjK+ThPMxsz9dw/OoLzxn4dsr6Szu9WtormNijoxOVIGcHjg46evbNc7qvw+vtQfUi3iDaupC2a7U2SnfJDtwwww2g7en69q0JfBPmag1z/aGM60mr7fJ/uxlPLzu79d36UXl2DmrdF/X3+guoePtNju9Dt9L2ag+rMREyybFVQdpJJHXPGMdQelacHi/QJ2uRFqlu32aNppDk4CKcMwOMMAeMjNZWk+BhYXejzNf+aunveuV8nb5guDnGd3G38c+1ZVr8MVtrG5sk1OJoHtpbWGRrTM0auMctvwceyrmleYuautbf1Zfrc6iXxn4ditFujq1s0DuyK0ZL5KgFuFBOACMnoM0l3408OWcyRXGr2qO4jZRuyCrjKtkcYIIOenNZviHwOuqnSpYrxYbixtza5lgMkcqEDOVDKRyM8N+dU5fh0H0nXLEaiiDU7a0twVtcLD5A6hd3IPpxj3p3mNyrdEv6XqaNx480tZdZt7c7rrS5FjlWZxGjZdUJDc8AuByBz+daz+JNITWF0t71FvmfyxGysAXxnaGxtzjtnNYGs+BpdQk8QKmqiG11d4JmjNtuaOSNozkNuGQQhGMfxZzxzHeeApbrxRHq8url0jv0vkjlty7qFGPKD78BO4AX86V5C5qye39a/8A6Dwz4hh1rwrba48f2WCWNpWVm3bFUkHJx7ZqKLxl4fkt5p/7UhSOF0SUyhoyhf7uQwBAODz0qPRfDL6X4HTw9HqEodIHhW8iTy3UsSdwGTgjPr2rmrL4ZNA8jy6tEzvLaytss9oPkMW5zISS2eTnr+VO8tBuVVJWV9NfU6Kz8daDd62+mwXgLrbi5E5wImTBY4bPZQScjGO9WIPGPh+a0uLlNVtxBAUEjvldu84U8gcHselU9a8I/2prl7eG+MdrfWBsLmARZZl+bDK+flILZ5Bzj3rGh+G7LYS20upQMzGACVLLa5WKQOAxMhznGOMAZzileQOVZdL7/8AA6nUJ4s0F7aa4XVLYwQosruG4Cs21T7gtxx3qWz1kS+IbzSJ4DDPDElxE27cJomJG4cDBDDBHuPWud8XeFZda8c+H75IWFlArG9k3qFkCMHijK5yfnBPTFa1rYXk/jm51W4hMFpb2YsrfLKTMWcO78E4A2qADz1p3dxqU72a6/1/Xc6OiiirNwooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAK5z4jy6vB4D1+Xw0rtrKWchtQgy+/afuju3oPXFdHSMwVSzEBQMknoBQB806HraadqWk3nw/1LUL0ReH7y58R/aZ5p0jnSDdC0okJCymXcCBg4zxiu4+F3izxPqHi7SLHxBqVrfWur+F4teRYrQQG3kZ41KAhjuGHOSe44A6V1Vj8SNHuvDcWtPDfRW8l9HY+WYt0itJtMblQfuskiP64YcZ4rcbxNpaX32SSaZJipKb7aVVkwhcqjFdrsFBO1SWwDxwaAPI9Y+IWvRfFu50Br2GTTjOYIrWyhjlZUEW5jOrESqM/8tFygHr347VfHGqN8NNM0yTULXQdNvPCN1eK6W+fttxl0+zRlj8mFw3HzfN7V9Ev4q0llgNndw3fmtbAGGQEBZ2xG27pz1A6kdBVnTde0/Ub6aztZZRcxLvMcsEkRZc43LvUb1zxuXI6c80AfP8AJ8RvFWkXujaZbXVhp9nbabpj20d8Aq6krxIZSHPzEgkqAnII5zmvTfi74o1Hw9e+Hbe31KLQ9KvpJxeaxLbiZbYpHujjwflBc5HP93A5NdfJ4l0mPVm017wC8VihUIxXfs8zy92Nu/Z82zO7HOMVh6f46S8+G+o+MBYlbS3s5b+GDzDvkiWLzAGJQBWI443AdmNAHmPhG41zxp8VfBd94nb7M6eGzqpsGhYIkouFTcBu+UtlXyc4Hy+9W/iN4h1nw38QvGWo6BCbi8t9AsSiFDIsQa6ZXk2DrtUk/hzwDXrFx4t0q0luI7yZo5IrhrZY0RpnkZUV22ogLHCuDjGcc9Ko6j4+0WDSri9srgXqwfZ3IQMoeKaVYxIjEYdQSeVyMjHWgDxu5+KXimHwi1zHr2hT41LyxepJCJHg8rdsDEeQJA3qRkEcA09viBr0a6prFjbF9Q/4R2xuGuLmwKTRrJcsjyvErHKqmXAHHGenFe2v4z0JIY5DeSZd5E8oW0plQx4374wu9Au5clgANy56jPQ0AeDL8QPFE+nWkGmataXUVz4pg0a11w2QKXVvJC7swQEKSrjG5SAcfWtrwB401m+1fTtK13W7JruLW9U0pwLJlfUVtkyrLtysRH3jkgEDAya9fooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKzvEmrRaD4d1TWLmN5INPtZbuRI8bmWNCxAzxnArnk+IOmyX2n2sdvcmS6spb187VFvsDZjkyeHykgwMgFDk9KAOyorlbzxtp0N1pdtCJLi4vZ4IWWNWKwmVd43SAFA20g7c5IORxzVLVviLp1pJfCyhlvY7XT5r8ygNGkgjdEKozLhwS5+ZSR8uKAO3orKh8Q6XNq7aZHdBrsM0YGxgjOoyyK+NrOByVBJAByODS3Wv6ba6qmnTXB+2EKSiRO4jDEhd7AFU3EHG4jODigDUornl8aeHjZ3F2+qRRWsHll5ZlaNdsjhI3UsBuRmOA4yp9alt/Fei3F5BbQ3oaWfaEPlvsDMu5UZ8bVcryEJDEEHHNAG5RXJ+HvHmjavoqX8s32Jvsy3UkUysNqE4yrFQJMNhflzyQOpAqPWfHlhZWontIZLpfJu5HVg0LxNBF5hR0ddysRjggcEHkGgDsKKxoPEenSX9vYySSxXc4GxXgkEbMU8zYshXYzbcnaDnAPHBqTRPEOk67p73+kX0N3ZqATNHkr90N178H8OnWgDVorn7fxloFzazXEOoK0USRyEmJwXWQ4jZAVzIGIIUrnJ4GTxVbW/HWjaZoE2ppK9yVgnmS3jhkMjeUPnDKFLR4OFYsAFJGcUAdTRWVa6/p1wkOLqNZJJxa7M8iYx+Z5f1281Ug8ZeH5xcMmpRCOCF7h5HVkQxoQrsrEAMFYgHaTgkA4JFAHQUVzB8aaaNStoCXitpLO6u5Li4R4DCIHgUqyOobn7QD+HfNbOkatZ6vBJLYSswify5EkjaKSNsA7WRwGU4ZTggcEHoRQBeooooAKKKKACiiigAooooAKKKKACs3xLpr6zoGoaZHcm1N5C0BmVdxRWGGI5HOCcHseeelaVcz8UJ5bb4aeLZ7aV4Z4tIu3jkjYqyMIXIII5BB70AZc3w8ige5OjahLaxySWVwkdyZLsJNbSbgxLybirIEQqCMBAQRzln/CB3f8AwlFtrb6rZy3NteS3kcktgzTZe3li8oyeb/qlMu4IAOFAJJ+asfU5tV8LowmvTo8Op3SpaxtqCyRW+yJy5eeeNwm8gYRVb7mRyzYZo3jLXL+wk1K6ukitLLw3aarcQWloJJJpZTdBthYgAfuVOCPxAzkA2tJ+Hn9mWZtIdU3W76jb6rJutVDNcI6vKcqQArlRhcfJzjIwom8HeBZPD+uR6lPqEF5Mlk9m0otDHPcZdG8yaQuxkf5OTgDk4A6VyOn+INS1rUbCzm1O3uxb63CLe8t5o7jKyWc5wzRoiMQw6BcdsnGavf8ACYeIL3RLy7M9ppX9nvBp121wUh33asftPlPICgGNgQsCpLHPQUAdZ/wiMv8AbZn/ALQT+y/7Q/tT7L5B8zz9m3Hm78bM/Nt25zxnHFO/4RH/AItZ/wAIb9u/5gv9kfbPK/6YeV5mzd+O3d7Z71xEvi/UZoVu7PUEtRJptpI09+8UDspuZ1faTmAOyoNrY2tkHoRjrP8AhI7t/himuWRme4aJT5tzCu5V8wK0pVDtYKuXyp2sBkcGgC3aeEfs/ib+1/tu7/TZ7zyvKx/rII4tud3by85xznGBjNY5+HMiaFpdhBq6LLYaVZ6akr2pZWNvLHIJCoccN5eNueM9awri4uPE2s6Lp8mrJqWjx6zJHHdiKKSO9RbIy/MANj7HLLlQBkDjcua6P4g61q1hfXEWl3otEttFvNU4hVzJJCU2qdwPyncc4wfQjrQBDq3w9udRiuZX1a1j1S7uJLia+js5EkiZooogbcrMGiwkKdWcMQCQcYr0FF2oqlixAxubqfc15m/izUtJ1pINT1GFtPE9lJcXNwiRLDHPFPlcjACiSKMAnJ+bBJrOPjvUXOjXcupQi0uZpEEFmYftEx+2PEp8uTmSPYqj90Q+cnngUAevUV5FqWvTap4fvHu9bjOoi+hWXR1VFa0CahEgJwPM+7jJYkNuBXAxUcHjLxFO+qN/ami2VwqXSmzvbhFazZHxG2wLvUbR8zOWU7lYYBwQD2GiuM8K+IbrUPBOpaja/adQvLUzrEJvJbz3RcqFeH926k8blx3BAINcVqur3viDTV06LXU1KwmudK867ihjwrzXBWW2YAbSoCodjAsAcOSGFAHtFFcp4jlvLK78MaPpd39hivJntpJYoULKiW7uNgYFVOUHYjHauMtfGmr22i2V9ql/JIuoaOt4xhhiQWsvnwxblLDAT99uZn3BQpboMUAevUV4lP491mHR2nn1myMFpd3ULSWk9vJcXYSOF4/K8xEjl/1jBlQIzfJt7k6w1i8i1bWYpdWlmkHiSyjjsZm2vBBIbfBA4YKdxGD8uc8E5oA9XoryOPxrO3huxu7nxIsWq37olzaKbeFNKlIZikjujeUo2mPMgcs2Nv3sVT0zxPql/JbXuo6ysHm6JeBbdHAhu5oZ5ELJkDLbVViVAOOwHFAHtFFeWaN4r1KTUbCBr6Nbk3FpbJpBRS01s9vE73OT852l3O4Hb8hUgtk1ofD/AF/V9RvdH/tS9FymqaQ2oFPJVBC6yRrhMDOCJOdxPI4wOKAPQ6KKKACiiigAooooAKKKKACiiigAooooAKKKKAMrxZpH/CQeFdZ0bz/s/wDaNlNZ+ds3+X5iFN23IzjOcZGfWsbVPA1hcXr3OnlLF5jdPcbYy3myTxCMufmGMYzgdTnoSTVj4oTy23w08Wz20rwzxaRdvHJGxVkYQuQQRyCD3rg9UbxToOsWk8xlupNPsr+DTrYTlxfCKEvHJIAeXb92hzyCjEfeoA6ez8B3FnPbJDq0f2GO9t9QeJrQmRpYoUiID78BWEYOCpIJPOMAVB8N7g6SNNk1mNrSDR5NFtcWZDxxFoyrOfMw7ARgHAXPXisTVfEd9OsYtPFXnaTbXunySazEsaIvmmZZYXK/JtXbC2G5HmAMSeavP4w1RL2fytRhmu1uL+GbTPLTNrbwxzNDcnHzYcxwnJJU+eAAMcgG/o/gaPSvEzalDJYywG7uL1RLZlrmOSbeXCzeZgDMj4+TO07c1euvDdy2sapcWuoRR2OqhBe28lsXc7U8s+XIHGzKADlW5GRis68udWHwl1TULvUg+pSaVLdJPbwiHyiYNwCjJ6HuTmuGvNuhta6edQisLS2n0qQ3YCRBPMNwWYg/uweByRyeWzQB1um/DgWdhDa/a9PHkS2TpPDp5jmdba5imCyN5hDFvKxlQoBYnB4FX38DRjxZcaxFJYvHcXcd5JHdWRllSRFVf3cgkAUfIpGVYg5wegHGXvjfxCILdI9SsLWHy7p7TU7ySK3h1Ax3DxxliylSpRUYhNpYPuUha19S8QeIDBr96usadZWdpqCWSRSKkJVCkLsVmkym87mC7lC889qAJ1+GMlxo1pp+q6vFcCwsxaWTw2Zi2Ynhm3SAyN5mXtocgbRgMO+RYl+HRm0+SBruwtpJEu1drKwMSMZ7dYdxUysSVCjktyABxirn/CR3b/DFNcsjM9w0SnzbmFdyr5gVpSqHawVcvlTtYDI4NYlv4i1q/vrTTdI1y3uLWfVJLSHVzbxzefEtn5xxsKozLJuXcoxxjBINAGnH8P5B4mstVl1KCcWl4LuMy2Za4UCExeUspkwsfJbaFHvk810Gh6I+i+BtP0KOb7U9jp0disu3Z5pSIJuxk4zjOMnGetVfFV3qH9u6FpenXzWKX/n+bMkSO42IGG3eCo59QePzrirT4jXzaJYz3lxZW99f6do13bQsADK1zJifYCcsAPT7vegC5p/w4vNQ8OaWviC9gXU7Wxs4IY47X91AYfmKyL5h83J+ViGUYHy7TzV24+Hk5srqOx1DTrGa8s7ixufI01hE0cuPmVPNyrgjqWYHPTpjF17XptS8O6/9q1uNNQjuJIm0ZVRWt447pUR+nmZKhWLElTvGABiobzxr4lB8RSW9zYLe2sOpeXpckiGdDCkhgZIQvmEtsQksxVg+VxxQB1kHgi5g1mC4TVYvsEWopqZtzaHzDKLbyCPM8zAUj5sbcg8ZNQT/AA6Waw022bVGVrGzubZHWAcvLcQTo+C3RWtwCv8AEG6jvla745muJNTk0XW9MXS7e6toxdLcQoXR4ZGZYpZMxF9yr97jAYcHFdDqXiG5X4d6brFtJLA1ytn51zcwqrW8crxrJK6ZKgqrM3dR1OVBoAi8QeCLrxJ5b65qsLypZ3FqDa2ZiUGSW2lVtrSP91rYZBJ3b+2OdnwloJ0K3ukf+zvMnkEjGytGt1OFC/MGkck8dc9MDHHPB2s114m8WeHIbrUFvdNtp76SCfyo3jvliNvslIA27gXkQOoHIJXGaX4lLOviXW7/AO0bl0vQFubeF0BCSO8yllb7yE7VyVIJAxnFAHrNFeKyJdWfiddXl12Syjm8Uz2lxcMkahIFtJ/LjdyOU3iNQrHG4qQN2DW34HvtRtNWs4GvWmsdQ1XXIzbOi4i8u9mKsrY3Z+8OTjBGAMZIB6fRXnnirX9Xs9f1P7JeiK0046YRbiFSJvtFw0cgdiCQNo424wfUcVhyeNtfW516VrzToZbSPUf+JbNKnnRCFXMLrFtDnIRWJZirB8rgYoA9forzXVNd8SaMbC0lu4b66123WGwmS02LBdlxuyoJyoicyYJ6QPzzR4V8UazqPjN7S9vLCJPtN1BLpsk6CeJI2YROkYUPkhVYszFSHyuOBQB6VRRRQAUUUUAFU9Zvv7M0m8vvJef7NE0pjQgMwUZIBPHQVcqjr1lLqWi31lbzpBLcwvCJXjMgTcMZ2hlz19RQBjjxro8NnZTanObGW5t47owyKXMMTnCvIygqq5GCxIA7mpx4v0Q24m+1vzcfZBH9nl81pvLMoQR7d5JQbhgcjkZzWLceBJbrS7u1uNUQy3OjRaQZEtSoHls58zaXPXf93PbrzxH4g8K6qfEtjqei3EHmyayL6V54N6WyLp01vkqJFL5YqOCCN/QgGgDoH8WaKsNlN9rZra8VHinWCRogGbau+QLtTLcfMRzxVHTNf8O6QkWnpPFZPcXl0kMLyGR55VmxKwOSSd8gJzyN3OMHHPX/AMLmureO3/taGSLy03farIzGOUTPM8sP7wLEXZyDwxwAAeK39L8GrZa4uoPemVQupKYhFtyLueGX727jb5W3pzuzxjBAL0XjDQZYLiZNQXyoVWQsY3AkVm2q0eR+9UthQU3AkgDJIp/hvxHb65Y394kb21vaXMtuzTgxnCYyzKwBXr0I4xXJ6d8MhYWENtBe2CyWgg+yXS6eRMDDKkiec3mYkB8tQwUJnkjBxjqdA0GbTdO1OC6u4bqe/uJbl3FvsRTIAMbCzZAx3PNACR+MNEkslukuZzG7qka/ZJvMmJUsPLTZucFQWyoIwCegNLL4x0CKS3Q6lGxnjhmQxqzqI5WKRuzAEKpZSu5iBniuTT4YMFid9TtmkgnEtvbfZJDZRL5ZRlELTFhnIPyuoBVcDru0T4ABtNRhW8t4BeWFpZbLa08uOLyJ5pdyrvPDefjGeNucnPAB0CeKNJknvIoriWVrTf5pjtpXXKMEdVYLh2VjtKqSQeCM1TbxvowvdLtkkuXk1CWWCPFu4MUkYBZZFIDIfmHBHfPTmsW/+H11c3+p3FtrSWEd2WbybO3kjSRmmSXM6+dtkJCFGKiNmEj5PNP0TwDNo93b3Vnf2MU0WoS3hjh0/wAuDZJEkbxqgkyp+QENuPJOQaANqHxlozR2pnulhkuAGC4LhFLlFZ2XKoGZSAWIBIIHIq3a+JtIu9VOm294Huw8ke0IwUvGfnQPjaWHUqDnHOMVysPw6lgspbKHV0FpeWyWt8rWpLSoksjjy23jyyRKykkN0BABznYsvCP2W+sLn7bu+y6neajt8rG7zxINmd3G3zOvfHQZoA1NT8RaVpl/FZ312sVw4VtuxmCKzFVZ2AIQMwIBYgEggc0N4j0dbeKd9Rt0hkaZFd22jMO7zck9Nmxs56YrJ8R+EZdW1C/lh1BLe01K2htb+FoC7OkbOR5b7xsJEjAkhuxAByTTvfh3aXt/4jlub2b7Lq1vLBFbogX7IZgondDzkuY42wRgEN13GgDXfxp4fis2urjUUtollWAi5jeF97KWUbHAb5gCV4+btmrup69p2mW9tNdzuBc/6lIoXlkk+XccIgLEADJOOB1xXN6Z4Fa1uLKeW401Jba8ju2ay09oPNCRSptbMrn/AJakg9BjGOc1q+NvDj+I7KCGGe1t5ImZlmmt3keMlcbo2SSNkb3DdOMUASyeK9LhkuFmlYeVMkKCNDK8zPEJQFRAWPynOMdAT05qno3jnSL/AEvSbq4lNrLqEEU4iKs4iEhwnmOF2puOQC2MkYHNUovA9za6smqWmslr+OZJFku7fzQ4FskDhwHUszbA24EYPYjrmWHwujsRZ7byxujHa29vP9tsDLuMWcPHiRdhIPQ7xkA465AO41rXNP0VYjqM5jMu7YiRtIzBRljtUE7QOScYA6kVl2viyC+8XnRLCNZo47WO6lut7bSsgYpswpVuFySWX7wxu5Asa/ot3e6pY6npV/FZX9rDPbBprczo0cpjLDaHXndFGQc9iMHNQ+E/CkPhuZvstw8luLCz0+ON1+ZVt1dQS2eSQ/oOnfNAFa28b2s2taxaG2nFtpswtWljhmmlkm2qxCxpGcqA3XOeDxjBOiPFeis9ksV6JjdxrNF5MbyYjY7VdyoOxScjLYGQR1BrH1TwTLd/azFqMW241Q6i8FzamWCRTAsXlSRh13gFQ45AyBkHFReFvBF54Ya3/srVrYIbeK2uVksch1jkkdTHiQeWcSsOdw4BwOcgHSaV4h0vVbuS2sLoSzIpcDYyiRQ20tGxAEig8FlJAJHPNatcX4H8DR+FLiLyZLGa3trU2lu4sylyI8oQHl8whuEXOEXJAJ6V2lABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFAFDX9Ug0PQ7/VbsO1vZQPcSCMZYqqknGeO3cgepFZll4mH2CW91e0Fjajy/JlinW5W4LkgKnl5ZnyANoBzuG0tzjbv4pprOaO1mWCdlISRo/MCn1K5GR7ZFefS/DGO4NzcS3OmwXkksEypZab5FoXi8z5pIfMJdmErKW3g4C4xjJAOmufGvh+2tYribUAI5EklGInZlWNtsjMoXKBDw24DaeuKsHxRoy3d3A16qm0VmnlKMIY9qhmBlxsyFOSN2QOornx4BBs7iH7XZ25m0y804raWRijBuHVjIFMjHI28gk7iScjpUF78OTe3V6ZNTW2tbq2lt5EsoGheUvGEDS5kKOVxkHYDkLkkZBAOiPjHQE0+S9n1FLe3jlWB/tCPEyuwyqlWAYbhyOOcjGatWniHSruO2e3vYnFzcG1iAyC0oUsUwRnIVWP0Gawx4Purm/XUNT1OGbUDd21w7QWpijKQB9qBDIxBJkYltx69OKWx8MyL8SNS1yRXjsfITyIi6lXuWULLOAOQfLSGMZ54fjByQBdc8bwaX4ml0j7N5n2e2jurmV3KBFkZ1QL8pUnMZzuZeCMbjxVjR/Gml391d2txJ9juLe4uYMTBgjiBiGIkIC5wNxXOQOTxzTPEHhH+17zWp/t3k/2lZWdnt8rd5fkTTSbvvDO7zsY4xtzk54yrv4dtqSXdlquqLLpMtzfXSQwWxilR7qOaNsyF2B2pPIBhRyQe1AG6fGnh5bKS7m1JIIEdEY3EbxHL52EKwBIbB2kDDYOCataX4k0rVbxrbT7lppACdwhcRkjGVDldpYbhlQcjuBXOab4Ce2eCSa600SxXVtcGS008wtKId+FcmVs58wkEYAycDmtDTfCktl4wn1pb6KOCXzS1rawPEJS5GGl/eFHYY+8EVjnk9cgGrceItKt9XXTJrtVvGZU27GKq7DKoz42qzDopIJ7A0/RNe0vXBOdIvYrtYG2SNFkhWyRjPTOQQfTFY194RludXu5l1BE028v7bU7m2MBMjTwCLZtk3gKp+zxZG09DyM1r+FtI/sLQrXTfP8/yN37zZs3bmLdMn19aAKkHjLQJzKI9RTbGhkLsjqjKHCMVYjDYZlU7ScEgHGas3/iTSbHzxcXeZIbgWjRRRvLJ5xjWUIqKCzHYwbAB457GuXufh152mWVp/am1rTT7uyV/s+ctNPBMrkbuimAArn5g3VcVPD4L1GLUptWGs2p1eTUWvg/2FvIAa0itmjMfm7jxEGDBwQeORnIBow+NNNaa/WYukVvNFDCUR5XuTJAsw2RqpYkKxyADwpPFaEfiTR5YGnj1G3eFUhcurZAWZtsR/wCBHgVzGqfD1tRv5NRuNQt5b9rlLn97ZloCRbrC4aMSAkHbuGGBU4HIzlkvw9uNpitNSsrS2mSzW5hi08hSbedpV8r978gO7BB3njOaAOt03XtO1O9ntbGdpZISwZhE4jJVtrbXI2vtbg7ScHg1HJ4l0mPVm017wC8VihUIxXfs8zy92Nu/Z82zO7HOMVmeHvCkuk+JbzVPt0QguFkH2O1geGJmeQP5kimRlMgwRuVUzvcnORhP+ERl/tsz/wBoJ/Zf9of2p9l8g+Z5+zbjzd+Nmfm27c54zjigCHS/Hdvd/D288YXFo8OnQ2z3qRoWeR4RGHGQVUBiD0BZR/ePare/EKOy0tJbmxX7fJJBEkEcrsm6ZpAu4+XvUBYmJPl+wDda0v8AhEf+LWf8Ib9u/wCYL/ZH2zyv+mHleZs3fjt3e2e9GpeEftviNtV+3bN01nN5XlZ/49zLxnd/F5vpxt754AKFt8SdLnSwdYLsLcXtxYSDyXZo5IfNB2qFJkBMJxgZwQSAcgdS2tacuhDWTeRDSzALn7Tn5PLIzuz6YrA0zwfNZalZzNqMclrZ6neajDELYq+bkzM6M+8g4ackEKOBg561L/wiP/FuP+EU+2/8uX2P7V5Xtjds3fpn8aALg8XaK1o9wt1IQs/2byhbSmYybN+0Rbd5Ow7uF+7z05qK68b+GrUxifWbRS9sL1cMTmA78Scfw/I+T0GOe1ZGvfD9NU1i51MXkIuHu1uo47i2MsQH2dYWRlDqWztDAgqQcdRnOhoXg+DTri9edrWW3u9Nt9OktYbbyogsb3DEhdzcN9oI25ONvU54ANTUPEWl6fNNDc3Q+0RNGrQxxtJIWcMVVUUFmJCMcAE4UnpV7T7221Gyhu7GZZraZdySL0I/oe2O1cHF8M0TQrK1l1P7ZqNrefazd3dtvSbEXkKskYZScRBVyGB3Lu7lT2fh3TBo+j29iBbDyt2fs0Hkx5LFjtQs2OT3J+tAGjRRRQAUUVQ1/V7PQNEvtW1OTyrKyhaeZwMkKoycDufQUAX6K880b4oW0+o2Vrr+j32gJqNlJqFhNdvG6zwxrvfOxiUcIQxU9s81veGfHXhnxRfTWfh/WbW+uoYhO8cROdhwNwyORkgHHQnBoA6Wiuau/HPh221uTR21OFtUQ7GhUMQrkZCM4BVWI7E59qwtU+KuhaV4Mt9avp7f7Zc2Et9bWEExmMwRScB1XhSRjeQBk0AehUVx0HxI8NBNITUdTt7K+1G3gnW2di3lecoKK7AYXOcDdjPatjxN4n0bwxbwza7fx2iTuUiBBZpCBk7VUEnA5OBwOtAGzRXJ6l8RvCOmJA95r1miz2yXkZUl90DMVEg2g/LkHntjmpL34geFbLVf7NutctEvPMiiMeSQrSqGjywGAGDAgk4OaAOoornbfxt4buPEUmhQ6vbNqqO8ZhBP31GWQNjaWUclQcjuKx7r4oeG3s5JdH1G0v3jkjUhpGhjZXlWPcshUqwyw+7nJwM80Ad1RXD6d8U/Ct5c+IYXv/sn9hzGG6e5AVTgqNyYJyNzBQOCTwB0re0bxNpWu6Pc6nol3He20DPHJtBUpIgyUYEAq3I4I7igDaorgdL+KvhuTwroms61eRaS2qW/2lLaRjIyJnBZto4UH+IgD3rWvPHvhq21b+yzq1u+oHZiJNzKC4ygZ1BVSwIIyeQQaAOooriofiV4cg0TSb/WdTsrFtRhM8caymZQgOC+5V4QHjeQBVnWviN4Q0TUjYarr9lbXYMYMbseBIMoSQMAEEcnjkc0AdZRVHTtWsNSnvobG6jnlspvs9yqHmKTAO0++CD+NXqACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKzPE+iWniTw9qOjakHNnfQNBJsOGAIxkH1HUfStOsTxvJDF4O1qS4mEEaWkreZ5hj2kKcHcCMc470AcMnwpvLxrZvEPiZtTk07TLjTNMK2Kwi3E0XlNK+HPmPtwP4Rx0zzWz4V+H/APYHiDQtU/tL7QdL8OR+H/L+z7PN2Ojebnccfc+7g9etc5P4j1Kz8PiXRNTQWuneHbbU1+VZxcSFpAyu7ZJU7MHBBz0Iq5qfifUdK1X+y9R1+O2tRra2MmpXCQxskL6dJcYyQEB8xQASDwQDk9QB178KpLn4gS+JY9c+xrJMZnhs7ZoXmym0JKwk2OvrmPcem6stvgvcwaNaWemeJlt5h4fl8O3csmniQTwOzNuVfMGxgWPdsj86j1L4gaxb2OnSfbY4b6OGKZ47gxwx38bXDRh40KNI5ZE3EKUC7hyelbela1rV34jt9OsbqKCFp9YnmDRea0ot7uBERSzfJkSsM8j0A4wAZN58EopNQS5g1eArLa2dvdxXdgZ1ka3jWNZIwJFCEhF4beAea7Xxv4RuNf1XQ9X0rVRpmr6QZxBNJbC4jKTIEcNGWXJwAQc8Y7g4rhtI8c6/NpLXV1qWmqZY7Y3aiSNpdLZ540lYxBQURFdsiXcVKZJIDV2fwtlE2m606351BP7WuNl0Sp81flwcoAv5ACgDzt/g/q9traaPouomy8OHwqui3GoTQJPJMWuJHlRU3goxV8hsEDOBk1YX4Tanf+J/FNhNd/2f4PupdK2p5SSzXsdrBGAoffmLDxgElcntxUukfEG/uPDun3j62l4L7TLOa6uLcQImmXUjoNjOQVRSGfO8MVK9PmC0o8b6z/ZS332i1mvLbTNaZJ428yOQwXVqkb8BVfKt1CjPUBQSKANyz+FX2fxDFcnW3fR7fU7jWLexNqu9LiZWDbpd3zICzELtB7EmsCz+BUkFteQf8JMY4Z2t2W2tbNo7ZTFOspfyjMw3nbtyu1QCfl5r0jwleX0mp+IdO1C7a8/s+6jjineNUYq8EchBCgDhmbHHTGcnk+dyfEPVRLq8lhfQzRf2VfX0UNw0TzWksE0KKkkaIvl8SnKuzt8vVeQQDW1z4SnVj4ohfXWisdZvY9TjjW1Be2uk2Ybfuw6fJjbtHXrxmui8DeC28M6LqdnLdWk01/I0jy2tmbdclAuSpkcseM5LflWFdeI9TsdbuNH1DW/s1nHqQgfV5Y4kaNWtFmWPlfLBLsQCR0GOWINR2897H+ztHc2N3cQ3sejCVbiInzFIXJYEcg4B57UAZU3wNT+z9Cjg1uJrrT9L/smZrqwMsNzDvZwfLEqlTl2/iIIPIq4/wdc+KbPV4NeWzSAQhksrMwSTLHEIxHIyybGQ45BjLY+Xdilu9UvbPxBq2qaZrYu4IotIVmRI3ju1luJI2JIHHyscbMc4zkDFUp/HfiGLT/Et615p0VzZ2Gozf2dLKhmtnhVzEREFD4wo3FyQ24FcAgEAm/4UxLBotjY2HiQwSrob+H72VrESC4tWcuSil/3b5ZhnLDnpwKu6z8IIb7S/GFhbau1vb69Z6fZR77fzDbLaDAJO8bywx/dx71N4q1nxJo0mroNYikk0vSk1PK2aqk7mWUbGBJITagHB3d93XMWseJ9S0y41DSLnWHjmj1JIIdQlMFsgU2qzFJHaNkX5mO3CFiAB2LUAd5oWmXen3mry3d/HdR3l0Z4ES1SEwJtA2Fl5kOQTubnnHatevOPhlq91ruuzajflPtFz4c0maQR5Cb2lvtxA7ZxWPd+N9atZfEMMN3Hf3kG50+zGKW2tYftSRFm2jzI3SNyzLICCUcg4UigD1+ivL9G1/W9Wn02wi12zaK6urmMX1k8N1J5aQxuoZggj3hmYHC4244BOaztF8e6vd3Hh+4ubiKeTUtOtriPTrFoSxkktfNbzY2/egFujoSoGMjqaAPYaK88+F/iPVNcmkOpahp90r2sczwxTIZraUn5kaNVBRewV8uCCCT2o3Hi/VI9RuRHfxPdrc6hDNpXlpmzghjmaG4P8fzmOHJJKnzwABjkA9Rori/Aurand6tdWep3n2sHSrDUlYxKmx5zcK6DaB8g8lSM5PJyTxXFXHiC/0Y6pNYyKJYovENyhkywDx3tsEyucEAOf6Ec5APaaK81k1nXbDWbuKXV2uoLLWbKw2Pbxr50dwsRbeVUcqZDt246fNu61zPhzxNqNp4fjg0jXrGcizupLgXTRhNOdblFTc4HylleQASZGVB4VWFAHuFFcb4c8Sm58AX2syPf3X2Rbli/lxSSy+Vu+55X7uTpgFcA9MA5rkdH8Za1ezS2MOr2twr3tjFHewyQ3LLHOJd67kRI9w8vj5WwTyWoA9gorwvxl4p1K78DeI7LUtYFiItM1eOKfZGj6jJBPcQBORgHZEjMEAOZARgDFeh/E65uLPTNInt9Uk0qJdUgFxdKQFWI7gd5PG3JXrx0oA7GivNG8TavayXWpXmqWi6PBra6cwaBUWKHcB5jyFsckgZ4HIqK38UavrUVgtjqaW0dzJrRFxBCjlktboxw7dwIxtxk4OfY8gA9QorxnQPFmoy+LraW4eOwsNUi06W6vXXdGJHt9y26jPyF2J+duOAoyzDHs1ABRRRQAUVk+LkMnhfVo11A6Yz2siC9AP+jkqRv4IPHXgg+4615dZeJY9Jsr0adNpNpH9o0+KbVbC/a7stkszIx/efLHKFyx+9wyFieBQB7PRXjl94w1aC2e8guo7owaZrMlreso23Kw3FosUpVSEbh2GQMHGVwGxWte+ItT0+/u9Mv9aFvZw6qlrNq8sUSNBE1n5wByvlrmTCBmUjDAcsQaAPTaK8T1HXNTvrbVpdT1Z7dbnwvO8FrgIl4yG5HmxqeQxQRyHbyARnitS78TajoyXGm3erScix8m9cQQLAZo5mZZJGRkSP8Ac4DFWbLheSRQB6xRXidp4vvGih1i/uSly+lm2a4tmTYrC/MIlLOuxVwAS5XABJ29BWho3inXtXjtbNdWgjbOpBry1WOfzRAYjGQxQIciTkhACOgHWgD1yivIx4n1iS0smvLpZ/tseg34UIIxCbm/SORF24JTbjG4k9ckg4rqPAGuSayXlvdail1FldrjSFWNWsWD42kAbxgcEuTuPIwOKAO0oryeHWdZh1a90+18QL9suPEb2nk3MSzNa27RSSKVTIIBCjaSccZweQWaj431a08XLaWFwt8RcXNk+nTPEszPFZzTK6RKm9VZ4hhmc5D8LyCAD1uivJTrstxeeE7iPxus9vNdbb14xCkcbtbSsInAGACy4VHywPcnFetUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAVUvNPtb25sJ7mLfLYzG4t23EbJDG8ZPB5+SRxg5HOeoBq3RQAUUUUAFFFFAFTSdPtdI0qy03T4vJsrOFLeCPcW2RooVRkkk4AHJJNW6KKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKKKKACiiigAooooAKq6jp9rqUcMd7F5iQzR3CDcRiRGDKeD2IBx0q1RQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAFFFFABRRRQAUUUUAf/9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from Kistler, JP, et al, Cerebrovascular Diseases, Harrison's Principles of Internal Medicine, 13th ed. McGraw-Hill, New York 1994. Copyright 1994 McGraw-Hill Companies, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5465=[""].join("\n");
var outline_f5_21_5465=null;
var title_f5_21_5466="Actinic cheilitis";
var content_f5_21_5466=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F68057%7EDERM%2F67012%7EDERM%2F79589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F68057%7EDERM%2F67012%7EDERM%2F79589&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Actinic cheilitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Erythema and scale are present on the lower lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Actinic cheilitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 327px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Scale is present on the lower lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Actinic cheilitis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 307px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A focal area of scale is present on the patient's right lower lip.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5466=[""].join("\n");
var outline_f5_21_5466=null;
var title_f5_21_5467="Maternal mortality";
var content_f5_21_5467=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F63961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F63961&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Estimated pregnancy related maternal mortality",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Type of pregnancy",
"       </td>",
"       <td class=\"subtitle1\">",
"        Death rate",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Legal pregnancy termination",
"       </td>",
"       <td>",
"        0.567 per 100,000 terminations",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Miscarriage",
"       </td>",
"       <td>",
"        1.19 per 100,000 miscarriages",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Live birth",
"       </td>",
"       <td>",
"        7.06 per 100,000 live births",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Ectopic pregnancy",
"       </td>",
"       <td>",
"        31.9 per 100,000 ectopic pregnancies",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Estimates based on data from over 57 million pregnancies in the United States from 1991 to 1999.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Grimes, D. Am J Obstet Gynecol 2006; 194:92.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5467=[""].join("\n");
var outline_f5_21_5467=null;
var title_f5_21_5468="Prev PA cath infection";
var content_f5_21_5468=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F75277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F75277&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=8\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Prevention of infection with central (pulmonary) arterial catheters",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement and relocation of catheter",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not routinely replace pulmonary artery catheters.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of catheter-site dressing",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace dressing when the catheter is removed or replaced, or when the",
"dressing becomes damp, loosened, or soiled. Replace dressings more",
"frequently in diaphoretic patients.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        There is no need to remove a gauze or opaque dressing if the patient has no clinical signs of infection.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Replacement of administration sets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace administration sets, including secondary sets and add-on",
"devices, no more frequently than at 72-hour intervals, unless",
"clinically indicated.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace tubing used to administer blood, blood products, or lipid emulsions within 24 hours of initiating the infusion.",
"        <strong>",
"         No recommendation*",
"        </strong>",
"        for replacement of tubing used for intermittent infusions.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Replace tubing used to administer propofol infusions every 6 or 12 hours, depending on its use.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Hang time for parenteral fluids",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Complete infusion of lipids or lipid-containing parenteral nutrition fluids (eg, 3-in-1 solutions) given alone, complete the infusion within 12 hours of hanging the emulsion.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"1\">",
"        Complete infusion of blood or blood products within four hours of hanging the blood.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         No recommendation*",
"        </strong>",
"        nonlipid-containing parenteral nutrition fluids.",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * No recommendation is made when there is insufficient data in the literature.",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5468=[""].join("\n");
var outline_f5_21_5468=null;
var title_f5_21_5469="Hip examination";
var content_f5_21_5469=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F69960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F69960&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=7\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Detailed examination of the hip",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Examination",
"signs",
"       </td>",
"       <td class=\"subtitle1\">",
"        Diagnosis",
"       </td>",
"       <td class=\"subtitle1\">",
"        Confirmation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness mid or superior trochanter**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        #1",
"Trochanteric bursitis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Local",
"anesthetic block",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Associations:",
"stiff back, short",
"leg, ankle or knee pathology, stroke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Normal",
"range of motion of the hip",
"with minimal end point stiffness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Stiffness",
"and mild pain with internal",
"or external rotation or both**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Osteoarthritis of",
"the hip",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Standing AP pelvis x-ray",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness",
"over the anterior hip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal",
"Patrick's maneuver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Hypesthesia",
"or paresthesias over the",
"anterolateral thigh**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Meralgia paresthetica",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        &nbsp;",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No",
"evidence of lumbar radiculopathy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        No",
"evidence",
"of hip disease",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute",
"loss and severe pain with internal or external",
"rotation or both**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Avascular necrosis of the hip;",
"acute arthritis;",
"septic arthritis",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        MRI; AP pelvis x-ray; or",
"aspiration of the hip by fluoroscopy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Limping",
"with an antalgic gait",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness",
"over the",
"anterior hip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal",
"Patrick's maneuver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Acute",
"loss and severe pain",
"with internal or external rotation or both following an injury**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        Occult",
"hip fracture",
"       </td>",
"       <td colspan=\"1\" rowspan=\"4\">",
"        MRI; AP pelvis x-ray",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Severe",
"antalgic gait or refusal to bear weight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Tenderness",
"over the anterior",
"hip",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal",
"Patrick's maneuver",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Diminished",
"dorsalis pedis and posterior",
"tibial pulses**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Vascular insufficiency",
"       </td>",
"       <td colspan=\"1\" rowspan=\"2\">",
"        Doppler",
"study",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Delayed",
"capillary fill times",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Straight",
"leg maneuver",
"reproduces radicular pain**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Lumbar",
"radiculopathy",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        CT or MRI demonstrating nerve",
"compression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Painful",
"and limited flexion and lateral",
"bending",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Abnormal",
"lower extremity neurologic examination",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pain",
"aggravated",
"by torque applied to the femur**",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Primary or",
"secondary involvement of the femur",
"       </td>",
"       <td colspan=\"1\" rowspan=\"3\">",
"        Full x-ray of",
"the femur; bone",
"scan",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Localized",
"bony tenderness",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Positive",
"Anvil sign",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     ** is used to identify the hallmark sign; that is, the sign that has the greatest specificity for the diagnosis listed.",
"     <br>",
"      #1 refers to the most common condition affecting the hip.",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5469=[""].join("\n");
var outline_f5_21_5469=null;
var title_f5_21_5470="Dyspnea in asthmatics";
var content_f5_21_5470=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F62712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F62712&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 575px\">",
"   <div class=\"ttl\">",
"    Perception of dyspnea in asthmatics",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 555px; height: 279px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Perception of dyspnea (Borg Score) (mean &plusmn;SE) during breathing at six levels of resistance in 12 normal subjects, 11 patients with asthma but no near fatal attacks, and 11 patients with near fatal asthma.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Redrawn from: Kikuchi Y, Okabe S, Tamura G, et al, N Engl J Med 1994; 330:1329.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5470=[""].join("\n");
var outline_f5_21_5470=null;
var title_f5_21_5471="Compensated cirrhosis";
var content_f5_21_5471=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F80443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F80443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pathogenic mechanisms of compensated cirrhosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 427px; height: 466px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_21_5471=[""].join("\n");
var outline_f5_21_5471=null;
        